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2 
SUMMARY 
 
This work describes a preliminary study to evaluate the use of Optical Project 
Tomography in the diagnosis of colorectal polyps. Colonic polypoid cancers are the 
earliest detectable form of colorectal cancer and can potentially be cured if completely 
excised. The diagnosis using conventional 2D histopathology can be difficult due to 
epithelial displacement and 3D imaging could improve this. Optical Projection 
Tomography is an in vitro 2D and 3D imaging technique for small biological 
specimens, which produces 2D virtual sections in three orthogonal planes as well as 3D 
rendered images. 
 
Important diagnostic features of colorectal polyps such as dysplasia and villous 
morphology have been studied on OPT. Differentiating between high and low grade 
dysplasia was challenging due the resolution of the images but a better correlation with 
H&E sections was found when diagnosing cancer polyps. The 3D properties of OPT 
enable the surface morphology to be seen in far greater detail than we have seen before 
and this, understandably, shows a poor association with the 2D classification method of 
tubular, tubulovillous and villous adenomas which we used in this study. The 3D 
endoscopic Pit Pattern Classification was demonstrated well on OPT and highlighted 
that pit patterns frequently co-exist although the clinical relevance of this needs to be 
explored further. 
 
Novel findings include the detection of specific vasculature patterns in benign and 
cancer polyps which may help us understand why some polyps bleed and some do not 
leading to the growth of interval colorectal cancers. A multispectral analysis of images 
has further explored the potential of OPT showing enhanced images of polyps when 
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different ultraviolet light filters are used. Inter-observer variation exists when 
diagnosing colorectal polyps on H&E and we have demonstrated that this is even more 
marked when using OPT.  
 
This is the first comprehensive study of OPT using human tissue and has brought with it 
many challenges for this reason. OPT has several limitations that prevent it from being 
marketed commercially as an independent diagnostic tool although it has potential as an 
adjunct to current histopathological techniques and it requires further validation.  
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ABBREVIATIONS 
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CHAPTER 1: COLORECTAL POLYP CANCERS: A REVIEW 
 
1.1. BACKGROUND 
Colorectal Cancer (CRC) is the third most commonly diagnosed cancer (41,142 cases) 
accounting for 13% of all cancers and the second most common cause of cancer death 
(16,013 deaths) in the UK [1]. Worldwide it is the fourth largest contributor to cancer 
mortality with 610,000 deaths per annum [2]. Screening programmes have played a 
major role in keeping mortality rates low and fairly steady over the last decade. Since 
the UK NHS Bowel Cancer Screening Programme was introduced we have seen a 
change in the epidemiology of the disease. Screening with faecal occult blood testing 
(FOBT) and colonoscopy has been shown to reduce mortality by 15-21% [3, 4] as well 
as the overall incidence of CRC [5]. More recently a large randomized control trial of 
170,000 patients has shown that the use of once only flexible sigmoidoscopy as a 
screening tool potentially reduces incidence by 23% and mortality by 31% [6]. As a 
result of screening, CRC is being detected in its early stages presenting patients with the 
best opportunity of cure.  
 
The adenomatous polyp has long been implicated in the development of CRC and is 
well documented in the adenoma-carcinoma sequence [7]. This widely accepted concept 
describes the gradual progression from normal colonic epithelium through dysplasia to 
established carcinoma. This occurs as a result of complex genetic mutations, which 
activate oncogenes and inactivate tumour suppressor genes rendering normal epithelium 
at risk of dysplastic change. It has been suggested that the majority of CRCs are derived 
through this pathway [8, 9]. Familial adenomatous polyposis (FAP) is an autosomal 
dominant condition caused by adenomatous polyposis coli (APC) gene mutations and is 
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good evidence for the adenoma-carcinoma sequence. FAP is characterized by the 
development of tens to thousands of colonic polyps [10] and affected patients are at a 
100% risk of developing CRC if left untreated [11]. The peak age at diagnosis of FAP 
with and without cancer are 39 and 27 years respectively suggesting a delay of about a 
decade before cancer develops [7]. This relatively short progression period, if true in 
sporadic adenomas, makes CRC an ideal target for a screening programme.  
 
An adenoma, by definition, must have an area of dysplastic change and occurs in 
several architectural subtypes described as villous, tubulovillous or tubular according to 
the WHO classification [12]. Not all polyps are adenomatous; other types include 
inflammatory, hyperplastic, metaplastic and hamartomatous. In more recent years a 
novel metaplastic grouping including hyperplastic polyps and distinctive serrated 
adenomas, so called because of the saw-tooth pattern of crypts in the pre-cursor polyp 
has been identified [13]. Up to 30% of colorectal carcinomas are thought to be derived 
through the serrated pathway from hyperplastic polyps with aberrant crypt foci [14, 15]. 
The reclassification of hyperplastic polyps has identified the sessile serrated polyp 
(SSP) to have high malignant potential and as an independent predictor of advanced 
neoplasia [16]. This polyp subtype is particularly prevalent in the proximal colon (63%) 
and frequently co-exists with other hyperplastic polyps inferring that all hyperplastic 
polyps should be removed at colonoscopy or biopsied [17]. 
 
A colonic polypoid cancer is the earliest detectable form of colorectal cancer where 
carcinoma, invades through the muscularis mucosa and into the submucosa (pT1) [18]. 
The cancer must be clearly identified and confined within the excised polyp. The 
natural history of polypoid cancers is variable and direct observations are difficult to 
accrue, as it is not feasible to leave a neoplastic polyp untreated. An accurate diagnosis 
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of this potentially malignant pre-cursor is paramount in identifying high-risk individuals 
for treatment. This review outlines the key clinic-pathological features of Colonic 
Polypoid Cancers derived from adenomatous precursors and the basis upon which this 
research has been developed. 
 
1.2. EPIDEMIOLOGY 
Epidemiological studies indicate that the incidence of adenomatous polyps varies 
greatly between and within populations with a higher prevalence in developed countries 
affecting men more than women[19]. Extrapolation of data collected from autopsy and 
colonoscopy studies have shown that the incidence of adenomatous polyps is age 
dependent affecting those in their sixth decade most (3.3% pa) [20]. In Western 
countries colorectal polyps have been identified in up to 30% of autopsies in patients 
>60 years [21]. Colonic polyps are not commonly seen in patients younger than 40 
years and if detected should prompt genetic interrogation for hereditary diseases such as 
FAP or rarer conditions such as Gardener’s and Turcot’s Syndrome [22]. 
 
The incidence of colonic polypoid cancers in endoscopic specimens has varied greatly 
in the pre-screening era from 2.0 to 9.3% [23-27]. In the UK screening population 
polypoid cancers comprise 9.8 to 16.6% of all detected CRCs [28, 29] and account for 
approximately 2.0% of all polyps detected at colonoscopy [29]. There has been a 
progressive increase in the number of new cases of polypoid cancers over the last 10 
years reflecting the growing number of polypectomies that have occurred as a direct 
result of screening [30]. Some pathology departments in the UK have reported an 
increase in their workload by up to 28% as a result [31]. Worldwide, polypoid cancers 
are thought to account for 10% of all diagnosed CRCs [32] (Fig 1-1). 
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Figure 1-1 H&E Section Of A Polyp Cancer  
Islands of cancer cells can be seen in the stalk 
 
Polyp cancers are defined by the TNM classification (7th Edition) as T1 tumours [33]. 
Tis or carcinoma in situ refers to intra-mucosal or intraepithelial lesions in which 
tumour cells are confined to the epithelial layer and although may invade the lamina 
propria, they do not cross the muscularis mucosa. The lamina propria has an abundant 
supply of mononuclear cells but it does not contain sizeable lymphatic vessels and 
hence Tis tumours have no metastatic potential and behave as benign lesions. However, 
in T1 lesions the tumour breaches the muscularis mucosa spreading into the submucosal 
layer carrying a risk of metastatic spread [24, 25, 34]. In the UK, using the terminology 
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‘carcinoma in situ’ (Tis) or ‘intramucosal cancer’ is discouraged to eliminate confusion 
and it is recommended they be described as high-grade dysplastic adenomas. 
 
The qualitative nature of histopathological analysis relies upon experience to give an 
accurate diagnosis and just as defining dysplasia is difficult, the polypoid cancer is no 
exception. There is much discrepancy in the literature regarding the incidence of 
polypoid cancers around the world and whether this is a greater reflection of the 
population characteristics or the diagnostic criteria it is unclear. 
 
1.3. ENDOSCOPIC AND PATHOLOGICAL CLASSIFICATIONS 
1.3.1. Paris Classification 
There are multiple classification techniques for colorectal polyps currently in use. The 
Paris Classification allows endoscopic categorisation of superficial neoplastic lesions, 
such as adenomas, according to their appearance. Although it is not specific to colonic 
lesions, it does carry significance in predicting outcome when applied to colorectal 
polyps. Gastrointestinal neoplastic lesions are categorised from Type 0 to Type IV. 
Superficial mucosal polyps are Type 0 with three further subtypes according to their 
appearance (Table 1-1): II and III sub-types are flat lesions which are ten times more 
likely to contain cancer than protruding type I lesions [35]. 
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Endoscopic 
Appearance 
Paris 
Classification Morphology Description 
% 
Malignant 
lesions 
Protruded 
Lesions 
0-Ip 
 
Pedunculated 
2.4% 0-Ips 
 
Subpedunculated 
0-Is  Sessile 
Flat 
Elevated 
Lesions 
0-IIa  
Flat elevation of 
mucosa 
1.3% 
0-IIa/c 
 Flat elevation 
with central 
depression 
Flat lesions 
0-IIIb 
 Flat mucosal 
change 
35.9% 0-IIIc 
 Mucosal 
depression 
0-IIIc/a  
Mucosal 
depression with 
raised edge 
Table 1-1 Type 0 Subtype Paris Classification [36]. 
 
1.3.2. Vienna Classification 
The Vienna Classification was introduced in 2000 in an attempt to minimise pathologist 
inter-observer variation when diagnosing gastrointestinal lesions. It simplifies 
neoplastic gastrointestinal biopsies according to specific cytological, architectural and 
invasive criteria and it was shown to improve concurrent opinions however it is not as 
widely used as other methods [37]. 
 
1.3.3. Haggitt Classification 
The Haggitt classification is the best-recognised histological classification method 
specifically for polypoid cancers. It was introduced to denote the depth of invasion of 
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cancer in pedunculated polyps and classifies invasive cancer from level 1 (submucosal 
invasion limited to the head of the polyp) to level 4 (invasion beyond the stalk but not 
involving the muscularis propria) (Fig 1-2). The detection of level 4 lesions should 
prompt surgical intervention [38].  
 
Figure 1-2 The Haggitt Classification. 
0: Limited to the mucosa without invasion of submucosal. 1: Invasion of submucosa but limited to the 
head of the polyp. 2: Invasion extending into the neck of the polyp. 3: Invasion into any part of the stalk. 
4: Invasion beyond the stalk but above the muscularis propria [39]. 
 
1.3.4. Kikuchi Classification 
Kikuchi described this histological classification method in a series of 182 polyps in 
1995. He found that the depth of invasion through the muscularis mucosa up to the 
muscularis propria was a significant risk factor for local recurrence and lymph node 
metastases (<0.0001). He defined three subgroups of depth of invasion: slight 
submucosal invasion from the muscularis mucosa to 200-300 µm (sm1), intermediate 
invasion (sm2) and invasion up to but not involving the muscularis propria (sm3) [40]. 
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1.3.5. Other recognised methods 
A further endoscopic technique recently validated by Hewett et al uses very simple 
methods to decipher between adenomas and hyperplastic polyps under narrow band 
imaging (NBI). Using the criteria of polyp colour, vessels and surface pattern the 
technique achieves 94.9% to 100% specificity in the hands of individuals not 
experienced in colonoscopy or NBI analysis [41]. However, it has become possible to 
semi-automate the analysis of the digital images acquired through NBI using a 
computer-based algorithm. This method has been shown to be as good as an expert 
endoscopist (93.1% versus 92.7% accuracy) but far superior to the non-expert (86.8%) 
[42]. 
 
Despite the diverse methods for classification there remains a lack of consistency in the 
terminology used amongst clinicians and pathologists around the world. A colonic 
polyp is a protrusion into the bowel lumen from a flat surface. It may be a flat raised 
lesion known as a sessile polyp or may be on a stalk and hence defined as pedunculated. 
It is worth remembering that not all polyps are adenomas and not all adenomas are 
polyps. Identifying the suspicious sessile adenomatous lesion with a colonoscope poses 
a substantial challenge for even the experienced endoscopist. 
 
1.4. CLINICAL DIAGNOSIS 
Colonic polypoid cancers are the least advanced and hence most curable stage of CRC 
so it is not surprising that the majority are picked up in the asymptomatic screening 
population. This is reflected by a marginal increase in incidence to 11% when surgical 
resection specimens are included alongside endoscopic specimens [43]. This is also 
likely to be attributed to the influence of FAP. Polyp cancers have a tendency to 
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ulcerate and bleed so may present acutely with fresh rectal bleeding but more 
commonly with symptoms of iron deficiency anaemia due to chronic bleeding. Rarely, 
polyps may also be the cause of tenesmus, pain, acute bowel obstruction and 
intussusception. 
 
Polypoid cancers are detected primarily through colonoscopy. This is an ideal tool to 
visualise the colon as it has both diagnostic and therapeutic capabilities lending itself to 
a definitive tissue diagnosis. Since colonoscopy began in 1967 [44] techniques for the 
detection and removal of potentially malignant lesions have developed considerably. 
Polypectomy is the most commonly performed endoscopic therapeutic procedure today 
and the single biggest contributor to colonoscopic complications of which haemorrhage 
is the most common [45].  
 
Endoscopic identification of a polypoid cancer is difficult. Webb describes several 
identifiable features that should raise suspicion of underlying malignancy. These 
features, in order of most to least importance, include friability, firmness, dunce cap 
sign (pyramid-shaped polyp), lobulation, irregular contour, depressed ulceration, flat 
lesions with a short immobile stalk and difficulty in raising a submucosal bleb to elevate 
the polyp prior to removal [46]. These criteria are a useful aide to the endoscopist when 
dealing with ambiguous lesions. 
 
Suspicions can be further clarified endoscopically using the Pit Pattern Classification 
(PPC). First described by Kudo et al in 1996, it identifies five patterns pertaining to the 
surface morphology of polyps best seen with magnifying chromoendoscopy, which 
enhances the mucosal architecture [47]. The classification describes the surface pattern 
of polyps as roundish pits (type I), ranging to gyrus-like pits (Type III) or unstructured 
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disarrayed pits (Type V) (Table 1-2). Type V are clinically the most relevant as they are 
strongly linked to malignant lesions with submucosal invasion and should prompt 
surgical rather than endoscopic resection. The original classification has since been 
modified and reported on to include Type VI and VN to describe superficial and 
extensive submucosal invasion respectively [48]. 
 
Pit Pattern Description Diagnostic Relevance 
I Round pits Normal mucosa 
II Asteroid or 
Papillary pits 
Hyperplastic or serrated 
adenoma. 
IIIS Small tubular or 
roundish pits 
Borderline malignant 
(72%) or adenocarcinoma 
(28%). Common in 
depressed lesions. 
IIIL Large tubular or 
roundish pits 
Adenoma (100%). 
Common in protruding 
lesions. 
IV Branch-like or 
gyrus-like pits 
Adenoma (100%). Found 
in almost all the 
tubulovillous adenomas. 
V Non- Structural pits Adenocarcinoma (100%) 
which had invaded 
submucosal or deeper 
layers. 
Table 1-2 Kudo’s Original Pit Pattern Classification [47]. 
 
Historically, hyperplastic polyps have been classified as a non-neoplastic benign type, 
but as discussed, the serrated pathway may contribute to the development of CRC with 
serrated features [49]. Therefore there is a need to improve the in vivo detection of such 
lesions to avoid unnecessary polypectomies. The traditional fibre optic endoscope has 
been adapted using optical image enhancement and magnification producing images 
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with a better resolution and visual field improving the detection of neoplastic lesions. 
Alternative techniques such as narrow-band endoscopy, chromoendoscopy, auto-
fluorescence, spectroscopy and confocal endomicroscopy have broadened our field of 
knowledge and individually targeted specific deficiencies that affect routine 
colonoscopy [50-52].  
 
Despite these developments, colonoscopic miss rates remain high and vary according to 
adenoma size [53, 54]. Tandem endoscopy studies, in which the patients undergo two 
full colonoscopies by different endoscopists, have reported a range of miss-rates from 
2.1% to as high as 26% [55, 56] and other evidence suggests this is three times more 
likely in the right colon [57]. Perhaps in the future these new expensive techniques will 
be available for wider use to reduce this miss rate. However, unless adequate quality 
control of the base line colonoscopy is enforced, for example insisting upon minimum 
withdrawal times and adequate bowel preparation, adenomas and polyp cancers will 
still be missed [58-60]. 
 
Sigmoidoscopy may have a role in improving outcome [6] but there are limitations to 
carrying out polypectomies in the non-sedated patient. If lesions are detected the 
patients are often recalled for a full colonoscopy and endoscopic removal [61]. If this 
were implemented long term, patient compliance to undergo two procedures would be 
questionable and endoscopy units would have an increased workload.  
 
Radiological investigations are not routinely incorporated into the CRC screening 
pathway. Double contrast barium enema X-rays are recommended when full 
colonoscopy is not technically possible but subtle mucosal changes are difficult to 
detect so it is of limited use. One study suggested the barium enema miss rate for polyps 
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≥1cm is as high as 52% [62]. The introduction of CT colonography (CTC) has shown 
promise with a better accuracy than barium enema x-rays but colonoscopy remains the 
superior diagnostic investigation of choice [63, 64]. Patient preference, when fully 
informed of the benefits and risks, for CTC versus colonscopy doesn’t vary greatly at 
42% versus 46% respectively [65]. Flat lesions are the most difficult group of adenomas 
to detect radiologically and contribute considerably to false-negative CTC results [66]. 
 
1.5. PATHOLOGY 
An accurate histopathological diagnosis of a polypoid cancer is key to determining 
optimum clinical management and there are many techniques the endoscopist can enlist 
to help achieve this. It is recommended that suspicious lesions should be tattooed 
endoscopically at the time of excision to help localise the site of disease if surgery is 
required or for further endoscopic evaluation at a later date [67]. More advanced non-
invasive methods such as endomucosal resection (EMR), endosubmucosal dissection 
(ESD) or transanal endoscopic micro-surgery (TEMS) are best suited for superficial 
laterally spreading tumours [68-70]. It is advised that these specimens are mounted on a 
corkboard and orientated to help the pathologist accurately diagnose the margins of 
disease. 
 
However, the histological diagnosis is often still difficult due to features such as 
epithelial displacement (EPD), where surface epithelial cells become misplaced into the 
stalk of the polyp mimicking true invasive carcinoma (Fig 1-3). 
 
 
 
33 
 
Figure 1-3 Benign Polyp With EPD 
H&E Slide of a benign polyp showing areas of EPD (arrow). 
 
This commonly occurs as a result of trauma or local infarction and internal haemorrhage 
following torsion or herniation of the polyp [71].  Characteristics such as lamina propria 
surrounding misplaced cells will help distinguish diagnoses. Similarly haemosiderin 
deposits in macrophages or abundant mucin is also associated with EPD. Features like 
individual cell invasion, known as budding, and stromal fibrosis (desmoplasia) should 
raise the index of suspicion of invasive carcinoma if identified [72]. Over diagnosis of 
EPD as cancer has a confounding effect, subjecting patients to unnecessary treatments 
and generating misleading incidence and prognostic records [73]. 
 
1.5.1. Pedunculated Vs Sessile Polyps 
Macroscopic lesions may be sessile, semi-pedunculated or pedunculated and invasive 
cancer spans all sub-types. The sessile polyp should be treated with caution, as it is 
more likely to contain cancer and yield inadequate resection margins [27, 74]. In 
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addition, the sessile serrated lesion is up to four times more likely to be found with a 
synchronous lesion [14]. Pedunculated polyps are more prevalent in the distal colon and 
sessile polyps are more likely to be found in the ascending colon [30]. The greater 
muscular activity of the bowel wall in the distal colon may provide an explanation for 
this with strong tenacious contractions encouraging long stalks to develop.  
 
1.5.2. Polyp Morphology 
Microscopically polyps are categorised discretely as tubular (87%), tubulovillous (8%) 
or villous (7%) adenomas of which tubular adenomas are the dominant group [39] (Fig 
1-4). Tubulovillous adenomas are defined according to the WHO classification using 
the ‘20% rule’. The polyp must exhibit features of both tubular and villous morphology 
with at least 20% of the minority sub-type [12].  However, it is more accurate to 
describe this surface morphology as a histological spectrum extending from entirely 
tubular to entirely villous lesions rather than discrete sub-types. 
 
Villous polyps dominate the literature, as they are strongly associated with invasive 
cancer [27]. The earliest evidence of this is from a consecutive dataset at St Marks 
Hospital London. Morson identified the benign component of 275 malignant tumours 
was equally divided amongst the three subtypes. However, when accounting for the 
lower incidence of villous polyps it is clear that they have greater association with 
malignancy than tubulovillous and tubular adenomas (40.7%, 22.5% and 4.8% 
respectively) [7, 75]. Of note, villous polyps are more likely to contain cancer but are 
not a proven precursor to it and all subtypes can and do develop into polypoid cancers. 
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Figure 1-4 H&E Polyp Morphology 
H&E of a Tubular (TA) Tubulovollous (TVA) and Villous (VA) Adenoma demonstrating the range of 
villous features attributed to each subtype. 
 
1.5.3. Polyp Size 
Polyp size is significantly associated with invasive cancer [27]. Small polyps (<1cm) 
are less likely to contain cancer compared with large (>2cm) polyps (1.3% and 46-50% 
respectively) [7, 75]. Villous polyps also tend to be larger and their high malignant 
association may be more likely to be a function of their size rather than their villous 
morphology. 
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1.5.4. Dysplasia 
Adenomatous polyps are described according to the extent of dysplastic change that 
occurs within the epithelial layer of the polyp; high grade or low grade dysplasia. It is 
judged according to nuclear changes, pleomorphism, loss of polarity and stratification. 
High grade dysplasia is usually associated with poorly differentiated tumours and 
reduced mucin production and is strongly linked with invasive carcinoma. Over a third 
of high grade dysplastic lesions contain cancer and this association is stronger in smaller 
polyps [7]. 
 
1.5.5. Prognostic Features in the Malignant Component of Polyp Cancer 
There are many histological features of colorectal polyp cancers that have prognostic 
significance. The three most important characteristics associated with a poor outcome 
are a poorly differentiated tumour, the presence of lymphovascular invasion (LVI) and a 
positive resection margin. 
 
1.5.5.1. Tumour Grade 
CRC is graded for differentiation according to gland and tubule formation and 
cytological features. Grade I is a well differentiated tumour with a better outcome than 
Grade III which accounts for 5-10% cases and is poorly differentiated [72]. Grade III 
tumours carry a 36-38% risk of residual lesion or recurrence so should be treated with 
vigilance [76].  
 
1.5.5.2. Lymphatic and Vascular Invasion 
Lymphatic vessels are identified in the muscularis mucosa as a microplexus and once 
breached this may give rise to metastatic spread. Description criteria vary between 
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pathologists [72, 77] and some consider lymphatic invasion as the presence of tumour 
emboli in an endothelial lined channel where the lumen is devoid of red blood cells 
[78]. Immunohistochemistry may help identify lymphatic channels with antibodies such 
as D2-40, which stains lymphatic specific endothelial cells, associated with invading 
tumour [79]. Approximately 12-16% of all polyp cancers have lymphatic invasion and 
the risk of relapse or residual disease in these patients ranges from 17 to 39% [39]. In 
vascular invasion, aggregates of tumour cells are seen within endothelial-lined vessels, 
surrounded by smooth muscles cells and often containing red blood cells. Vascular 
invasion commonly occurs with lymphatic invasion and one study reports a prevalence 
of up to 39%. Although it occurs in parallel with tumour spread, it is an independent 
poor prognostic indicator [80].  
 
1.5.5.3. Resection Margins 
Clear resection margins have been long established as an important factor in 
determining disease recurrence or lymph node metastases in polyp cancers [81-83]. A 
clear margin of ≤1mm is often considered acceptable for ‘complete excision’ [72] 
although much of the literature describes a 2mm margin [34, 43, 84]. This has been 
brought about largely because of the ambiguity that exists in some pathological 
specimens due to their piecemeal excision or diathermy necrosis at the excised edges. 
Therefore, where it is not possible to confidently assess the margins they should be 
considered as high risk for recurrence [84]. 
 
Volk et al described a series of malignant colorectal polyps removed endoscopically and 
reported that 47% of patients with a positive resection margin and 22% with a resection 
margin that is not assessable had an adverse outcome and should be recommended for a 
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colectomy post polypectomy. An adverse outcome in this study involved residual 
disease or lymph nodes metastases following surgical resection, recurrent 
adenocarcinoma on follow up endoscopy or detection of adenocarcinoma in the 5 year 
follow up period [34]. 
 
1.6. INTER-OBSERVER VARIATION 
The histopathological diagnosis plays an important role in the overall clinical 
management of the polyp cancer and therefore it is crucial that intra and inter-observer 
variation is kept to a minimum. Classification systems are designed with this in mind. 
Results from the NHS Bowel Cancer Screening pilot highlighted the issues with inter-
observer variation and prompted the use of guidelines for diagnosing colorectal polyps 
in order to minimise this [85]. However although agreement is good to very good when 
assessing adenomatous change (Kappa, κ0.83), excision margins (κ0.74), high grade 
dysplasia (κ0.61) and invasive malignancy (κ0.84), it is poor when diagnosing villous 
morphology (κ0.18) [86]. 
 
There is a clear divide between Japan and the Western world in their diagnostic criteria 
for polyp cancers. In Japan, changes in nuclear characteristics and glandular structure 
prompt a diagnosis of cancer where as in western countries malignancy is only 
diagnosed with submucosal invasion [37]. Thus many ‘early’ cancers described in 
Japanese studies would be considered as high grade dysplasia in the West.  This could 
account for much of the heterogeneity that exists in the literature. 
 
The differentiation of EPD from invasive cancer is also prone to variation. Agreement 
between specialist pathologists when identifying polyp cancer characteristics such as T 
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stage (κ0.725) and resection margins (κ0.668) is good but when they are compared with 
general or junior pathologists the agreement on these same features is much worse 
(κ0.516 and κ0.555 respectively) [87]. There is, fortunately, better concurrence between 
pathologists when identifying the three ‘curative criteria’ of polyp cancers. It is widely 
agreed that in the presence of an adequate margin of clearance (>1mm if a stalk or 
diathermy burn is identifiable), no lymphovascular invasion and a well differentiated 
tumour the patient is cured of CRC. A fourth criterion has also been recommended 
suggesting that a follow up endoscopy must also show no evidence of recurrence or 
residual tumour at the polyp site [88, 89]. 
 
1.7. MANAGEMENT OF ADENOMAS AND POLYPOID CANCERS 
A multidisciplinary team approach to individualise treatment pathways is essential for 
managing the malignant polyp and there are many clinico-pathological factors that 
should be taken into account. The uncomplicated adenomatous polyp should be 
managed according to recommended guidelines (Figure 1-5) [90]. 
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Figure 1-5: Colonoscopy Surveillance In The Bowel Cancer Screening Programme 
UK Guidelines for Colonoscopy Surveillance in the NHS Bowel Screening Programme after the index 
colonoscopy procedure. (*additional considerations including age, comorbidities, family history and 
accuracy and completion of the endoscopy) [90]. 
 
The treatment of polyp cancers falls into two categories; endoscopic and surgical. 
However, no randomised controlled trials exist comparing endoscopic polypectomy 
with radical surgery, as diagnosis cannot be confirmed in vivo. Current UK guidelines 
suggest if a polyp cancer is well or moderately differentiated with clear margins of 
excision (>1mm) and no evidence of lymphovascular invasion then regular surveillance 
is adequate management [91]. For these lesions, the risk of death from radical surgery 
may be greater than the risk of local recurrence or metastatic lymph nodes [92]. 
 
1.7.1. Endoscopy 
The suspicious looking colorectal polyp poses a significant dilemma for most 
endoscopists. They have a potentially curative treatment at their fingertips but with the 
knowledge of metastatic potential, decision-making is difficult. There is unequivocal 
evidence that an effective polypectomy using conventional techniques reduces the 
incidence of colorectal cancer [5, 82, 84] and is an adequate and safe management 
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strategy [93]. It has a complication rate of 3% and a low mortality rate of <0.1% [94]. 
The use of diathermy, at the time of excision, may also be beneficial in destroying any 
residual cancer that may have been present [89]. This is demonstrated by the absence of 
cancer in surgical resection specimens from patients, following a reportedly ‘incomplete 
excision’ of a polyp cancer as defined by the histopathologist. 
 
What presents more of a challenge to even the most skilled endoscopist are the large 
(>2cm), sessile polyps and laterally spreading tumours. Removing such lesions has been 
possible via EMR, which has been in use for over 10 years [68]. However, this method 
often results in a piecemeal resection, which makes it difficult to establish the extent of 
the disease margins and completeness of excision from a histopathological perspective.  
 
More recently ESD, a technique initially trialled for early gastric cancers in Japan, has 
been used for colonic lesions with promising results [68, 69, 95]. ESD allows en bloc 
resection and hence a more reliable assessment of tumour margins than EMR and it is 
not limited by lesion size. ESD is associated with significantly lower recurrence rates 
than EMR (2% vs 14%) [69] and is more favourable than the morbidity and mortality 
occurring with transabdominal surgery. However the risk of visceral perforation with 
ESD is much greater than EMR or polypectomy and in inexperienced hands puts 
patients at unacceptable risk. A minimum of 30 cases is recommended for trainees to 
become skilled in the technique to provide a satisfactory cure (93%) with miminal 
complications (4%). In Western societies this is difficult to achieve [68]. 
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1.7.2. When to Operate 
Colorectal cancer is age dependent with a median age at diagnosis of 64 and with 
today’s aging population this is only set to rise in the future. Trans-abdominal surgery 
carries a moderate risk even to the fittest of patients so in individuals with multiple co-
morbidities it is not the optimum treatment of choice [96]. Overall mortality is relatively 
low at 0.8% [83] but some studies have suggested it can be as high as 9% in older 
populations >85 years [97]. Less invasive procedures, such as those carried out 
endoscopically carry less morbidity and as techniques improve are beginning to produce 
competitive prognostic results. However surgical resection is still frequently 
recommended for patients who are fit enough and some of the indications for this in a 
polyp cancer are outlined in below (Table 1-3).   
 
INDICATIONS FOR SURGERY 
Recommendations: 
Involved resection margins (<1mm) 
Poorly differentiated tumours 
Lymphovascular Invasion 
Familial Adenomatous Polyposis (FAP) 
Considerations: 
Sessile Polyps 
Dysplastic Associated Lesions/Masses (DALMs) 
(i.e.: Ulcerative Colitis)  
Haggitt Level 4  
Patient choice 
Table 1-3 Surgical Treatment Of A Polyp Cancer 
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1.8. FOLLOW UP 
All patients who have had at least one adenoma removed are recommended for 
surveillance colonoscopy and this usually constitutes about 20% of the screening 
population [90, 98]. A complete cure from a polyp cancer is only possible with an 
adequate margin of resection, no lymphatic or venous invasion and well-differentiated 
lesions. Failure to meet these agreed criteria carries an increased risk of residual 
carcinoma and lymph node metastases [99]. According to UK guidelines, surveillance 
colonoscopy is advised for any equivocal cases, where a colonoscopy, biopsy and tattoo 
of the site of the polyp cancer should be carried out within 3 months of the index 
procedure. Regardless of the outcome, a further colonoscopy is recommended 6 months 
later. In the absence of recurrent disease the patient is then referred back to the routine 
screening programme [98]. 
 
The Polyp Prevention Trial Study showed that despite intensive follow up with 
colonoscopy, there is still an on going risk of colorectal cancer (1.2-1.74 per 1000 
person years of observation). A history of advanced adenoma excision increases this 
risk and close surveillance for this sub-group is advised [100]. Incomplete 
polypectomies may account for up to 27% of CRCs detected post screening [57] 
especially sessile lesions that have a higher incidence of metachronous CRCs and early 
recurrence [101]. Controversially, one study suggests that close surveillance has no 
effect on overall recurrence rates or survival of patients diagnosed with polyp cancers 
[102].  
 
The distance from the muscularis mucosa to the muscularis propria was found to be a 
statistically significant risk factor for developing lymph node (LN) metastasis in early 
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CRCs. And tumours located at the apex of haustral folds have a lesser tendency to 
metastasise [103]. 
 
An interval cancer is the term given to a symptomatic CRC that is detected in the period 
between two screening tests where the first yielded either a negative FOBT or a positive 
FOBT with no cause identified on colonoscopy. The aetiology of such lesions is still 
very much under scrutiny. Whether these are truly ‘new lesions’ or represent those 
missed during initial colonoscopy or are due to incomplete adenoma removal is still 
undetermined. Colonoscopy remains the best technique for evaluating the bowel lumen 
but relies on an adequately trained endoscopist performing the test. Current guidelines 
recommend that screening or surveillance colonoscopy should only be carried out by 
recognised skilled endoscopists [104]. 
 
1.9. CONCLUSION 
The CRC screening programmes have detected an increasing number of early colon 
cancers and created a new era for pathologists, endoscopists and surgeons in the clinical 
management of these lesions. The emphasis should now be placed on the detection of 
the early elusive right sided cancers which are either frequently missed or undergo rapid 
and aggressive growth. The ambiguity that continues to exist in the histopathological 
diagnosis of complex adenomas and polyp cancers could be improved with an 
automated or semi-automated technique and hence provide a more reproducible and 
accurate diagnosis to the multidisciplinary team. In the future we will inevitably see the 
role of the endoscopist in preventing and curing this disease continue to grow. 
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CHAPTER 2: OPTICAL PROJECTION TOMOGRAPHY 
 
2.1. PRINCIPLES OF OPT 
2.1.1. Background 
Optical Projection Tomography (OPT) is a novel three dimensional (3D) imaging 
technique invented by James Sharpe in 2001 to improve the understanding of the 
complex tissues interactions that occur during embryo development [105, 106]. Despite 
the many techniques available to study gene mapping in developmental biology, there 
was a clear deficiency of a 3D imaging method that could analyse how the positions of 
genes and proteins relative to one another can affect the function of a tissue and 
subsequent growth. 
 
Figure 2-1: The Imaging Spectrum And OPT 
Different imaging modalities and how OPT fits into this spectrum 
 
At the time of development, OPT was unique in its field. It allowed scientists to carry 
out 2D virtual sectioning of a specimen whilst avoiding tissue destruction and retaining 
the specimen’s original architecture. OPT bridges the imaging gap that exists between 
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confocal microscopy, which can image small specimens up to 1mm thick, and Magnetic 
Resonance Imaging (MRI) or Computed Tomography (CT) that is capable of 
visualising much larger organs, several centimetres thick. OPT is optimised for 
biological specimens between 1mm and 15mm in size (Figure 2-1). 
 
2.1.2. The OPT Scanner 
The OPT scanner is a table top device approximately 1.2m in length connected to a 
desktop computer that controls the functions of the scanner such as exposure, 
alignment, focus and resolution as well as performing daily calibrations (Figure 2-2).  
 
 
Figure 2-2: OPT Scanner 
Bioptonics OPT Scanner with a hinged cover (A) lifts to expose the ‘working end’ connected to a desktop 
computer. 
 
A 
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Figure 2-3 OPT Scanner Components 
Working end of the OPT Scanner with the rotating magnetic platform (A) that is lowered into a glass 
cuvette containing BABB (B). 
 
The working end of the OPT scanner houses the components where the specimen is 
mounted for image capture. This consists of a rotating platform upon which the 
specimen is attached before it is lowered into a glass cuvette containing Benzyl Alcohol 
Benyl Benzoate (BABB) (Figure 2-3). BABB is used as it has comparable refractive 
properties to that of the glass cuvette and hence minimises any light scattering and 
artefact that may occur. 
 
2.2. HOW DOES OPT WORK? 
The word tomography refers to the imaging of an object from different angles and is 
derived from the greek tomos (cut or section) and graphein (to write) to mean the 
imaging of sections using a penetrating wave. In the case of OPT, ultraviolet (UV) light 
and visible light waves can be used. There are several different types of tomographic 
imaging and OPT utilises two techniques whereby the light rays are either transmitted 
through the specimen (transmission) or emitted from the specimen (emission) and the 
A B 
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beams are captured and a standard back-projection algorithm is used to generate high-
resolution images. 
 
 
Figure 2-4 The OPT Microscopy Setup.  
The specimen is rotated within a cylinder of agarose while held in position. Light transmitted from the 
specimen (blue lines) is focused by the lenses onto the camera-imaging chip or charged-coupled device 
(CCD). The apparatus is adjusted so that light emitted from a section that is perpendicular to the axis of 
rotation (red ellipse) is focused onto a single row of pixels on the CCD (red line) [107]. 
 
In order for these images to be acquired, the object must be optically cleared to 
minimise the diffraction and scattering of light as it passes through the specimen. If the 
specimen is inadequately cleared the scan quality is significantly reduced and therefore 
high quality image acquisition is reliant upon accurate specimen preparation.  
 
The object rotates 360° in aliquots on a mount (Figure 2-4) to produce 400 (0.9° 
fractions) and 800 (0.45° fractions) images for standard and high resolution scans 
respectively. Ordinarily, views obtained through a 180° rotation would be adequate to 
generate an image as those from one direction should be a mirror image of that from the 
other. However in OPT the depth of focus presents a limitation whereby half the image 
 
 
49 
is in focus and half out of focus and this is compensated for in the back projection 
algorithm and with the 360° rotation. The scattering and diffraction of light is also 
adjusted for in this way. 
 
For the purposes of this study, the objects being imaged are colorectal polyps using the 
‘emission’ technique under UV light. Under the influence of UV light, formaldehyde-
fixed pathology specimens exhibit a natural auto-fluorescence as a result of the CH2 
cross-linkage that occurs between soluble proteins and structural proteins when the 
specimens are fixed in formaldehyde and OPT has shown to be a useful imaging 
technique for this unstained tissue [105, 108]. This natural auto-fluorescence is detected 
by the CCD and interpreted through the back projection algorithm to produce a digital 
image of the specimen.  
 
2.3. FUNCTIONS OF OPT 
OPT is an ex-vivo whole-mount technology that utilises a non-destructive technique in 
order to obtain 3D images. Specimens are not sectioned or structurally altered therefore 
further histological analysis with immunohistochemistry (IHC) staining is possible post 
OPT. The 3D OPT images can be virtually sectioned in 3 orthogonal planes (Figure 2-5) 
allowing detailed analysis of the specimen, which can in turn be re-orientated to enable 
these planes to be manipulated further. 
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Figure 2-5 Orthogonal Planes Of A Colorectal Polyp on OPT 
. 
The architecture of tissues can be easily visualised in unstained specimens using the 
natural auto-fluorescent properties described earlier. In addition, fluorescent labels and 
coloured stains can be used to further define cell groups within tissues (e.g.: Islets of 
Langerhans). Using specialised stains, OPT also allows gene and protein expressions to 
be interpreted in the context of 3D giving rise to the potential importance of their 
visuospatial relationship to one another [107].  
 
The digital data generated using this technique can be archived and easily retrieved to 
re-analyse images, sent electronically for further opinions and can be utilised as a 
teaching tool. In a future where digital pathology is becoming increasingly relevant, it is 
important to note that OPT enables an automated or semi-automated analysis of features 
that pathologists may disagree upon. 
 
9.6m
m
 
Sagittal 
(X axis) 
Coronal 
(Y axis) 
Trans Axial 
(Z axis) 
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2.4. USES OF OPT SO FAR 
An understanding of how biological tissues interact and move relative to one another 
has given us an invaluable insight into understanding embryo development and, in turn, 
the intricate genetic processes that exist. Until OPT was developed, serial sectioning of 
specimens was the optimum method for obtaining this information. However, 
reconstructing these images into 3D and interpolating between data points creates a 
significant margin of error in such small biological specimens and is extremely time 
consuming. 
 
2.4.1. Animal Studies 
Much of the early work in OPT, both designing the technology and optimising the 
scanning technique, was done using mouse embryos and OPT has been well 
documented for its studies in developmental biology. It has demonstrated its ability to 
visualise, in detail, the anatomical structures such as neurofilaments, vertebrae and the 
brainstem cortex by labelling specific cells within each tissue type (Fig 2-6) [105, 107]. 
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Figure 2-6 OPT Images Of A Mouse Embryo 
OPT images of a mouse embryo rendered to visualise the iso-surface (A). Anatomical structures can be 
isolated (B) using fluorescent signals from double-antibody staining to identify the neurofilaments in 
green, endoderm (HNF3beta) in blue and the red blood cells in the heart (C). The brainstem cortex of a 
mouse embryo can be visualised in a similar way to demonstrate the evolving cranial nerves (CN) of the 
neural tube (trigeminal (CN V) in yellow; facial (CN VII) in green; glossopharyngeal CN (IX) in red; 
vagus (CN X) and accessory (CN XI) in pink ((D)[105]. 
 
As OPT can visualise absorption and emission tissue profiles it enables 3D gene-
expression mapping through fluorescent labelling. Using these techniques it is possible 
to picture the spatial distribution of certain groups of cells that may be important in 
disease processes. The Islets of Langerhans of a mouse pancreas, through the staining of 
Interleukin-2 (Fig 2-7), can be seen and in diseases processes, such as diabetes, the size, 
A B 
C D 
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shape and distribution of these Islets alter within the pancreas. Using these animal 
models it may be possible to understand how these structural changes influence the 
disease process and can lead to targeted drug treatments or alternative therapies [109, 
110].  
 
Figure 2-7 A Mouse Pancreas 
Images show the iso-surface (A) viewed using OPT and the Islets of Langerhans (B - purple) [109]. 
 
The rabbit foetal heart, using auto fluorescence of unstained formaldehyde fixed tissue 
can also give detailed anatomical information using OPT imaging techniques (Fig 2-8) 
and may show subtle morphological changes that can be linked to underlying 
cardiovascular disease processes. Cardiac tissue re-modelling and function post 
myocardial infarction is multifactorial and infarct load is a crucial determinant of long 
A B 
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term prognosis and a more recent study has shown that OPT is a useful tool to quantify 
this infarct load in mouse embryos in vitro [111]. 
 
 
Figure 2-8 A Rabbit Foetal Heart 
Serial monochrome sections showing the ventricles, inter-ventricular septum, aortic and pulmonary root 
and outflow valves. 
 
2.4.2. Clinical Studies 
Very few clinical studies have been carried out to explore how OPT visualises human 
tissue and whether it is ultimately useful as a diagnostic or research tool.  
 
The identification of micro-metastatic deposits in lymph nodes is paramount in 
determining whether further surgical resection is required and in deciding chemo-
radiotherapy treatment regimens. A comparison study of 24 lymph nodes from patients 
with known breast or colon adenocarcinoma was carried out to see if it was possible to 
identify areas of architectural features of the lymph node and areas of metastatic 
deposits (Fig 2-9 and 2-10) in OPT images and H&E Sections [112]. 
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Figure 2-9 H&E Section Of A Lymph Node 
A large tumour load (A) is seen with the correlating OPT image (B) demonstrating a distinct lack of 
cellular resolution and a ‘glassy’ appearance 
 
Diagnosing lymph nodes using OPT is theoretically possible but the time taken for 
processing specimens is the greatest limitation. The scan of the specimen takes minutes 
to produce but the processing of the tissue to prepare it for scanning can take several 
hours to days depending predominantly on its size. Therefore, using current OPT 
technology it not possible to be used for intra-operative lymph node diagnoses. 
 
A 
B 
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Figure 2-10 Lymphoid Follicles In A Lymph Node 
An axillary lymph node on H&E (A) and an equivalent area on OPT (B) demonstrating lymphoid follicles 
with germinal centres and medullary sinuses. A lymph node with some metastatic deposits on OPT shows 
medullary sinuses and trabeculae (arrows)(C). 3D OPT Images can be rendered to demonstrated features 
that can also be correlated to H&E sections [112]. 
 
A multispectral study of liver biopsies showed that certain features such as hepatic 
sinusoids, vessels, necrosis and stroma relating to a focus of tumour were more clearly 
visible in OPT multispectral images that were falsely coloured to super-impose 
information obtained from different wavelengths. However, the cellular detail that H&E 
provides is not seen on OPT (Fig 2-11) [108]. 
 
A B 
D C 
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Figure 2-11 A Liver Biopsy 
OPT images of a liver biopsy with a focus of tumour at the top (arrow). The tumour is visible on 
monochrome (A) slices but the multispectral (B) images enhance the appearance of hepatic sinusoids, 
vessels, areas of necrosis and stroma [108]. 
 
OPT has also been used to quantify the 3D spread of breast cancer tumour cells in a rat 
collagen culture medium. As the tumour cells are cultured over a 2-3 week period, the 
malignant epithelial cells spread into the collagen in a similar fashion to what would be 
expected in human tissue [113] (Fig 2-12). Leeper et al has shown how tumour load is 
reduced in response to tamoxifen therapy and using OPT was able to quantitatively 
A 
B 
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identify responsive and non-responsive tumours [114]. Potentially, OPT could be used 
to detect changes in the growth pattern of tumour cells in response to drug treatments 
and further individualise cancer therapy regimens by screening a wide range of 
therapeutics rapidly in a single tissue type. 
 
 
Figure 2-12 Breast Cancer 
OPT images of a breast invasive ductal carcinoma tumour core (blue) and the surrounding malignant 
epithelial growth (multi-coloured) into a collagen culture medium [113]. 
 
2.5. COMPARISON TO OTHER IMAGING MODALITIES 
Confocal microscopy is an alternative 3D optical imaging technique that uses a 
confocal microscope to obtain sub-cellular detailed images in a single focal plane at 
high resolution of fluorescently labelled specimens. It has the advantage over OPT that 
it can image live specimens and uses a much higher resolution, however it is more 
expensive and can only image specimens that have been fluorescent-labelled and not 
unstained tissue. The technique is limited by the size of the specimen and is optimised 
for 0 to 100 µm but may image specimens up to 10mm although its resolution 
deteriorates. 
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Optical Coherence Tomography (OCT) works in a similar way to confocal 
microscopy utilising near-infrared light to obtain sub-surface images to a depth of 
500µm. This is largely due to the longer wave-length of the light used which is able to 
penetrate the specimen further to obtain more detail at greater depths. However, it 
remains a more expensive technique than OPT and is limited on the size of specimens it 
can image. Conversely, it is able to visualise images in 4D, factoring in the dynamic 
nature of tissues over time, which OPT cannot do. 
 
Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) are very 
common imaging tools used in the clinical setting. They are designed and optimised to 
image much larger specimens obtaining a resolution down to approximately a 
millimetre. MRI and CT can also image live specimens but remain considerably more 
expensive technique that cannot use stains and fluorophores to enhance and detect 
specific features of the tissue. OPT additionally has a lower contrast in unstained tissue 
making features less easily detectable in comparison to MRI. 
 
However, serial sectioning is the current gold standard for histopathological diagnoses. 
It can identify sub-cellular details of human tissue and use multiple different stains to 
aid diagnoses and improve sensitivity and specificity. OPT scanning, in comparison, is a 
less labour-intensive technique than sectioning with faster image acquisition. It is also 
non-destructive, enabling the original 3D architecture of the specimen to be 
undisturbed. However, the lower resolution of OPT in relation to sectioning and the 
time of specimen preparation remains its greatest challenges. 
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2.6. POTENTIAL DIAGNOSTIC BENEFITS 
Preliminary pilot studies have shown OPT is able to visualise human tissue in 
reasonable detail and is comparable to that of H&E sectioning. The exact nature of the 
potential clinical application of this is yet to be established and it is clear there are many 
limitations that exist when comparing OPT to other imaging modalities. 
 
The NHS Bowel Cancer Screening programme has resulted in a large volume of 
colorectal polyps being removed through colonoscopy. Colorectal polyps are an ideal 
size for OPT imaging (1-15mm) and given the difficulties that exist in making a 
consistent and accurate diagnosis, they are an ideal specimen on which to trial a new 3D 
technology such as OPT. Routine microscopic diagnosis of polyps is normally based on 
up to 3 of the 5µm H&E sections. Most of the polyp is not actually examined 
microscopically. OPT has potential in firstly identifying abnormalities such as cancer 
and High-grade dysplasia which may be missed on routine sections and secondly in 
distinguishing epithelial misplacement from invasive cancer. 
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CHAPTER 3: AIMS, MATERIALS AND METHODS 
 
3.1. AIMS OF THIS RESEARCH 
The NHS Bowel Cancer Screening Programme (BCSP) was rolled out in the UK from 
2000 to 2009 and resulted in an increased prevalence of polyp cancers. These are the 
earliest detectable form of colorectal cancer and if fully excised with clear resection 
margins, no evidence of lymphovascular invasion (LVI) and a well-differentiated 
tumour then these patients will potentially be cured of cancer. However, the inter-
observer variation that exists when diagnosing colorectal polyps is well documented 
[87]. This is largely due to the phenomenon of epithelial displacement that exists as a 
result of the two-dimensional section images. 
 
OPT has several theoretical advantages over H&E as it enables non-destructive virtual 
sectioning of whole polyp specimens and visualises more tissue than would be seen on 
H&E. Standard H&E methods sample only a very thin slice of tissue, ranging from 3-4 
µm, upon which diagnoses are made in two dimensions. OPT, as a three dimensional 
technology, may help distinguish features such as epithelial displacement with better 
clarity and the utility of OPT in diagnosing colorectal polyps was explored in this study. 
 
Primary Objective 
• To evaluate the potential of OPT imaging technology in the pathological 
assessment of colorectal polyps and polyp cancers. 
 
Secondary Objectives: 
• To assess the usefulness of multispectral imaging in OPT 
 
 
62 
• To explore the practicalities of using the Pit Pattern Classification technique for 
OPT rendered images 
• To evaluate, by way of an inter-observer variation study, the ease and 
reproducibility of polyp diagnoses using different imaging modalities, including 
OPT. 
 
3.2. ETHICAL APPROVAL 
Anonymised human tissue, available through the NHS Tayside Tissue Bank, was 
utilized in this study. The authorisation to use this tissue was granted by Tayside Local 
Research Ethics Committee through Tayside Tissue Bank (Appendix I). 
 
3.3. STUDY LOCATION 
A collaborative agreement was set up between NHS Tayside Tissue bank, NHS Tayside 
Pathology Department, The University of Dundee, Medical Research Council 
Technology (MRCT), Edinburgh and The University of Cambridge. 
 
Colorectal polyps were sourced through the NHS Bowel Cancer Screening Programme 
from NHS Tayside Tissue Bank in association with diagnostic information from NHS 
Tayside Pathology Department. Specimens were processed and scanned by a team of 
expert OPT technicians in the laboratory at MRCT, Edinburgh and analysis was carried 
out by me at the University of Dundee. Dr R Keogh from the University of Cambridge 
carried out the statistical analysis. 
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3.4. STUDY DESIGN 
Three distinct phases of this study were used to address the primary objective (Fig 3-1). 
 
 
Figure 3-1 Study Design 
A schematic diagram showing the key elements of each phase. 
 
3.4.1. Phase One (Technique Optimisation and Training) 
OPT has not been used to visualize and diagnose human tissue in this way before. The 
knowledge obtained from experimental studies of lymph nodes and liver biopsies 
provided the basis upon which the technical scanning aspect of this study was built. 
However, further optimisation of this technique was required to improve its accuracy 
specifically for colorectal polyps and this was an essential objective to achieve during 
phase one.  
 
PHASE ONE 
Technique Optimisation 
Training 
Feature Recognition 
Specimen source: Archived Polyps 
PHASE TWO 
OPT Diagnosis: Diagnosing polyps using 
OPT only & blinded to the H&E diagnosis 
Specimen source: Archived Polyps 
PHASE THREE 
Clinical Integration 
Specimen source: Whole Fixed Polyps 
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Colorectal polyps, embedded in paraffin wax were selected from the archive in the NHS 
Tayside Tissue Bank and processed for OPT scanning. Each specimen was scanned at a 
high and low resolution and on three different optical channels to identify which 
channel or channels would be most informative for Phase two. 
 
During phase one each OPT dataset was reviewed alongside its corresponding H&E 
digital slide and gold standard histopathological diagnosis. Any identifiable features and 
characteristics of particular polyp sub types were noted. A minimum of 250 polyps was 
included for this training phase. 
 
3.4.2. Phase Two (OPT Diagnosis) 
Phase two of the study involved large scale OPT scanning of over 600 colorectal polyps 
from the Tayside tissue bank archives. The archived polyps were processed and scanned 
according to the standards laid out following Phase One. All original H&E slides 
corresponding to the selected specimens were re-diagnosed by a single Gastro-Intestinal 
Specialist pathologist, Professor Frank Carey, to minimise time and observer bias. All 
specimens had a minimum of 5 year follow up. 
 
OPT image datasets for each colorectal polyp were reviewed by me and diagnosed 
according to the WHO Bowel Cancer Screening Diagnostic criteria [109], whilst 
blinded to the original gold standard histological diagnosis. 
 
Sample size calculations, based on kappa statistics to measure agreement, were 
performed to identify the appropriate number of polyps that should be included in this 
phase to ensure adequate power to the study (Appendix II). These were based upon the 
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expected number of polyps of each sub-type, which would be obtained from a random 
sample from the tissue bank archive. The single exception to this random selection was 
that in order to ensure that sufficient polyp cancers were included in the study, ‘cherry-
picking’ was required. An independent team of research technicians at MRCT 
reversibly anonymised all specimens before OPT analysis in order to reduce selection 
bias. 
 
3.4.3. Phase three (Clinical Integration) 
The main purpose of phase three was to assess the practicality of using an OPT scanner 
in the diagnostic pipeline within a pathology department. This was trialed at Ninewells 
Hospital, Dundee. Written consent was obtained from patients presenting through the 
NHS BCSP who had colorectal polyps removed during colonoscopy (Appendix III). 
 
The colorectal polyps were fixed in formaldehyde as per hospital protocol and prepared 
for OPT scanning prior to being embedded in wax and sectioned for conventional 
histological diagnosis. The OPT Image datasets were reviewed to identify if features 
previously seen in phases one and two were also reliably identifiable on these fixed 
whole polyps. It was also necessary to evaluate whether modifications in the design of 
the OPT process or scanner would be required prior for future clinical use. 
 
3.5. SPECIMEN SELECTION 
OPT is a non-destructive technology and the study design, to ensure adequate statistical 
power, meant that prospective specimen selection was not possible.  Therefore archived 
specimens were used and quality control measures had to be adhered to ensuring the 
diagnostic information of these specimens was retained. 
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The Colorectal Cancer screening programme began in NHS Tayside in 2000 and all 
colorectal polyps removed from patients since this time period were identified using the 
pathology electronic database (MasterLab). Polyps were then selected chronologically 
from the database by a single observer. The paraffin wax blocks and corresponding 
Haematoxylin and Eosin (H&E) stained slides were removed from the archive and 
further analysed to ensure they were appropriate for OPT scanning and adhered to the 
selection criteria (Fig 3-2). These criteria came about as a result of the constraints to 
ensure quality control but also from experiences encountered during phase one with 
regards to processing and scanning the specimen. 
 
 
Figure 3-2 Inclusion & Exclusion Criteria  
The criteria used to select specimens to ensure they were appropriate for the study and OPT scanning. 
SIZE (Quantitative Assessment) 
Is the Specimen <15mm in the paraffin wax block? Yes – Include 
Is the specimen confirmed as a polyp and not a biopsy wrongly coded? 
Yes – Include 
COLOUR (Subjective Assessment of tissue block) 
Is the Specimen of a reasonable colour (not too dark) that it will clear 
adequately for scanning? Yes - Include 
Is there any evidence of haemosiderin deposits? Yes - Exclude 
FRAGMENTATION (Subjective Assessment) 
Is the Specimen in <3 parts? Yes - Include 
Is the polyp at risk of fragmentation when removed from wax? Yes - 
Exclude 
MISSING DATA 
Is the H&E missing? Yes -Recut Slide 
Is the Paraffin wax block missing? Yes - Exclude 
PREVIOUS RESEARCH USE 
Has the specimen been used for other research studies and physically been 
damaged (e.g: Tissue Micro Array construction)? Yes - Exclude 
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3.6. MATERIALS 
3.6.1. OPT Scanner 
The colorectal polyps were scanned on an OPT Scanner 3001 manufactured by 
SkyScanner, Belgium in 2007. Specimens were scanned following guidelines set out in 
the Bioptonics OPT Scanner 3001 User Manual V1.11.1 [115].  
 
3.6.2. OPT Software 
Each dataset for every polyp specimen scanned was saved on an external Hard Drive at 
MRCT, Edinburgh and backed up off site to ensure data was adequately preserved and 
protected. The size of each dataset from a single filter channel ranged from 45MB to 
100MB depending on the size of the specimen.  Images were viewed using several 
software programmes (Table 3-1) and the final analysis and global diagnosis of each 
polyp was carried out using information obtained from them all. 
 
SOFTWARE INTERFACE PROPERTIES 
Dataviewer 2D 
Virtual 
Sections 
Monochrome & colour 
Raw image acquisition  
Virtual 2D Sections 
Manipulation of three orthogonal planes in any direction 
Bioptonics Viewer 2D 
3D 
 
Monochrome & colour 
3D rendered surface 
Rotated through 360° in any plane 
Maximum Intensity Projection View 
Virtual 2D section in any plane in context of 3D image 
Quicktime Movies Monochrome and Colour 
Generated through Bioptonics Viewer 
Improve efficiency of analysis 
Images cannot be digitally manipulated 
 
Table 3-1 Properties Of Software Used For OPT 
Summary of the types and properties of software programmes used to view OPT datasets. 
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3.6.2.1. Dataviewer 
This is a 2D software programme that enables the user to scroll through virtual 
monochrome images of the polyp and view it in the three orthogonal planes used 
frequently to describe biological specimens (Chapter 2 Fig 2-5). Specimens can be 
measured using a scale tool within Dataviewer but this was not considered important in 
addressing the primary objective and was therefore not readily utilised. The polyps 
range from 4mm to 15mm in this study. It is also possible to view the original raw 
dataset in Dataviewer that was acquired prior to reconstruction (Fig 3-3). This was 
commonly used as a predictor of poor image quality post reconstruction. 
 
In order to identify architectural features for phase one and enhance the learning process 
it was essential that the OPT image was aligned as closely as possible with the original 
H&E slide. Using Dataviewer, the dataset can be re-orientated to change the angle of 
the orthogonal planes in order to align the specimen in the vertical plane. This enabled 
consistency between datasets and when making a direct comparison with the original 
H&E slide (Fig 3-4).  
 
 
Figure 3-3 Raw Images of Colorectal Polyps 
The raw images of three colorectal polyps viewed using Dataviewer prior to reconstruction. 
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Figure 3-4 Correlation Of OPT Cross-Sections And H&E 
OPT Images in Dataviewer (A) could be aligned to correlate as closely as possible with their 
corresponding H&E Slide (B). 
 
3.6.2.2. Bioptonics Viewer 
This 3D software enables the user to rotate images through 360° in any plane and 
visualise the surface morphology of the polyps (Fig 3-5). 2D virtual sections of the 
specimen can also be viewed in the context of 3D using Bioptonics software, although 
the resolution of detail in these sections is superseded by dataviewer.  
 
Invasive Cancer High Grade Dysplasia Low Grade Dysplasia 
A 
B 
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Figure 3-5 Surface Morphology Of Colorectal Polyps 
Using Bioptonics Viewer. 
 
It is also possible to view the polyp dataset in maximum intensity projection (MIP) 
view, which infers how the vascular structure within each specimen may differ. MIP is 
a visualisation technique for 3D datasets that enables volume rendering and is a well 
described methodology used by radiologists [116]. It identifies the voxel with the 
maximum intensity that lies in the path of each parallel ray and in CT images MIP 
views typically identify bone or contrast filled structures such as vessels [116].  
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Information from different filter channels can also be superimposed in MIP view to 
maximise the information available (Fig 3-6). 
 
 
Figure 3-6 MIP View Of Colorectal Polyps 
Maximum Intensity Projection view of polyps from a single channel (A) and from two (B) different filter 
channels (GFP+ and Cy3) super-imposed. 
 
3.7. METHODS 
3.7.1. Specimen Labelling and Tracking 
Each polyp specimen was given a specific identification number that it retained 
throughout the study until it was returned to the NHS Tayside Tissue Bank Archive in 
its original pathology cassette. This was known as the MRCT ID and it was recorded, 
with the original pathology number, by two individuals and kept in a secure database.  
 
To reduce the risk of error in sample labelling, two individuals carried out the crucial 
steps - information was cross-checked and the number of specimens passing through the 
A B 
GFP+ Cy3 
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process were limited in accordance with the Standard Operating procedure (SOP) 
LAB423v1.8 (Appendix IV). A maximum of 10 wax blocks, known as a batch, were 
processed at any one time and each batch of specimens were photographed prior to 
undergoing OPT processing. This was used primarily as a quality control measure and a 
visual reference for when the specimens required wax re-embedding at the end of the 
process. 
 
3.7.2. Specimen Processing Pre-Scanning 
Tissue specimens for phase one and two of the study were embedded in paraffin wax 
blocks and in order to prepare them for OPT scanning the tissue had to undergo various 
chemical processes before they could be optically cleared for scanning. 
 
The chemical processes involved were: 
• De-waxing and Rehydration 
• Embedding 
• Trimming and Mounting 
• Dehydration 
• Clearing 
 
3.7.3. De-waxing and Rehydration 
Polyp specimens in their paraffin wax blocks were processed through the Leica 
ASP300S Tissue Processor according to SOP LAB422v1.2 (Appendix V) Each wax 
block was placed in individual Tissue Tek Cassettes and labelled with the MRCT ID. 
Following removal from paraffin wax each specimen was transferred into a 7ml Bijoux 
bottle with the corresponding MRCT ID. The specimens were then placed into 
Phosphate Buffered Saline (PBS) for two 30-minute incubations at room temperature. If 
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specimens were to be embedded within 72 hours they were stored in PBS in a cold 
room at 4°C. If they required storing for more than 72 hours they were placed in 10% 
Neutral Buffered Formalin (NBF) and also stored at 4°C. Polyps for phase three that 
had not been in paraffin wax were washed in PBS and then prepared for embedding. 
 
3.7.4. Embedding 
The Polyp specimens were embedded in 1% Low Melting Point (LMP) Agarose in 
distilled water (Invitrogen 155170-019) according to SOP LAB 370 (Appendix VI). 1% 
LMP Agarose was used as the standard embedding solution for the majority of 
specimens but for larger specimens (12-15mm) a 1.2% solution was used because it was 
firmer and ensured the specimen retained its structure. A petri dish was filled with the 
Agarose solution and placed on the cold plate. Each specimen was carefully transferred 
from the PBS solution to its corresponding petri dish labelled with the MRCT ID 
ensuring as little excess PBS on the specimen as possible. 
 
The specimen was orientated within the agarose and as its temperature reached setting 
point (28°C) the specimen was suspended in the middle of the agarose with its long axis 
parallel to the base of the petri dish (Fig 3-7). Each polyp from the archive has at least 
one flat ‘cut surface’ as a result of having undergone processing in a clinical pathology 
laboratory to produce the H&E slides. Therefore this ‘cut surface’ was used to help 
orientate and align the specimens within the petri dish. Once set the specimen was 
placed in the cold room for a minimum of 15 minutes. 
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Figure 3-7 Alignment Of A Polyp In Agarose 
Cross-Sectional view through a petri dish demonstrating how the polyp is suspended in the agarose 
solution parallel to its base along the mid-line ensuring the specimen is encased by agarose. 
 
3.7.5. Trimming and Mounting 
This was a crucial stage in the processing of the specimens. The polyp was carefully 
removed from its petri dish and excess agarose trimmed from around the specimen and 
discarded. This was necessary to ensure the specimen would sit securely on the mount 
for scanning and to reduce the length of time required to optically clear the sample. 
Careful attention was paid to ensure the agarose did not split and was cut smoothly to 
avoid any ridges in its surface as acute angles in the agarose surface around the 
specimen created scanning artefacts. The remaining polyp was left encased in a plug of 
agarose (Fig 3-8). 
 
 
Figure 3-8 A Polyp Embedded In A Plug Of Agarose. 
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Each agarose plug contained one polyp specimen and was mounted and fixed onto a 
cylindrical metal base with strong adhesive in preparation for OPT scanning. The 
specimen had to be suspended in the OPT scanner from a magnet to undergo scanning 
and it was imperative for scan quality assurance that the specimen did not fall or move 
from the mount during this process.  
 
3.7.6. Dehydration 
Once secured onto a mount the specimen was placed into a 60ml glass bottle containing 
methanol which was changed three times in a 24 hour period with at least one overnight 
incubation period at room temperature. 
 
3.7.7. Clearing 
The fully dehydrated specimen was finally placed into Benzyl Alcohol- Benzyl 
Benzoate (BABB) to undergo optical clearing prior to scanning. The length of time 
required to adequately clear the specimen, in BABB, was dependant primarily upon the 
size of the agarose plug. A minimum of 48 hours in the clearing solution was required 
per specimen and I qualitatively assessed each one prior to scanning. 
 
The optical clearing of the specimen was the longest part of the pre-scanning process 
and additional experiments were conducted on non-archive tissue specimens to see if it 
was possible to expedite this. Various techniques such as heating or agitation were 
trialled and alternative clearing agents were researched but BABB remained the clearing 
agent of choice that was most suitable for OPT. 
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3.8. SCANNING TECHNIQUE 
Each Polyp specimen was scanned using the 3001 OPT Scanner following the OPT 
Scanner Manual v1.11.1 [115]. An alignment calibration was carried out at the 
beginning of each day using an alignment pin in accordance with the scanner manual 
instructions. This ensured that any day-to-day variation in the scanner was avoided as 
well as optimising it for image acquisition. If the Misalignment pixel value exceeded ± 
128 pixels or the Rotation measurement was ±1 degree then the scanner was not 
suitable for scanning specimens and had to be reported to the manufacturer. 
 
3.8.1. Setting up the scan 
In order to optimise the OPT instrument to generate the best images for analysis the 
scan ‘set-up’ must be meticulous. This was achieve by carefully adjusting various 
parameters such as specimen alignment, zoom, focus and exposure were set for each 
individual specimen prior to scanning to ensure the final dataset was of the highest 
quality possible. 
 
The specimen was attached to the magnetic base on the scanner (Fig 3-9) and the 
chamber door shut. The UV light was switched on and the specimen lowered into the 
Quartz Cell containing BABB. If the specimens were very large then less BABB would 
be required due to displacement. Once the specimen has been lowered into the field of 
view it was visualised in the live screen on the OPT Scanning software on the desktop. 
The scanner was controlled entirely through this software. 
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Figure 3-9 Rotating Component Of OPT Scanner 
The magnetic rotating metal base in the OPT Scanner to which the specimen was attached. 
 
A rough alignment and rough exposure setting was made prior to adjusting the zoom 
and then setting a rough focus. The dark flat field was then acquired.  This is a 
background image captured for each filter channel. It is subtracted from the final scan 
image to minimise any artefacts that might occur as a result of minute dust particles in 
the BABB or pixel damage on the camera lens. Once the flat fields have been acquired 
the specimen alignment, exposure and focus can be re-adjusted and set more accurately. 
The zoom cannot be altered post acquisition of the flat fields otherwise these need to be 
re-captured. 
 
Specimens could be scanned using high or standard resolution and with different 
rotation steps in degrees.  Three standard UV filters built into the OPT Scanner were 
available for use; Cy3, GFP1 and GFP+.  
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3.8.2. Resolution 
Standard resolution (512x512 pixels) images were created using 2x2 bining hardware 
and therefore four times as much light was collected per pixel for the same exposure 
time. These images demonstrate less noise as there is less information and require a 
shorter exposure time than images produced at a high resolution (1024x1024 pixels). 
The data sets produced at a high resolution are 8 times larger and require a longer 
exposure time so take much longer to complete the scan than that of a standard 
resolution image. 
 
3.8.3. Rotation Step 
In addition to altering the resolution it is possible to vary the degrees of rotation that are 
made between every frame capture. At a standard resolution this is usually set at 0.9° 
and at a high resolution it is 0.45°. Therefore at a high resolution twice as many frames 
(800 images) are collected than at a standard resolution (400 images).  
 
3.8.4. Exposure 
The exposure for each specimen was individually set using an exposure graph to ensure 
the specimen was not under or over exposed. This had to be set individually for each 
filter channel used. In order to produce the highest quality of reconstructed images the 
brightest area of the specimen should fall just below saturation point on the exposure 
graph, which was used as a guidance tool. 
 
3.8.5. Quality Check and Data Storage 
The raw dataset was checked post-scan by an OPT expert for quality assurance, 
ensuring there had been no movement of the specimen and that the exposure and focus 
 
 
79 
was satisfactory. This was a subjective assessment based upon experience gained from 
phase one of the study. Once approved, the dataset was saved in accordance with SOP 
LAB423v1.8 (Appendix IV). The specimens were not de-embedded from their agarose 
plug until the reconstruction of images had taken place and no further clearing in BABB 
or rescanning was required. 
 
3.9. RECONSTRUCTION OF IMAGES 
The raw images obtained from the OPT scan were reconstructed using the software 
NRecon in order to create the cross-sectional images of the polyps and enable 3-
dimensional viewing with Dataviewer and Bioptonics respectively. Each dataset was 
reconstructed in accordance with the 3001 OPT Scanner Manual v1.11.1 [115]. This 
process involved further alignment checks and fine tuning to match the first and final 
image of the dataset, which should be identical, as the specimen would have completed 
a full 360° rotation with images being captured every 0.45° or 0.9° depending on the 
resolution selected.  
 
3.10. POST-OPT SCANNING PROCESSING 
Once the OPT scan had been saved and reconstructed satisfactorily the agarose plug 
was removed from the mount and processed according to SOP LAB 413 v1.0 and de-
embedded from their agarose plug (Appendix VII). Once they had been rehydrated 
through graded ethanol solutions from 70% to 30% and stored in PBS, the polyps were 
returned to their original Tissue Tek Cassettes for processing back through the 
ASP300S Tissue Processor in accordance with SOP LAB 310 v1.4 (Appendix VIII). 
The polyps were then re-embedded in paraffin wax in their original NHS Tayside 
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Pathology cassettes with their corresponding NHS Pathology ID. They were then 
returned to the NHS Tayside Tissue Bank Archive. 
3.11. IMAGE ANALYSIS 
3.11.1. Tools Used 
The polyp datasets were visualised using Dataviewer and Bioptonics Viewer as 
described in section 3.6. A QuickTime movie of each polyp on each channel was also 
created to improve the efficiency of analysing large numbers of images.  
 
3.11.2. Evaluation of OPT Images 
The diagnostic analysis of colorectal polyps was based upon the NHS Bowel Cancer 
Screening Programme guidelines and their pathology proforma sheet [85]. During Phase 
One, the original H&E diagnosis of the polyp was used to categorise specimens and 
learn what features where characteristic of each subtype. The polyps were categorized 
according to two main criteria: 
 
Dysplasia:  
• Low Grade Dysplasia (LGD) 
• High Grade Dysplasia (HGD) 
• Invasive Carcinoma (ICA) 
 
Villous Morphology: 
• Villous Adenoma (VA) 
• Tubulovillous Adenoma (TVA) 
• Tubular Adenoma (TA) 
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Information regarding the margins of the specimen and whether they had been 
completely removed could not be accurately commented upon as the specimens were 
often in two or more pieces and scans were analysed individually. During phase two 
dysplasia and villous morphology were recorded in addition to specific features that 
were highlighted from phase one to carry some diagnostic value and interest: 
 
Additional Features recorded included: 
• Anatomical features such as stalk, mucus lakes, ulceration, muscularis mucosae 
• Presence of a vasculature network 
• Percentage of villous component  
• Pit Pattern Classification 
• Level of confidence of diagnosis (Score 1-5) 
• Viewing software tool that was predominantly used (subjective assessment) 
• Evidence of epithelial displacement (Yes or No) 
• Length of time spent reviewing the images 
 
Each image was also given an Image Quality (IQ) score, which could later be used to 
determine whether image quality had any effect on the accuracy of the diagnosis. A pro 
forma sheet was constructed for phase two for data analysis (Appendix IX). 
 
3.12. QUALITY CONTROL 
Colorectal polyp tissue was a valuable component of the Tissue Bank Archive and 
therefore it was necessary to ensure that the OPT process did not damage their tissue 
architecture or render them obsolete for further diagnostic and research use. OPT adopts 
a non-destructive methodology and in order to prove this, H&E slides of two batches 
(20 wax blocks) were re-cut by the Pathology Lab at Ninewells Hospital, NHS Tayside 
for re-diagnosis post OPT processing.  
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3.12.1. Minimising bias 
All specimens from the Tissue Bank Archive were removed along with their 
corresponding H&E slides. Each specimen to be included in the study was re-diagnosed 
by a single expert Gastro-intestinal pathologist, Carey, to reduce inter-observer bias that 
may have existed in the original diagnostic information. The Standard Operating 
Procedures, aforementioned, were also followed throughout to ensure a uniform 
laboratory process at MRCT Edinburgh. 
 
3.12.2. Blinding of Study Information 
All of the polyp specimens, on arrival at MRCT Edinburgh, were checked-in by two 
MRCT laboratory technicians and the NHS Pathology number was re-allocated the 
study MRCT ID. This ensured each specimen could be reliably tracked throughout the 
OPT process. This information was recorded in a secure database held at MRCT 
Edinburgh. The principal study researcher who analysed the final images was not 
involved in this stage. 
 
The original pathology diagnostic information was obtained and recorded in a separate 
secure database with no patient identifiers to maintain patient confidentiality. The 
principal study researcher who had NHS Tayside Tissue Bank authorisation to view this 
information collated this data, which was held securely on site at Ninewells Hospital, 
NHS Tayside. 
 
As discussed, during phase one, the study researcher analysed the polyp datasets in 
association with their H&E diagnostic information in order to learn how OPT visualise 
this tissue. During Phase Two the study researcher had no visibility of the H&E 
diagnostic information prior to analysis of the images.  
 
 
83 
CHAPTER 4: PHASE 1 – DIAGNOSTIC OPTIMISATION OF OPT 
 
As discussed, OPT has never been used to visualise human tissue in this way before and 
therefore limitations due to the study design and the OPT processing of specimens were 
expected. During phase one many of these limitations became apparent and led to the 
OPT technique and the study design being modified to accommodate them where 
possible. 
 
353 polyps were selected for inclusion in phase one and the distribution of polyp sub 
types is seen in Table 4-1.  
 
 TA TVA VA N/A Total 
Low Grade Dysplasia (LGD)  59 146 6 - 211 
High Grade Dysplasia (HGD) 18 71 0 - 89 
Invasive Cancer (ICA) 3 42 0 8 53 
Total Number (n) 80 259 6 8 353 
 
Table 4-1 Phase One Polyp Characteristics 
Distribution of phase one polyps according to dysplasia subtype and surface morphology. 
 
4.1. SPECIMEN DISTRIBUTION 
All polyps specimens were pre-selected using their classification as an ‘adenoma’ and 
the original H&E slides were re-diagnosed by an expert pathologist, Carey, noting 
specifically if the polyp had HGD, LGD or invasive cancer and if they were of a 
tubular, tubulovillous or villous morphological subtype. Although the original diagnosis 
was used to aid polyp selection it was disregarded for the purpose of data analysis. 
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Only 1.7% (n=6) of the polyps selected for scanning were of villous morphology. The 
majority of the polyps were tubulovillous (73.4% n=259) or tubular (22.7% n=80). Low 
Grade Dysplasia Polyps made up 59.8% (n=211) of the study sample and 25.2% (n=89) 
were High Grade Dysplasia. 15.0% (n=53) of samples were polyp cancers and 15.1% 
(n=8) of these cancer polyps had no designated morphological subtype. 
 
4.2. SPECIMEN SELECTION 
The selection of specimens for phase one was based upon the dysplasia diagnosis rather 
than the villous morphology. Therefore the sub-groups were not of equal size but as this 
was a training and optimisation period, this was less important as long as characteristics 
of each sub-type could be identified on OPT. 
 
Due to low numbers it was necessary to preserve any cancer polyps, in the archive, for 
phase two of the study. Therefore, as many separate cancer polyps as possible, were 
selected without compromising the chronological selection process for phase two.  
 
4.3. TECHNIQUE OPTIMISATION 
40 specimens encountered problems during OPT processing due to either specimen 
related issues such as fragility and fragmentation having undergone de-waxing or due to 
technical processing issues such as interference from wax and dye on the specimen 
(Table 4-2). These problems led to the polyps either being re-processed for optimisation 
or excluded from the analysis completely. 
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Problem Encountered Number 
Wax  20 
Fragility & Fragmentation 8 
Dye interference 9 
Size – too small 3 
 
Table 4-2 Reasons For Excluding Specimens Post-OPT Processing. 
 
4.3.1. Wax 
50% (n=20) of the problems encountered were due to wax interference. During the de-
waxing process some specimens were not fully cleared of wax and this reduced the 
quality of the OPT image and the amount of detail that could be seen within the 
specimen (Fig 4-1). The wax was best identified on the raw image prior to 
reconstruction. It may have manifested as a thin film over the specimen making the 
image appear sharper or as ‘lumps’ of wax still adherent to the polyp surface (Fig 4-2). 
 
 
 
Figure 4-1 Wax Interference I 
A thin coating of wax can be seen over the edge of the specimen (A& B) in the raw images. When viewed 
in dataviewer (C) after reconstruction there was no detail within the specimen. 
 
 
A 
B 
C 
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Figure 4-2 Wax Interference Ii 
An elongated ‘lump’ of wax that can be seen (arrow) still adherent to the specimen (A) and the resulting 
cross-sectional OPT image (B) post reconstruction demonstrating the effect of this wax. 
 
The SOP was subsequently adjusted to ensure excess wax was trimmed off the block 
and the specimen melted down on the embedding station before being placed in the 
tissue processor. In addition, the xylene phase of the de-waxing process was extended to 
60 minutes with a light pressure and vacuum function also applied. All settings on the 
Tissue processor were altered within the recommended safe limits in order to optimise 
the clearance of wax and preserve the polyp tissue. 
 
4.3.2. Dye 
If polyps are not considered endoscopically resectable when first identified they may be 
tattooed with permanent ink for identification later by another endoscopist or surgeon. 
Pathologists also use marking ink when they receive the specimen in order to identify 
the resection margins at a later stage when viewed on H&E slides. 
 
 
A B 
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Nine of these specimens covered in marking ink were processed in phase one. The dye 
renders the cleared specimen less permeable to UV light than those without and in order 
to acquire a satisfactory image the exposure has to be dropped significantly. Therefore 
the clarity of the tissue structure within the polyp was very poor in these specimens. The 
resulting OPT images were not suitable for analysis and were therefore excluded. This 
was picked up early in the processing stage and was most evident when the polyp had 
been cleared in its agarose plug (Fig 4-3).  
 
 
Figure 4-3 Dye Interference 
Polyps in their agarose plugs after clearing demonstrating the dye that affected image acquisition 
 
The dye may have been apparent when examining the specimen in its wax and therefore 
if identified early the specimens were excluded at this selection stage of the process. 
 
4.4. HAEMOSIDERIN AND DARK CORES 
Haemosiderin is a dark golden-brown pigment that accumulates in areas of 
haemorrhage [117]. It is an insoluble glycoprotein and iron storage complex containing 
ferritin. Haemosiderin deposits were identified in a few of the polyp specimens and they 
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were most likely due to bleeding into the polyp as a result of torsion or trauma in vivo. 
Therefore when seen in the context of EPD and misplaced lamina propria it supports a 
benign diagnosis rather than malignant. 
 
These deposits cluster within polyp stalks and manifest as ‘dark cores’. The stroma in 
the stalk of the polyp is denser when viewed macroscopically and this makes the 
specimens difficult to optically clear for OPT scanning. Haemosiderin affects image 
acquisition in the same way as dye interference producing suboptimal results with 
patchy detail and under exposed images. The dark cores may have been recognised in 
their wax blocks and were therefore excluded at this stage. However, this assessment is 
subjective and the dark cores were not always apparent until the clearing stage.  Once 
specimens had been processed and cleared they underwent a prolonged period of time in 
BABB if dark cores were evident. This avoided their exclusion from the study and 
therefore prevented selection bias and enhanced image acquisition (Fig 4-4). 
 
 
Figure 4-4 Haemosiderin Interference 
Polyps with dark cores caused by haemosiderin deposits picked up after clearing. 
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4.5. CLEARING  
Biological samples including human tissue samples consist of several components that 
have very different refractive indices.  The refractive index (RI) is a measure of the 
speed of light in the substance in relation to that through a vacuum expressed as a ratio 
(e.g. water 1.33). Different RIs within tissue specimens leads to diffraction and optical 
aberration within the sample producing poor quality images. In order to enhance the 
images it is necessary to optically clear the sample. In order to render a tissue 
transparent and hence suitable for optical imaging the water content of the sample must 
be extracted and replaced with a substance that has a similar RI to the proteins and 
lipids within the tissue sample [118]. Therefore there will be minimal variations in the 
RIs of the tissue components and better images will be produced.  
 
BABB is composed of 2 parts Benzyl Benzoate (RI 1.54035) and 1 part Benzyl Alcohol 
(RI 1.5681). It is also traditionally known as Murray’s Clear and has been used as an 
optical clearing agent since 1993 [119]. It was first described by Murray and Kirschner 
when they used it to look at amphibian eggs and embryos but it had also been used for 
some mammalian embryos [120]. There are other clearing agents such as Potassium 
Hydroxide/Glycerol, Methyl Salicylate, Carbon Disulfide, Xylene and Glycerol but 
BABB is by far the most commonly reported on in optical imaging. It is also the most 
effective for this purpose as the RI needs to be the same as the quartz cuvette so no 
distortion of the image occurs as light enters the cuvette. However, Xylene is used more 
commonly in routine histopathology. 
 
When using a clearing agent is necessary to consider the staining reagent used, its 
compatibility with aqueous solutions and its effect on fixed tissues. BABB is not 
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compatible with aqueous solutions so in order for it to adequately clear the tissue, all the 
water content of the tissue must be completely removed and replaced with alcohol prior 
to using BABB. Therefore some water-soluble dyes, such as Hoechst 33342, used in 
flow cytometry as a nucleic stain to identify DNA damage are removed by the alcohol 
dehydration procedure [121]. However this is more an issue with confocal microscopy 
and not optical projection tomography. Other disadvantages of BABB are that it renders 
the samples brittle during the procedure making it more likely to fragment [118], which 
is a further reason why villous polyps were more likely to be excluded. 
 
The length of time required to adequately clear a specimen for OPT was the main rate-
limiting step of the study. Although it was important to standardise the pre-scanning 
process as much as possible, different size and colour polyps required different lengths 
of time in BABB to produce the same quality images. This became apparent after 
scanning whole post-mortem polyp specimen, i.e. tissue not previously been through the 
wax processing (Fig 4-5). Archived polyps required a minimum of 4 days in BABB and 
no longer than 7 days before scanning. 
 
Experiments were carried out to see if altering the composition of the BABB, heating 
the solutions gently in a water bath or agitating the sample could speed up the process.  
The heat distorted the agarose plug and altered its composition so that it became more 
opaque and therefore was inadequately cleared for OPT scanning. Altering the 
composition of BABB from the standard 2:1 ratio of Benzyl Benzoate to Benzyl 
Alcohol to 1:2, 2:2 and 3:1 had no observed effect. When the Benzyl Alcohol 
proportion was increased it appeared to slow the process. Agitation of the specimens 
improved the images marginally but created technical difficulties with securing the 
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agarose plug on the mount and subsequently caused movement artefact during the 
scanning process. 
 
 
Figure 4-5 Uncut Post Mortem Polyps  
Post-Mortem Polyps scanned at 3 days and then subsequently at 32 and 35 days demonstrating the 
enhanced OPT image with a prolonged clearing period in BABB. 
3 DAYS 32 DAYS 
3 DAYS 35 DAYS 
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4.6. CHANNEL & RESOLUTION  
The length of time taken to scan each specimen using OPT depended on a multitude of 
factors relating to the polyp characteristics and the scanning technique. These are 
outlined below: 
 
Polyp Characteristics 
• Size 
• Colour 
• Quality of Clearing process 
 
Scanning Technique 
• Channel selected 
• Exposure settings 
• Resolution selected 
 
A standard resolution scan on a single filter channel would take approximately 5-8 
minutes and at a high resolution from 14-20mins. Scanning on three filter channels 
(GFP1, Cy3 and GFP+) could take up to 45mins. The set-up time for each specimen 
was approximately 10-15mins and needed to be meticulous and accurate to avoid 
rescans as a result of technical errors. A full high-resolution scan of all three channels 
could take approximately an hour. Following this the raw images would then need to be 
aligned and reconstructed and then the data copied to a secure location on two external 
hard drives. 
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4.6.1. Comparative study 
A small comparative study was carried out to determine which resolution and filter 
channels were optimum to try and improve the efficiency of the scanning and data 
copying stage.  
 
4.6.1.1. Resolution 
Eight OPT polyps were compared at high and standard resolution by four observers, 
proficient in examining OPT images. The filter channels chosen to make the 
comparison varied to include at least two examples of each filter (GFP1, GFP+ and 
Cy3). The observers were blinded to the scan settings for each polyp and asked to 
compare the datasets on Dataviewer and Bioptonics selecting which image they felt 
showed the most information.  
 
Results showed that the high-resolution scan was considered a better quality image, as 
expected, in 81.3%% (n=26/32) of cases. One observer felt that there was no difference 
between high and standard resolutions in one particular dataset (Fig 4-6).  
 
 
Figure 4-6 Comparison Study: Bar Chart Of Image Resolution 
Bar Chart showing how frequently high or standard resolution polyps were selected as the best images. 
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4.6.1.2. Filter Channel 
Seven OPT polyps were scanned on the three standard filters (Cy3; GFP1 and GFP+) 
and compared by four observers. As before, the observers were blinded to the scan 
settings and asked to compare the three datasets and select the images they felt showed 
the most information. Finally, the four observers were asked to compare a new red 
filter, Texas Red (TXR) with the standard Cy3 filter on three further polyps. 
 
Altering the UV filter channel used for each OPT scan changes the wavelength at which 
the specimen is being scanned at and hence the amount of information obtained. 
Therefore by changing the filter channel the images will give a different type of 
information about the specimen. The two channels that were the most informative were 
Cy3 and GFP+. The GFP1 filter was considered superior on two occasions (Fig 4-7).  
 
 
Figure 4-7 Comparison Study: Bar Chart Of Filter Channel 
Bar chart showing the most commonly selected filter channel that produced the best images. 
 
The TXR filter was selected to show better images in 75% of cases (n=9) however 
feedback indicated that it was extremely difficult to decide between Cy3 and TXR so 
therefore any benefits were considered marginal. This small qualitative study did not 
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take into consideration the different types and sizes of polyps or factors such as inter-
observer variation. However, following the analysis a high resolution setting and filters 
GFP+ and Cy3 were selected for phase two of the study. 
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CHAPTER 5:  PHASE 1 – POLYP CHARACTERISTICS 
 
Once the technique for scanning had been optimised the polyp images were reviewed to 
look for identifiable features that were characteristic of colorectal polyps with particular 
histological features.  This included any specific anatomical features, the surface 
morphology and villousness of the specimen and the dysplasia or cancer diagnosis. 
Each specimen was compared with their corresponding H&E slide to enable accurate 
identification of these features. 
 
5.1. ANATOMICAL FEATURES IDENTIFIED 
OPT images were primarily assessed to see if there were any features relating to the 
structure or anatomy of the polyp that would be useful later in determining dysplasia. 
However, in order to identify abnormal features of a polyp it was essential that features 
of a ‘typical’ polyp could be accurately interpreted first.  
 
The features that were consistently identified were: 
• Polyp stalks 
• Normal bowel mucosa 
• Mucus Lakes within the polyp 
• Surface ulceration 
• Vasculature of the polyp 
• Polyp epithelium which determines villous morphology and dysplasia 
 
5.1.1. Polyp Stalks 
To determine the completeness of removal of a polyp it is necessary to identify the stalk 
and therefore the transition point between normal gut epithelium and dysplasia in the 
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adenoma. This has implications regarding the follow up and future surveillance 
recommended for these patients. In many OPT polyps the stalk was very clearly 
identified but this was truer of pedunculated rather than sessile polyps. Bioptonics 
viewer software was the best tool to identify the stalk giving an overall global 3D image 
of the polyp (Fig 5-1).  
 
Figure 5-1 Stalk Of Polyps Identified Using Bioptonics 
 
In Dataviewer, the cross-sectional image correlated well with the H&E section 
demonstrating the differentiation between adenomatous tissue and the stalk more clearly 
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(Fig 5-2). The stalk appeared to have a more uniform architecture with less variation 
between polyps and demonstrated a smoother surface structure than the adenoma itself.  
 
 
 
Figure 5-2 Polyp Stalks On H&E And OPT 
Stalk of two polyps (A&B) with their corresponding H&E slide. A feeding vessel (V) is visible in Polyp A, 
which is a LGD TVA. Polyp B is a HGD TVA. 
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The main vessel feeding the polyp was also identified in Dataviewer in a few cases (Fig 
5-2 Polyp A). Some polyps did not have a recognisable stalk (Fig 5-3). This may have 
been due to the piecemeal excision technique used endoscopically or the method in 
which it had been cut in the pathology lab and embedded into wax blocks. Without 
visualising a stalk or normal bowel mucosa it was not possible to accurately comment 
on whether the specimen had been fully excised or not. 
 
 
Figure 5-3 Polyps With No Stalks 
Tubulovillous (A) and Tubular (B) LGD polyps which do not exhibit a stalk on either Dataviewer or 
Bioptonics viewer. 
 
A 
B 
 
 
100 
5.1.2. Normal Bowel Mucosa 
The surface features of normal bowel mucosa are ultimately the same as that of the 
stalk. On two occasions the OPT image contained no evidence of any adenomatous 
tissue and instead was normal bowel mucosa and therefore, it was necessary to 
recognise this in order to exclude the sample from analysis. The bowel mucosa 
specimens may have been stalks that had been disconnected from the adenoma due to 
their fragility. 
 
Propidium iodide (PI) is a nucleic acid stain often used in confocal microscopy, flow 
cytometry and fluorescence microscopy. It has been well documented in cell viability 
studies for the last 30 years and is known to pass through dead cell membranes but is 
impermeable in live cells [122]. PI works by binding to the DNA between the bases of 
cells and its fluorescent properties have been used to identify cellular structures more 
specifically on confocal microscopy. OPT is a comparable in vitro scanning technique 
albeit for slightly larger specimens and hence it was thought that theoretically PI could 
be of some use and may enhance the quality for the images. 
 
Six post mortem polyps were stained with PI during phase one and scanned on OPT. 
They demonstrated many anatomical features of a polyp very clearly and in particular 
the layers within the bowel wall (Fig 5-4 and 5-5) such as the longitudinal and circular 
muscles of the muscularis externa and the arterioles and venules in the submucosal 
layer. 
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Figure 5-4 Anatomical Layers Of The Bowel Wall 
Schematic diagram demonstrating the layers of the wall of the colon [123]. 
 
The muscle layers of the Muscularis Externa were not seen on any of the polyp 
specimens scanned from the Tissue Bank archive. The normal resection margins of 
these polyps endoscopically should be submucosal and not full thickness of the bowel 
wall. In a situation where a full thickness resection has occurred the patient is at 
significant risk of suffering a bowel perforation as a direct result of the procedure. 
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Figure 5-5 An OPT Polyp Stained With Propidium Iodide 
An OPT cross-sectional view of a sessile polyp taken from a post-mortem specimen demonstrating the 
longitudinal (A) and circular (B) muscle layers of the muscularis externa and structures within the 
Mucosa and submucosa (C) layers. Specimen stained with propidium Iodide. 
 
5.1.3. Mucus Lakes 
It was possible to identify mucus lakes or pools within a polyp on OPT. Their 
significance is non-specific but when interpreted in the context of other features they 
can be an important diagnostic aid. The presence of mucus pools at the base of an 
adenoma should prompt concern regarding an underlying mucinous adenocarcinoma. If 
the mucus pools are uniform and well rounded then it is more likely to be related to 
pseudoinvasion or EPD rather than an invasive mucinous adenocarcinoma. If the mucus 
pools are larger and irregular and contain free-floating neoplastic cells then a malignant 
process should be considered.   
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These became apparent when, having identified voids within polyps, the original H&E 
slides were revisited to confirm what the structures were. Clear fluid such as mucus was 
represented on OPT by a well-demarcated structure that appeared black on OPT (Fig 5-
6). 
 
Figure 5-6 Mucous Pools 
An OPT cross-sectional image of a polyp that has changed its shape slightly during the OPT process 
demonstrating an area of mucus pooling (circle) and how the specimen has been orientated (arrow). 
 
5.1.4. Surface Ulceration 
Ulceration of a polyp is more likely to be associated with a suspicious underlying 
diagnosis rather than a benign adenoma. Cancer polyps are more likely to exhibit 
features of ulceration [46]. 
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Figure 5-7 Surface Ulceration 
Ulceration of the surface of a polyp demonstrated on OPT and seen on its corresponding H&E section 
with underlying invasive cancer (ICA - circled). 
 
Ulceration was seen in some of the archived polyps and was identified by a break in the 
surface structure as seen on H&E. When compared with OPT views it was an irregular 
shaped fossa on the edge of the polyp (Fig 5-7). Similar irregularities were visualised on 
3D views that would not have been captured by the H&E section so raised the 
possibility that small foci of invasive cancer may be overlooked by sectioning the polyp 
in the middle. 
 
5.1.5. Vasculature of Polyp 
When OPT polyps are viewed in Maximum Intensity Projection (MIP) in Bioptonics the 
intricate network of vessels within the polyp specimen could be seen (Fig 5-8). It is 
evident that vasculature patterns differed greatly between specimens. However, the 
branching network of vessels is not always well demonstrated and this may be a 
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limitation of the study design that uses slices of specimens rather than whole polyps 
(Fig 5-9 C).  
 
 
Figure 5-8 Vasculature Pattern 
Two LGD (A&B) polyps and an ICA (C) polyp viewed in MIP on Bioptonic demonstrating very different 
vasculature patterns. 
 
Information from different filter channels could also be superimposed creating an image 
that is more detailed than a single channel would be (Fig. 5-9 and Fig 5-10). When 
information from two filters are merged they are each falsely coloured in order to 
display which information has been drawn from which channel. Commonly the Cy3 
Filter was coloured red and GFP+ filter was coloured green. Therefore in merged 
datasets it is possible to decipher which channel is most informative by identifying 
which colour is most dominant and therefore provides the most information. 
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Figure 5-9 Rotational Views Of A LGD Polyp In MIP On Two Filters 
MIP view of a polyp with two merged datasets (Cy3 Red; GFP+ Green). Rotational views on serial 
images demonstrating a poor representation of the vascular branching pattern in the polyps slice.  
 
 
Figure 5-10 Vasculature Seen With Merged Filters On MIP 
LGD polyps viewed using Bioptonics in MIP with information from two (A) or three (B) filters 
demonstrating a more intricate pattern of vessels. 
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5.2. DYSPLASIA AND INVASIVE CANCER FEATURES 
Distinguishing between high grade and low grade dysplasia using OPT was challenging 
and, not surprisingly, it became more evident that cellular dysplasia represents a 
spectrum of change rather than a discrete change between the two diagnostic subtypes.  
 
5.2.1. Low Grade Dysplasia 
LGD polyps typically produced better quality images, which were crisp and well 
defined demonstrating a more discrete architecture than HGD polyps. The structure of 
the ‘tubules’ or ‘villi’ appears more organised as can be seen in the examples below 
(Fig 5-11). LGD made up the majority of the study sample accounting for 59.8% of the 
polyps scanned in phase one.  
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Figure 5-11 Low Grade Dysplasia Polyps (A-D). 
 
5.2.2. High Grade Dysplasia 
HGD polyps showed a more crowded and dense structure than LGD (Fig 5-12). The 
‘villi’ and ‘crypts’ or ‘tubules’ were less clear and the architecture, although identifiable 
was not as well defined as with the LGD polyps. The HGD polyps gave a more solid 
appearance and many of the anatomical structures were still detectable such as the 
muscularis mucosa (Fig 5-12 D) 
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Figure 5-12 High Grade Dysplasia Polyps (A-D). 
 
5.2.3. Invasive Cancer  
Cancer polyps appeared very dense on cross-section in Dataviewer and the architecture 
was far less pronounced (Fig 5-13). The cancer tissue was more homogenous and glassy 
in its appearance on OPT and features which were seen on H&E staining such as LVI 
was not easily distinguishable on OPT.  
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Figure 5-13 Invasive Cancer Polyps (A-D) 
Some polyps exhibit features of Lymphovascular invasion (LVI). 
 
When Cancer polyps were viewed in MIP the vasculature, which had previously been 
quite clear in LGD and HGD polyps, was almost obliterated with only the larger feeding 
vessels at the base of the polyp seen (Fig 5-14). This, in part, may be due to the density 
of the cancer tissue and the inability of UV light to optimally penetrate it to give more 
detail or perhaps because the vessels in this tissue type tend to be smaller and thinner-
walled so are not easily distinguishable from the cancer tissue by OPT. 
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Figure 5-14 Cancer Polyp In MIP 
An MIP view of a cancer polyp from two merged datasets (GFP+ and Cy3) showing large feeding vessels 
at the base of the polyp. 
 
5.2.4. Mixed Dysplasia and Cancer 
A polyp is diagnosed and managed according to its ‘worst’ diagnosis. Therefore most 
polyps are not purely HGD or purely ICA. Invariably HGD polyps arise on a 
background of LGD and similarly cancer polyps may consist of areas of HGD and LGD 
within the same specimen. This makes diagnoses using OPT alone more challenging. 
 
In early cancer polyps the focus of invasive cancer may be very small and difficult to 
distinguish clearly on H&E and deeper sections may be taken to confirm the diagnosis. 
On OPT, in these circumstances, the areas of ICA in a polyp are not clear and although 
the less discrete architecture is still apparent, the solid and homogenous nature of the 
ICA tissue, previously described as characteristic, is absent (Fig 5-15). Similarly, 
specimens with a focus of HGD within a predominantly LGD polyp could easily be 
mistaken for a LGD polyp without the aid of H&E as the transition point between HGD 
and LGD is not well defined on OPT (Fig 5-16). The specimen in Figure 5-16 has also 
become physically distorted as a result of the rehydration and dehydration processing 
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that it has been processed through. This makes a direct correlation with the H&E 
difficult. 
 
 
Figure 5-15 A Polyp With A Focus Of ICA On A Background Of HGD 
 
 
Figure 5-16 A Polyp With A Focus Of HGD On A Background Of LGD 
This polyp has lost its shape in the OPT process and the architecture is distorted. 
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Areas of ICA within a HGD polyp may be identified by the nature in which they seem 
to invade the stalk and cause an interruption in the muscularis mucosa as well as the 
over all higher density appearance on Dataviewer (Fig 5-17). 
 
 
Figure 5-17 Cancer Polyp With Invasion Through Muscularis Mucosa 
An ICA specimen showing the direction of invasion of cancer into the stalk (arrows) through where the 
muscularis mucosa would have been (dotted line). 
 
When examining the polyps on H&E, which have LGD and HGD tissue within the 
same polyp it is difficult to accurately distinguish a discrete cut off between where one 
tissue sub-type ends and another starts. Therefore as OPT shows a lower resolution and 
less cellular detail it becomes even more difficult, as demonstrated by these images. 
 
 
 
 
 
 
 
114 
5.3. SURFACE MORPHOLOGY OR VILLOUSNESS 
The villous diagnosis given to a polyp according to the WHO principles on H&E is 
subjective and based, often, upon a single thin slice of tissue. These diagnoses seemed 
to correlated well with distinctive image features on OPT when viewed through 
Dataviewer in cross-section (Fig 5-18). 
 
 
Figure 5-18 Surface Morphology 
Each polyp sub-type on H&E with their corresponding OPT image from dataviewer. 
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However, the architecture of specimens did become distorted as they were processed 
from wax blocks through various cleaning solutions and graded alcohols for OPT 
processing and this may account for some of the discrepancies that existed (Fig 5-6).  
 
Therefore, we accepted that the WHO diagnostic criteria could, reasonably be applied to 
these images in order to characterise them into the three well-documented sub-types. 
However when using Bioptonics to view the images the surface morphology was far 
more intricate than a cross-sectional slice could demonstrate so it was important to try 
and understand how the original pathology villous diagnosis translated into three 
dimensions. 
 
5.3.1. Villous Adenoma (VA) 
For reasons already described there were only six villous polyps in the study sample in 
phase one. Between these samples the surface morphology varied greatly (Fig 5-19). 
The polyp surfaces were irregular with a more haphazard appearance. The specimen 
was lobulated and multiple projections could be seen as expected in a villous sample. 
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Figure 5-19 Villous Polyps On OPT 
Two villous polyps showing an example of the variation in surface morphology. 
 
5.3.2. Tubulovillous Adenoma (TVA) 
TVA polyps were the dominant group in phase one accounting for 73.4% of the 
specimens scanned. In 3D these polyps showed a more organised structure with 
elongated crypts and a few circular or oval shaped pits interspersed between them (Fig 
5-20). Although some lobulations and villous projections could be seen in some samples 
it was less reproducible and consistent between specimens than in villous polyps alone. 
The surface morphology of the TVA polyp can be likened to that of the cerebral cortex 
showing gyri and sulci. 
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Figure 5-20 Tubulovillous Polyps On OPT 
Two TVA Polyps viewed in 3D using Bioptonics demonstrating the elongated connecting crypts and a 
small area of pits. 
The variation between polyps in this category was also quite pronounced but given the 
WHO classification uses the ‘20% Rule’ this was to be expected (Fig 5-21). The 
original diagnosis is based upon a subjective qualitative assessment and not an 
automated quantification of villousness so intra-observer variation might be expected. 
Similarly, the underlying dysplasia or cancer diagnosis can distort the polyp and 
ulceration may also alter the surface morphology.  
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Figure 5-21 Variations In Tubulovillous Polyps (A-D) 
A B 
C 
D 
 
 
119 
5.3.3. Tubular Adenoma (TA) 
 
Figure 5-22 Tubular Polyps On OPT 
TA polyps of LGD (A&B) and ICA (C) with their corresponding original H&E slide. 
 
TA polyps made up 22.7% (n=80) of the study sample in phase one of which LGD were 
the most common (73.7%, n=59/80) with fewer ICA polyps (3.8%, n=3/80). The LGD 
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TA polyps exhibited a uniform pattern with round or oval pits when the surface 
morphology was viewed in Bioptonics. They appear to have a more solid structure and 
stronger architecture (Fig 5-22 A and B). ICA polyps showed a slightly different 
structure, more similar to that of a TVA or VA, with distortions of the surface likely 
secondary to ulceration or the underlying dense cancer cells that stiffen the tissue (Fig 
5-22 C). 
 
5.3.4. No Diagnosed Villous Morphology 
Some polyps were not designated a morphological sub-type of the adenomatous 
component because they were cancer polyps and for the purpose of follow up the 
villous nature of the specimen was then deemed irrelevant for the patient’s clinical 
management. Instead features such as lymphovascular invasion and completeness of 
excision became more important. However when viewing these particular specimens on 
Bioptonics they exhibited similar characteristics to VA polyps with a disorganised 
irregular morphology and several villous projections (Fig 5-23).  
 
 
 
121 
 
Figure 5-23 Irregular Surface Morphology Of ICA Polyps On OPT 
ICA Polyps demonstrating similar characteristics to villous polyps in 3D on Bioptonics. 
 
5.4. EPITHELIAL DISPLACEMENT (EPD) 
EPD is an important diagnostic differential that, as previously reported, can be mis-
interpreted using conventional histopathology techniques due to its two-dimensional 
limitations and subsequently labelled as an invasive carcinoma. Using OPT it is possible 
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to identify these areas of EPD (Fig 5-24) that were identified on H&E and demonstrate 
on serial sections how this can occur. This was evident from results obtained in Phase 
one although it was less clear in phase two, without the benefit of close correlation of 
the OPT images with their H&E slides. In some specimens on OPT it is possible to over 
diagnose EPD by digitally manipulating and scrolling through the images in different 
planes. Therefore it is very important to interpreting these findings in the context of the 
rest of the polyp tissue. 
 
 
Figure 5-24 Epthelial Displacement 
Sequential images (1-4) of a LGD polyp demonstrating an area of EPD and how it becomes contiguous 
with the surface adenomatous tissue. 
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5.5. DISCUSSION 
The retrospective study design using archived specimens limited the number of villous 
polyps available for use. Polyps were excluded from the study (See section 3, Table 3-
1) if they appeared fragmented in the block and were at risk of breaking apart during the 
OPT de-waxing process or if they were too large. Villous polyps tend to be larger and 
were more likely to fragment on de-waxing so subsequently fewer VA polyps were 
included in the study due to these restrictions. VA polyps are known to have a high 
malignant potential and therefore de-selecting these polyps would potentially have 
limited the number of HGD and ICA polyps in the study if ‘cherry picking’ of these 
specimens had not been done for this learning set [27].  
 
Polyp adenoma morphology is less relevant if there is associated invasive cancer and 
therefore a small proportion of the specimens had had no morphological subtype 
assigned. However, if it was possible to distinguish the underlying morphology then a 
diagnosis of TA, TVA or VA was made. Some polyps were so destroyed with the 
invasion of cancer and ulceration over the surface it was not possible to accurately 
diagnose the architecture. In these cases it was more appropriate to exclude that 
information rather than make a false assumption. However we have seen that the 3-
Dimensional OPT images of these polyps show villous characteristics which are not 
seen on H&E. This may be of important diagnostic use and potentially could help 
clinical decision-making at endoscopy. 
 
Previous studies suggest that the majority of polyps are TA but most of the specimens 
in phase one were TVA. The specimens were selected in chronological fashion adhering 
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to the exclusion criteria from the start of the archive period so it would be reasonable to 
assume that this trend of TA dominance should have been seen. However, the sample 
size was small and cancer polyps had to be ‘cherry picked’ in order to get a 
representative sample for analysis and training. This is likely to have impacted on the 
distribution of polyp subtypes in this phase. 
 
The identification of polyp stalks and normal bowel mucosa was very clear in many 
specimens but the completeness of removal was not taken into consideration, as it could 
not be consistently or accurately commented upon. This was largely due to the design of 
the study. As a learning exercise, each paraffin wax block was classified as a separate 
specimen and therefore larger polyps may be repeated as more than one OPT specimen. 
Hence each H&E polyp section was individually re-diagnosed so it could be correlated 
with each OPT dataset. Therefore, a polyp may have been divided into two or more 
tissue blocks and each polyp fragment was diagnosed individually without visualising 
all of the polyp tissue. Therefore, in these circumstances, it was not possible to 
comment on completeness of excision. Similarly, when the stalk was not visible it was 
unclear whether this was due to the piecemeal excision method used at endoscopy or 
due to the fragmentation of the specimen during the OPT processing or indeed that the 
specimen had not been completely excised. 
 
Conventional H&E slides are cross-sectional and therefore it seemed appropriate that 
looking at OPT images in cross-section using Dataviewer would be the optimal viewing 
tool to relate to histology, instead of Bioptonics which looks only at the surface. It was 
not possible to distinguish the type of dysplasia of the polyp with any degree of 
certainty by using Bioptonics alone as it was predominantly a surface visualisation tool 
rather than useful to diagnose the cellular make-up of the polyp. Irregularities on the 
 
 
125 
polyp surface such as ulceration may raise the suspicion of an underlying malignancy 
but is not diagnostic on its own and indeed may be a result of polyp trauma and torsion 
causing distortion of the polyp surface and pesudoinvasion in some cases. Therefore the 
information obtained using OPT was best analysed in a multi-modal method using 
different viewing tools to give a global diagnosis of the specimen. This comprehensive 
viewing of the surface and of multiple sections has a potential advantage over routine 
histology. 
 
The inter-observer and intra-observer variation in colorectal polyp diagnoses is well 
documented [86, 87]. It occurs, in part, because histopathology is a qualitative and 
subjective diagnostic technique. However, we have already established that dysplasia 
represents a spectrum of change rather than a discrete alteration in the cell structure 
which makes diagnoses all the more difficult. OPT accentuates this feature of dysplasia 
and shows how challenging it can still be to discriminate between LGD and HGD. 
However, features that are sometimes present in the surface morphology can aid the 
differential diagnosis when considered alongside the cross-sectional images of the 
polyps. We wished to test this further in a ‘blind fashion’ (Chapter 6) and to assess 
inter-observer variation (Chapter 8). 
 
It is evident, when visualising a polyp in 3D that the surface morphology is far more 
complicated and intricate than the 20% villous WHO Classification would indicate. 
There are recognisable patterns that are reproducible in the study sample which are 
similar to the Pit Pattern Classification of Kudo et al [47]. There are many external 
factors that could affect the appearance of a polyp such as the location in the colon, the 
length of time it has taken to grow, the underlying diagnosis and the size. Villous 
Morphology is not an independent predictor of histopathological diagnosis although it 
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does have a strong association with invasive cancer. Therefore categorising the surface 
morphology and the identifiable features such as ulceration in a more detailed way may 
enable OPT to determine a new classification technique that is more accurate in 
predicting the underlying polyp type. This would then provide useful information for 
the endoscopists who excise the lesions and guide an earlier and more appropriate 
management plan such as complete excision or tattooing at the polyps location in the 
bowel.  
 
Adenomatous polyps are usually asymptomatic and commonly picked up through the 
BCSP. In order for a patient to have a positive faecal occult blood test leading to a 
colonoscopy then blood must be detected and the source of this is most likely from the 
polyp itself. However, there are interval cancers detected in between surveillance 
colonoscopies or cancers picked up after a negative FOBT. Whether a polyp bleeds or 
not may be related to a number of factors and in part may be due to the vasculature 
pattern within the polyp itself. Using OPT we can see the 3D vasculature of the polyp 
with good clarity for the first time and this could help us understand why some cancer 
polyps may be missed. 
 
5.6. CONCLUSIONS 
Phase one was an important stage of the study to optimise the OPT processing 
technique for efficiency of scanning and in order to obtain the best quality images. 
Several modifications were made to the SOPs that were first used in OPT to scan 
embryos. The specimen selection criteria were also altered to ensure less time was 
wasted scanning specimens that could not be analysed appropriately and having 
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identified some features specific to OPT, such as percentage villousness and pit pattern 
classification, the analysis criteria were modified to include these (Appendix XI). 
 
It is evident that there are many reproducible features seen on OPT that are not clear on 
H&E when less tissue is analysed. This raises the possibility of the usefulness of OPT 
as a diagnostic and research tool to explore features such as the vasculature pattern and 
the surface morphology and their significance in polyp diagnosis, clinical management 
and prognosis. 
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CHAPTER 6:  PHASE TWO – OPT DIAGNOSIS 
 
6.1. BACKGROUND SUMMARY 
The primary aim of this phase was to validate the reliability of the observations made in 
phase one. It was necessary to test the sensitivity and specificity of OPT in making an 
accurate diagnosis of the colorectal polyps. All specimens were selected from the 
Tayside Tissue Bank Archive and processed according to the SOPs modified from 
phase one (Appendices V to IX). Each specimen was scanned on GFP+ and Cy3 filter 
channels at the high-resolution setting. A single OPT observer (me) viewed the OPT 
datasets using Dataviewer, Bioptonics viewer and QuickTime movies to make a 
diagnosis based on the criteria observed in phase one. 
 
One expert Gastro Intestinal Pathologist (Carey) re-diagnosed all corresponding H&E 
slides of the specimens for correlation later with the results. These H&E diagnoses were 
considered the ‘gold standard’. Within the context of medical research a ‘gold standard’ 
refers to a reference point that is the most accurate under reasonable conditions and 
without restrictions. Ideally the gold standard would have 100% specificity and 100% 
sensitivity but from the literature we know that inter-observer variation exists when 
diagnosing colorectal polyps although this is less marked in experienced gastro-
intestinal pathologists. Therefore for the purposes of this study we used a solitary 
pathologist to reduce inter-observer variation and a pathologist who was a leading 
expert in this field to ensure the most accurate results.  
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6.1.1. Variables Recorded 
The variables recorded by both the OPT observer and H&E observer were 
• Dysplasia (LGD, HGD or ICA),  
• Morphology (TA, TVA or VA) 
• Presence of EPD (Yes or No) 
• Presence of Ulceration (Yes or No) 
 
Additional variables recorded by the OPT observer only were: 
• Percentage Villousness (0-100% in 10% aliquots) 
• Pit Pattern Classification (Type I, II, IIIL, IIIS, IV and V) 
• Presence of a Stalk (Yes or No) 
• Presence of Vessel Pattern (Yes or No) 
 
All OPT diagnoses were given a confidence score (CS) from 1 to 5 based on a 
subjective assessment of how easy it was to make the diagnosis. A score of 1 indicated a 
significant degree of uncertainty and conversely a score of 5 was selected when I was 
reasonably confident in making the diagnoses. OPT datasets were also give an Image 
Quality (IQ) score (1-5) which could be correlated with the results to identify if 
inaccurate diagnoses were given when images were of poor quality (score 1) or were 
more accurate when the images were of high quality (score 5).  
 
Other factors that could potentially affect the diagnoses were also recorded such as the 
type of specimen. Polyps are cut into halves or several slices in the pathology lab in 
order to embed them in paraffin wax blocks to generate H&E slides.  Each polyp 
segment was considered separately as an individual specimen in OPT. Specimens fell 
into two categories, those with one cut surface termed ‘end’ polyp segments and those 
with two cut surfaces termed an ‘internal slice’ (Fig 6-1).  
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Figure 6-1 End And Slice Polyps 
Some polyp specimens may be divided into two halves (Polyp I) or several slices (Polyp II) and be 
examined in OPT as an ‘end segment’ (A, B, C and F) or as a ‘internal slice’ (D and E). 
 
6.2. STATISTICAL ANALYSIS 
The statistical analysis was designed to address the primary objective of the study. 
Contingency tables showing OPT and H&E diagnoses with their agreement were 
calculated. Sensitivity and specificity of OPT diagnoses were based upon H&E being 
treated as the current Gold Standard (GS). 
 
Kappa statistics were used to assess agreement between H&E and OPT diagnoses [124, 
125]. P-values were calculated predominantly using chi-square test for association and 
chi-squared goodness of fit test (Pearson’s). A Kruskal-Wallis test is a non-parametric 
method for determining variance and in the context of this study was used to assess the 
difference in median values. 
 
The statistical analysis looked at the following criteria: 
A B C D E F 
I II 
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1. Agreement between H&E and OPT Diagnosis: Dysplasia, Morphology, EPD and 
Ulceration (Kappa test for agreement). 
2. Whether specimen type, confidence score or image quality was associated with the 
OPT and H&E diagnoses in part 1 above (Chi-squared test for association). 
3. Whether specimen type, confidence score or image quality was associated with 
agreement of OPT and H&E diagnoses in part 1 above (Kappa test for agreement, 
Chi-squared goodness of fit test and Kruskal-Wallis test for difference in medians). 
4. Whether dysplasia diagnosis on H&E and OPT is associated with surface 
morphology, EPD or ulceration (Chi-squared test for association) 
5. Whether dysplasia diagnosis is associated with variables identified on OPT to 
include percentage villousness*, PPC, visible stalks or visible vessels (Chi-square 
test for association and * Kruskal-Wallis test for difference in medians). 
6. Whether differences in ICA diagnoses on OPT and H&E are associated with 
morphology, EPD, ulceration, percentage villousness*, PPC, visible stalks or 
vessels (Chi-square test for association and *Kruskal-Wallis test for difference in 
medians). 
 
The results are presented in a series of contingency tables, which show the categories 
that are being directly compared. Within each category there are three components 
presented: the number of polyps that were observed (n) and this number represented 
firstly as a percentage of the number of polyps in the category along the row (% row) 
and secondly in the category down the column (% column). For example in Table 6-1 
266 polyps (n) were recorded as LGD in both OPT and H&E. This represents 57.5% of 
all polyps diagnosed as LGD on H&E (% row) and 88.9% of all polyps diagnosed as 
LGD on OPT (% column). 
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6.3. RESULTS 
665 colorectal polyp specimens were obtained from the hospital tissue bank archive and 
diagnosed by a single observer who was blinded to the original histopathological 
diagnoses of the polyp. 
 
6.3.1. Assessment Of Agreement Between H&E And OPT 
6.3.1.1. Dysplasia 
The proportion of specimens diagnosed as ICA using OPT (n=151) was over twice that 
of those on H&E (n=70). 10% of H&E LGD polyps and 38.1% of H&E HGD polyps 
were classified as ICA on OPT suggesting that OPT had a tendency to over diagnose 
ICA in specimens. 
 
77.1 % of H&E ICA specimens were also diagnosed as ICA on OPT and only three ICA 
polyps were classified as LGD on OPT. 88.9% of LGD specimens on H&E were also 
diagnosed as LGD on OPT suggesting a better correlation between the benign 
diagnoses. The HGD specimens were very difficult to reliably diagnose as was apparent 
by only 39.6% (n=53) of specimens being diagnosed as HGD on both OPT and H&E 
(Table 6-1). 
 
Overall agreement of dysplasia between H&E and OPT was fair (55.9%, κ0.27). A 
weighted Kappa statistic was also calculated to take into consideration the extent of 
disagreement between observations. For example, a diagnosis of LGD for a cancer 
polyp would be considered more severe than if it was called HGD. The kappa value 
improves slightly when this is taken into account (wt κ0.36). 
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 OPT LGD OPT HGD OPT ICA Total 
H&E LGD 265 
(57.5%)(88.9%) 
150 
(32.5%)(69.4%) 
46 
(10.0%)(30.5%) 461 
H&E HGD 30 
(22.4%)(10.1%) 
53 
(39.6%)(24.5%) 
51  
(38.%1)(33.8%) 134 
H&E ICA  
3 
(4.3%)(1.0%) 
13 
(18.6%)(6.0%) 
54 
(77.1%)(35.8%) 70 
Total 298 216 151 665 
% Agreement 55.9% 
Kappa (SE) 0.27 (0.03) ‘Fair’ 
Weighted Kappa  0.36 ‘Fair’ 
Sensitivity/Specificity* 77.1%/57.5% 
Table 6-1 Agreement Of Dysplasia On H&E And OPT 
Number (n); % Row; % Column *Treating H&E as gold standard 
 
In a further analysis, HGD and LGD were considered as a combined variable to see the 
agreement between benign and malignant diagnoses (Table 6-2). The results showed the 
agreement improved to 83.0% (κ0.40). Only 16 specimens (3.1%) of cancer polyps 
were ‘misclassified’ as benign on OPT assuming the gold standard diagnosis is the ‘true 
diagnosis’. In comparison, when considering only the LGD and HGD polyps the results 
showed a much poorer agreement (63.9%, κ0.18) (Table 6-3). This suggests it was more 
difficult to distinguishing between LGD and HGD than between benign (LGD and 
HGD) and malignant specimens on OPT. 
 
 OPT LGD/HGD OPT ICA Total 
H&E LGD/HGD 498 
(83.7%) (96.9) 
97 
(16.3%) (64.2%) 595 
H&E ICA 16 
(22.9%) (3.1%) 
54 
(77.1%) (35.7%) 70 
Total 514 151 665 
% Agreement 83.0% 
Kappa (SE) 0.40 (0.03) 
Sensitivity/Specificity* 77.1%/83.7% 
Table 6-2 Agreement Of Dysplasia (Benign Vs Malignant) On H&E & OPT 
Comparison of Dysplasia Diagnoses on H&E and OPT combining HGD and LGD as a single variable. 
Number (n); % Row; % Column *Treating H&E as gold standard 
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 OPT LGD OPT HGD Total 
H&E LGD 265 
(63.9%)(89.8%) 
150 
(36.1%)(73.9%) 415 
H&E HGD 30 
(36.1%)(10.2%) 
53 
(63.9%)(26.1%) 83 
Total 295 203 498 
% Agreement 63.9% 
Kappa (SE) 0.18 (0.04) ‘Poor’ 
Sensitivity/Specificity* 63.9%/63.9% 
Table 6-3 Agreement Of Dysplasia (LGD Vs HGD) On H&E & OPT 
Comparison of Dysplasia Diagnoses on H&E and OPT assessing HGD and LGD only. Results as 
Number (n); % Row; % Column *Treating H&E as gold standard 
 
6.3.1.2. Morphology 
The surface morphology of the polyps was classified according to the WHO guidelines 
as Tubular adenoma (TA), Tubulovillous Adenoma (TVA) and Villous Adenoma (VA) 
(Table 6-4). One specimen did not have a morphology diagnosis on H&E and was 
therefore excluded from the study. 
 
TVA polyps dominated the study sample on both OPT and H&E accounting for 58.3% 
and 70.3% respectively. More specimens were diagnosed as VA on OPT than H&E 
(10.1% versus 1.5%). 83.6% of these specimens were TVA on H&E and 7.5% were 
TA. This higher proportion of VA may reflect the fact that OPT shows a larger surface 
area of the polyp than an H&E slide would. 
 
More polyps were also diagnosed as TA on OPT (31.6%) than H&E (28.2%) with an 
agreement in 66.8% of specimens. The overall agreement between morphology 
diagnoses was fair (68.6%, κ0.38).  
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 OPT TA OPT TVA OPT VA Total 
H&E TA 125 
(66.8%) (59.5%) 
57 
(30.5%) (14.7%) 
5 
(2.7%) (7.5%) 
187 
H&E TVA 85 
(18.2%) (40.5%) 
326 
(69.8%) (84.3%) 
56 
(12.0%) (83.6%) 
467 
H&E VA 0 
(0%) (0%) 
4 
(40.0%) (1.0%) 
6 
(60.0%) (9.0%) 
10 
Total 210 387 67 664 
% Agreement 68.8% 
Kappa (SE) 0.38 (0.03) ‘Fair’ 
Sensitivity/Specificity* 60.0%/66.8% 
Table 6-4 Agreement Of Morphology On H&E & OPT 
Comparison of Morphology Diagnoses on H&E and OPT. Number (n); % Row; % Column *Treating 
H&E as gold standard 
 
 OPT TA OPT TVA/VA Total 
H&E TA 125 
(66.8%) (59.5%) 
62 
(33.2%) (13.7%) 
187 
H&E TVA/VA 85 
(17.8%) (40.4%) 
392 
(82.2%) (86.3%) 
477 
Total 210 454 664 
% Agreement 77.9% 
Kappa (SE) 0.47 (SE 0.04) 
Sensitivity/Specificity* 82.2%/66.8% 
Table 6-5 Agreement Of Morphology (Villous Vs Non-Villous) On H&E & OPT 
Comparison of Morphology Diagnoses on H&E and OPT comparing villous (TVA/VA) with non villous 
(TA) diagnoses. Number (n); % Row; % Column *Treating H&E as gold standard 
 
A further analysis of the morphology was carried out classifying the specimens as 
villous (TVA and VA) or non-villous (TA) (Table 6-5). The agreement improved to 
77.9% (κ0.47). Under these circumstances the sensitivity and specificity of diagnosing 
villousness in specimens was 82.2% and 66.8% respectively. 
 
6.3.1.3. Epithelial Displacement 
From the literature, we knew that EPD could be misdiagnosed as invasive cancer in 
benign polyps. Therefore, in order to establish if it was influencing the OPT 
classification of cancer polyps it was necessary to firstly assess whether EPD could be 
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seen on OPT and if it was being identified reliably when compared to the gold standard 
(Table 6-6). 
 
 OPT No OPT Yes Total 
H&E No 557  
(94.6%) (89.3%) 
32 
(5.4%) (78.1%) 
589 
H&E Yes 67 
(88.2%) (10.7%) 
9 
(11.8%) (22.0%) 
76  
Total 624 41 665 
% Agreement 85.1% 
Kappa (SE) 0.08 (SE 0.04) ‘ Poor’ 
Sensitivity/Specificity* 11.8%/94.6% 
Table 6-6 Identification Of EPD On H&E And OPT 
Comparison of EPD Diagnoses on H&E and OPT classifying it according to whether it existed (Yes) or 
was absent (No). Number (n); % Row; % Column *Treating H&E as gold standard 
 
The agreement between OPT and H&E diagnoses of Epithelial Displacement (EPD) 
was very poor with only 11.8% of samples being diagnosed as positive on both H&E 
and OPT (Table 6-6). OPT under-diagnosed EPD when compared to H&E with 88.2% 
of samples showing EPD on H&E that were subsequently classified as negative on 
OPT. We assess the influence of EPD on the dysplasia diagnosis later in this chapter but 
with such a poor pick up rate for EPD it is unlikely to carry the same significance as it 
does when differentiating between invasive cancer and benign specimens on H&E. 
 
In 3D on OPT EPD would manifest as a depression on the surface of the polyp (Figure 
6-2) so that when a cross-section is taken through the specimen it would appear that 
epithelial mucosa is invading through the muscularis mucosa. However, on cross-
sectional images in Dataviewer this was not readily identified. 
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Figure 6-2 EPD In Colorectal Polyps On OPT In 3D 
Arrows indicating where the depression is seen 
6.3.1.4. Ulceration 
Only six specimens were recorded as having ulceration using H&E but on OPT it was 
recorded in 19.4% of polyps. Overall agreement was extremely poor (80.3%, κ0.01) and 
any trends were likely to have occurred by chance (Table 6-7). 
 
 OPT No OPT Yes Total 
H&E No 
532 
(80.7%) (99.3%) 
127 
(19.3) (98.5) 
659  
H&E Yes 
4 
(66.7) (0.8) 
2 
(33.3) (1.5) 
6 
 
Total 536 129 665 
% Agreement 80.3% 
Kappa (SE) 0.01 (SE 0.01) ‘Poor’ 
Sensitivity/Specificity* 33.3%/80.7% 
Table 6-7 Identification Of Ulceration On H&E And OPT 
Comparison of ulceration diagnoses on H&E and OPT classifying it according to whether it existed (Yes) 
or was absent (No). Number (n); % Row; % Column *Treating H&E as gold standard 
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6.3.2. Variables Affecting H&E And OPT Diagnoses 
Other variables were recorded during the analysis and analysed for association and 
agreement to see how they affected the diagnoses: Specimen Type (End or Slice), OPT 
Image Quality (Low or High) and OPT Confidence Score (Low or High). 
 
6.3.3. Specimen Type 
In the study sample, 25.6% of the polyp specimens were ‘slices’ and 74.4% were ‘end’ 
specimens. When assessing the influence of the specimen type on dysplasia in OPT we 
found that slices were more likely to be diagnosed as LGD and less likely to be HGD 
than ends specimens. However this trend seen did not reach statistical significance 
(p=0.089) (Table 6-8 and 6-9). The proportion of polyps diagnosed as ICA did not 
differ according to the specimen type on either OPT or H&E. There was no association 
between dysplasia and specimen type on H&E (p=0.299). 
 
 End Slice 
H&E LGD 345 (69.7%) 116 (68.2%) 
H&E HGD 103 (20.8%) 31 (18.2%) 
H&E ICA 47 (9.5%) 23 (13.5%) 
Total 495 170 
P-value* 0.299 
Table 6-8 H&E Dysplasia Of Polyps According To Specimen Type 
Number (n); % Column; *chi-squared 
 
 End Slice 
OPT LGD 212  (42.8%) 86  (50.6%) 
OPT HGD 172  (34.8%) 44  (25.9%) 
OPT ICA 111 (22.4%) 40  (23.5%) 
Total 495 170 
P-value* 0.089 
Table 6-9 OPT Dysplasia Of Polyps According To Specimen Type 
Number (n); % Column; *chi-squared 
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The diagnosis of surface morphology was significantly linked to the specimen type. 
Slices were more likely to be diagnosed as TVA or VA rather than TA (Table 6-10 and 
6-11). Interestingly, this trend was applicable to both the H&E (p=0.001) and OPT 
diagnoses (p<0.000). 
 
 End Slice 
H&E TA 157 (31.8%) 30 (17.7%) 
H&E TVA 331 (67.0%) 136 (80.0%) 
H&E VA 6 (1.2%) 4 (2.4%) 
Total 494 170 
P-value* 0.001 
Table 6-10 H&E Morphology Diagnoses According To Specimen Type 
Number (n); % Column; *chi-squared 
 
 End Slice 
OPT TA 183 (37.0%) 28 (16.5%) 
OPT TVA 269 (54.3%) 118 (69.4%) 
OPT VA 43 (8.7%) 24 (14.1%) 
Total 495 170 
P-value* <0.000 
Table 6-11 OPT Morphology Diagnoses According To Specimen Type 
Number(n); % Column; *chi-squared 
 
On OPT, Epithelial displacement (EPD), was observed more frequently on slices 
(14.1%) than end specimens (3.4%) and this difference was statistically significant 
(p<0.000). This trend was also seen on H&E although the difference was marginal and 
did not reach statistical significance (p=0.120) (Table 6-12 and 6-13). 
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 End Slice 
H&E No 444 (89.7%) 145 (85.3%) 
H&E Yes 51 (10.3%) 25 (14.7%) 
Total 495 170 
P-value* 0.120 
Table 6-12 H&E EPD Diagnoses According To Specimen Type 
Number (n); % Column; *chi-squared 
 
 End Slice 
OPT No 478 (96.6%) 146 (85.9%) 
OPT Yes 17 (3.4%) 24 (14.1%) 
Total 495 170 
P-value* 0.000 
Table 6-13 OPT EPD Diagnoses According To Specimen Type 
Number(n) % Column; *chi-squared 
 
There was no association between specimen type and ulceration using either H&E (p= 
0.661) or OPT (p=0.114) (Table 6-14 and 6-15). 
 
 End Slice 
H&E No 491 (99.2%) 168 (98.8%) 
H&E Yes 4 (66.7%) 2 (33.3%) 
Total 495 170 
P-value* 0.661 
Table 6-14 H&E Ulceration Diagnoses According To Specimen Type 
Number (n) % Column; *chi-squared 
 
 End Slice 
OPT No 406 (82.0%) 130 (76.5%) 
OPT Yes 89 (18.0%) 40 (23.5%) 
Total 495 170 
P-value* 0.114 
Table 6-15 OPT EPD Diagnoses According To Specimen Type 
Number (n) % Column; *chi-squared 
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Overall agreement in H&E and OPT dysplasia diagnoses for end and slice specimens 
was 55.4% (κ0.27) and 57.7% (κ0.26) respectively (Table 6-16). Agreement was 
marginally better when assessing this agreement with morphology (end κ0.38; slice 
κ0.32) (Table 6-17). 
 
  OPT LGD OPT HGD OPT ICA Total 
H&E LGD 
End 
192 
(55.7%) (90.6%) 
118 
(34.2%) (68.6%) 
35 
(10.1%) (31.5%) 
345 
Slice 
73 
(62.9%) (84.8%) 
32 
(27.6%) (72.7%) 
11 
(9.5%) (27.5%) 
116 
H&E HGD 
End 
19 
(18.5%) (9.0%) 
45 
(43.7%) (26.2%) 
39 
(37.9%) (35.1%) 
103 
Slice 
11 
(35.5%) (12.8%) 
8 
(25.8%) (18.2%) 
12 
(38.7%) (30.0%) 
31 
HGD ICA 
End 
1 
(2.1%) (0.5%) 
9 
(19.2%) (5.2%) 
37 
(78.7%) (33.3%) 
47 
Slice 
2 
(8.7%) (2.3%) 
4 
(17.4%) (9.1%) 
17 
(73.9%) (42.5%) 
23 
Total 
End 212 172 111 
665 
Slice 86 44 40 
% Agreement 
End 55.4% 
Slice 57.7% 
Kappa (SE) 
End 0.27 (0.03) ‘Fair’ 
Slice 0.26 (0.05) ‘Fair’ 
Sensitivity/ 
Specificity** 
End 78.7%/83.5% 
Slice 73.9%/84.4% 
Table 6-16 Agreement Of Dysplasia On H&E & OPT According To Specimen Type 
Number (n); % Row; % Column ** Using two groups LGD/HGD and ICA 
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  OPT TA OPT TVA OPT VA Total 
H&E TA 
End 
110 
(70.1%) (60.4%) 
44 
(28.0%) (16.4%) 
3 
(1.9%) (7.0%) 
157 
Slice 
15 
(50.0%) (53.6%) 
13 
(43.3%) (11.0%) 
2 
(6.7%) (8.3%) 
30 
H&E TVA 
End 
72 
(21.8%) (39.6%) 
222 
(67.1%) (82.5%) 
37 
(11.2%) (86.1%) 
331 
Slice 
13 
(9.6%) (46.4%) 
104 
(76.5%) (88.1%) 
19 
(14.0%) (79.2%) 
136 
HGD VA 
End 0 
3 
(50.0%) (1.2%) 
3 
(50.0%) (7.0%) 
6 
Slice 0 
1 
(25.0%) (0.9%) 
3 
(75.0%) (12.5%) 
4 
Total 
End 182 269 43 
664 
Slice 28 118 24 
% Agreement 
End 67.8% 
Slice 71.7% 
Kappa (SE) 
End 0.38 (0.04) ‘Fair’ 
Slice 0.32 (0.06) ‘Fair’ 
Sensitivity/ 
Specificity** 
End 78.6%/70.1% 
Slice 90.7%/50.0% 
Table 6-17 Agreement Of Morphology On H&E & OPT According To Specimen Type 
Number (n); % Row; % Column ** Using two groups LGD/HGD and ICA 
 
  OPT No OPT Yes Total 
H&E No 
End 
430 
(96.9%) (90.0%) 
14 
(3.2%) (82.4%) 
444 
Slice 
127 
(87.6%) (87.0%) 
18 
(12.4%) (75.0%) 
145 
H&E Yes 
End 
48 
(94.1%) (10.0%) 
3 
(5.9%) (17.7%) 
51 
Slice 
19 
(76.0%) (13.0%) 
6 
(24.0%) (25.0%) 
25 
Total 
End 478  17  
665 
Slice 146  24  
% Agreement 
End 87.5% 
Slice 78.2% 
Kappa (SE) 
End 0.04 (0.04) ‘Poor’ 
Slice 0.12 (0.08) ‘Poor’ 
Sensitivity/ 
Specificity** 
End 5.9%/96.9% 
Slice 24.0%/87.6% 
Table 6-18 Agreement Of EPD According To Specimen Type  
Number (n); % Row; % Column. ** Using two groups LGD/HGD and ICA. 
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When considering the specimen type, agreement of EPD (Table 6-18) and ulceration 
(Table 6-19) was extremely poor but this was expected, as the overall agreement was 
also poor as noted in Table 6-6 and 6-7. 
 
  OPT No OPT Yes Total 
H&E No 
End 
403 
(82.1%) (99.3%) 
88 
(17.9%) (98.9%) 
491 
 
Slice 
129 
(76.8%) (99.2%) 
39 
(23.2%) (97.5%) 
168 
 
H&E Yes 
End 
3 
(75.0%) (0.74%) 
1 
(25.0%) (1.1%) 
4  
Slice 
1 
(50.0%) (0.8%) 
1 
(50.0%) (2.5%) 
2  
Total 
End 406  89  
665 
Slice 130  40  
% Agreement 
End 81.6% 
Slice 76.5% 
Kappa (SE) 
End 0.01 (0.02) 
Slice 0.03 (0.03) 
Sensitivity/ 
Specificity** 
End 25.0%/82.1% 
Slice 50.0%/76.8% 
Table 6-19 Agreement Of Ulceration According To Specimen Type 
Number (n); % Row; % Column ** Using two groups LGD/HGD and ICA. 
6.3.4. Confidence scores 
Confidence scores (1 to 5) were assigned to OPT diagnosed images only and were 
determined by several of factors such as image quality and specimen type (end or slice) 
and for the purposes of data analysis grouped into a high confidence (score 4 to 5) and a 
low confidence (score 1 to 3). 
 
An assessment was made to determine the effect the Confidence Score had on the 
following: 
• Overall Dysplasia 
• Overall Morphology 
• Agreement in Dysplasia 
• Agreement in morphology 
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The median OPT confidence score was 3 for dysplasia and 4 for morphology inferring 
that the morphology diagnosis was easier to make (Table 6-20). Confidence scores were 
only allocated for EPD and ulceration when it was observed as being present and 
therefore are not included in the analysis. 
 
Confidence Score Dysplasia Morphology 
1 74 (11.1%) 23 (3.5%) 
2 209 (31.4%) 91 (13.7%) 
3 178 (26.8%) 186 (28.0%) 
4 162 (24.4%) 302 (45.4%) 
5 42 (6.3%) 63 (9.5%) 
Mean 2.8 3.4 
Median 3 4 
Table 6-20 Confidence Scores In The Overall Dysplasia And Morphology 
Number(n); % Column 
 
The confidence score was significantly associated with OPT dysplasia diagnoses 
(p<0.000) (Table 6-21) using the chi-squared goodness for fit statistical test. OPT 
diagnosed HGD polyps were associated with a lower confidence score (mean 2.4; 
median 2) and this was statistically significant when using the Kruskal-Wallis test 
(P<0.000). There was no association between confidence score and OPT morphology 
(Table 6-22). 
 
 
 
 
 
 
 
 
 
145 
 Low High Mean Score Median Score 
LGD 185 
(62.1%) (40.1%) 
113 
(37.9%) (55.9%) 3.1 3 
HGD 181 
(83.8%) (39.3%) 
35 
(16.2%) (17.2%) 2.4 2 
ICA 95 
(62.9%) (20.6%) 
56 
(37.1%) (27.5%) 3.0 3 
Total 461 204   
P-value 0.000*  0.000** 
Table 6-21 Association Of Confidence Score With OPT Dysplasia 
Number (n); % Row; % Column *chi-squared. **Kruskal-Wallis test 
 
 Low High Mean Score Median Score 
TA 100 
(47.4%) (33.3%) 
111 
(52.6%) (30.4%) 3.4 4 
TVA 163 
(42.1%) (54.3%) 
224 
(57.9%)(61.4%) 3.5 4 
VA 37 
(55.2%) (12.3%) 
30 
(44.8%) (8.2%) 3.4 3 
Total 300  365   
P-value 0.100*  0.22** 
Table 6-22 Association Of Confidence Score With OPT Morphology 
Number (n); % Row; % Column *chi-squared. **Kruskal-Wallis test 
 
Agreement between H&E and OPT dysplasia diagnoses was considerably better among 
specimens with high OPT confidence scores (κ0.53 versus κ0.15). 35 ICA polyps on 
H&E were allocated a high OPT confidence score and of these, 33 specimens were also 
diagnosed as ICA on OPT giving a sensitivity of 94.3%. The remaining 2 specimens in 
this group were classified as HGD and therefore the observer still had a high index of 
suspicion when making a diagnosis (Table 6-23). 
 
In contrast, when considering the ICA polyps on H&E with a low OPT confidence score 
the sensitivity only reached 60.0%. This suggests that the quality factors controlling the 
confidence score, as previously mentioned, have an indirect impact on diagnostic 
accuracy.  
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  OPT LGD OPT HGD OPT ICA Total 
H&E LGD 
Low 159 
(49.1%) (86.0%) 
129 
(39.8%) (71.3%) 
36 
(11.1%) (37.9%) 
324 
High 106 
(77.4%) (93.8%) 
21 
(15.3%) (60.0%) 
10 
(7.3%) (17.9%) 
137  
H&E HGD 
Low 23 
(22.6%) (12.4%) 
41 
(40.2%) (22.7%) 
38 
(37.3%) (40.0%) 
102 
High 7 
(21.9%) (6.2%) 
12 
(37.5%) (34.3%) 
13 
(40.6%) (23.2%) 
32 
HGD ICA 
Low 3 
(8.6%) (1.6%) 
11 
(31.4%) (6.1%) 
21 
(60.0%) (22.1%) 
35 
High 0 2 
(5.7%) (5.7%) 
33 
(94.3%) (58.9%) 
35 
Total 
Low 185 181 95 
665 
High 35 56 113 
% Agreement 
Low 47.9% 
High 74.0% 
Kappa (SE) 
Low 0.15 (0.03) 
High 0.53 (0.05) 
Sensitivity/ 
Specificity** 
Low 60.0%/82.6% 
High 94.3%/86.4% 
Table 6-23 Agreement Of Dysplasia By Confidence Score 
Number (n); % Row; % Column 
 
Overall agreement of surface morphology was better with a high confidence score 
(74.8%, κ0.49) than a low confidence score (61.5%, κ0.25). 71.9% polyps were 
classified with a villous (i.e. TVA/VA) morphology on H&E but on OPT 17.8% of 
these were re-diagnosed with a non-villous (i.e. TA) morphology. However only 6.7% 
of these specimens were allocated a high confidence score so this is unlikely to be of 
any significance. 
 
It was clear that a high confidence score correlated with a better agreement between 
morphology diagnoses similarly to dysplasia. When assessing the percentage agreement 
between each morphology sub-group, it was noticeable that when a high confidence 
score was recorded the agreement was better than when a low confidence score was 
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recorded. This trend was observed in each sub group. Sensitivity and specificity for 
surface morphology agreement was also better in the high confidence group (87.4% and 
70.5% respectively) than in the low confidence group (76.3% and 61.3% respectively) 
(Table 6-24). 
 
  OPT TA OPT TVA OPT VA Total 
H&E TA 
Low 46 
(61.3%) (46.5%) 
25 
(33.3%) (15.3%) 
3 
(5.3%) (10.8%) 75 
High 79 
(70.5%) (71.2%) 
32 
(28.6%) (14.3%) 
1 
(0.9%) (30.7%) 112 
H&E TVA 
Low 53 
(23.9%) (53.5%) 
137 
(61.7%) (84.1%) 
32 
(14.4%) (86.5%) 222 
High 32 
(13.1%) (28.8%) 
189 
(77.1%) (84.4%) 
24 
(9.8%) (80.0%) 245 
HGD VA 
Low 0  1 
(50.0%) (0.6%) 
1 
(50.0%) (2.7%) 2 
High 0 3 
(37.5%) (1.3%) 
5 
(62.5%) (16.7%) 8 
Total 
Low 99 163 37 
664 
High 111 224 30 
% Agreement 
Low 61.5% 
High 74.8% 
Kappa (SE) 
Low 0.25 (0.04) 
High 0.49 (0.04) 
Sensitivity/ 
Specificity** 
Low 76.3%/61.3% 
High 87.4%/70.5% 
Table 6-24 Agreement Of Morphology By Confidence Score 
Number (n); % Row; % Column 
 
6.3.5. Image quality 
Image quality (IQ) was scored in a similar way to the confidence score on a scale of 1 to 
5 as a subjective assessment made by the observer (me). The median IQ was 4 
indicating that the majority of OPT images were considered of good quality and this is a 
reflection of the precision taken during the processing of polyp specimens in the 
laboratory prior to OPT scanning. It emphasises how important the optimisation phase 
one stage of the study was (Table 6-25 and Figure 6-3).   
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Image Quality (IQ) Number (n,%) 
1 20 (3.0%) 
2 65 (9.8%) 
3 153 (23.0%) 
4 306 (46.0%) 
5 121 (18.2%) 
Mean 3.7 
Median 4 
Table 6-25 Summary Of Distribution Of IQ Scores 
A Table and Pie Chart showing the distribution of IQ scores 
 
For the purposes of analysis the IQ was classified into two main groups: low IQ (Score 
1 to 3) and high IQ (score 4 to 5). The analysis showed there was an association 
between the IQ and both the dysplasia (Table 6-26) and morphology diagnoses (Table 
6-27). 
 
 Low High Mean Median 
OPT LGD 108 
(36.2%) (45.4%) 
190 
(63.8%) (44.5%) 3.7 4 
OPT HGD 91 
(42.1%) (38.2%) 
125 
(57.9%) (29.3%) 3.5 4 
OPT ICA 39 
(25.8%) (16.4%) 
112 
(74.2%) (26.2%) 3.8 4 
Total 238 427   
P-value* 0.006 
Table 6-26 Association Of Image Quality With OPT Dysplasia 
Number (n), %o Row, % Column; *chi-squared 
 
 Low High Mean Median 
OPT TA 84 
(39.8%) (35.3%) 
127 
(60.2%) (29.7%) 
3.5 4 
OPT TVA 141 
(36.4%) (59.2%) 
246 
(63.6%) (57.6%) 
3.7 4 
OPT VA 13 
(19.4%) (5.5%) 
54 
(80.6%) (12.7%) 
3.9 4 
Total 238  427   
P-value* 0.009 
Table 6-27 Association Of Image Quality With OPT Morphology 
Number (n), %o Row, % Column; *chi-squared 
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High quality images were more likely to be ICA on OPT than low quality images with 
74.2% of ICA polyps on OPT classified as IQ 4 or 5. Similarly a greater proportion of 
VA polyps were graded as high quality (80.6%) in comparison to low quality (19.4%). 
The IQ was not significantly associated with either the presence of EPD (p=0.434) or 
ulceration (p=0.517). 
 
  OPT LGD OPT HGD OPT ICA Total 
H&E LGD Low IQ 
98 
(53.6%) (90.7%) 
66 
(36.1%) (72.5%) 
19 
(10.4%) (48.7%) 
183 
 High IQ 
167 
(60.1%) (87.9%) 
84 
(30.2%) (67.2%) 
27 
(9.7%) (24.1%) 
278 
H&E HGD Low IQ 
8 
(19.1%) (7.4%) 
20 
(47.6%) (22.0%) 
14 
(33.3%) (35.9%) 
42 
 High IQ 
22 
(23.9%) (11.6%) 
33 
(35.9%) (26.4%) 
37 
(40.2%) (33.0%) 
92 
H&E ICA Low IQ 
2 
(15.4%) (1.9%) 
5 
(38.5%) (5.5%) 
6 
(46.2%) (15.4%) 
13 
 High IQ 
1 
(1.8%) (0.5%) 
8 
(14.0%) (6.4%) 
48 
(84.2%) (42.9%) 
57 
Total Low IQ 108 91 39 
665 
 High IQ 190  125  112 
% Agreement 
Low IQ 52.1% 
High IQ 58.1% 
Kappa (SE) 
Low IQ 0.17 (0.04) 
High IQ 0.32 (0.03) 
Sensitivity/ 
Specificity 
Low IQ 46.2%/85.3% 
High IQ 84.2%/82.7% 
Table 6-28 Agreement Of Dysplasia By Image Quality (IQ) 
Number (n), % Row, % Column 
 
There was a stronger agreement between H&E and OPT diagnoses for dysplasia when 
there was a high IQ (58.1%, κ 0.32) compared to a low IQ (52.1%, κ 0.17) although the 
difference was marginal.  However, the sensitivity was considerably better (84.2% 
versus 46.2%) than with a low IQ (Table 6-28).  
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  OPT TA OPT TVA OPT VA Total 
H&E TA Low IQ 54 
(65.9%) (64.3%) 
28 
(34.2%) (19.9%) 0 82 
 High IQ 71 
(67.6%) (56.4%) 
29 
(27.6%) (11.8%) 
5 
(4.8%) (9.3%) 105 
H&E TVA Low IQ 30 
(19.5%) (35.7%) 
113 
(73.4) (80.1) 
11 
(7.1%) (84.6%) 154 
 High IQ 55 
(17.6%) (43.7%) 
213 
(68.1%) (86.6%) 
45 
(14.4%) (83.3%) 313 
H&E VA Low IQ 0 0 2 
(100%) (15.4%) 2 
 High IQ 0 4 
(50.0%) (1.6%) 
4 
(50.0%) (7.4%) 8 
Total Low IQ 84 141 13 
665 
 High IQ 126 246 54 
% Agreement 
Low IQ 71.0% 
High IQ 67.6% 
Kappa (SE) 
Low IQ 50.5 (0.06) 
High IQ 50.0 (0.04) 
Sensitivity/ 
Specificity 
Low IQ 80.8%/65.9% 
High IQ 82.9%/67.6% 
Table 6-29 Agreement Of Morphology By Image Quality (IQ) 
Number (n), % Row, % Column 
 
Image quality, based primarily on cross-sectional images, did not affect agreement 
between the morphology of H&E and OPT diagnoses and conversely a slightly better 
agreement was seen on the low quality images (71%) than the high quality images 
(67.6%) (Table 6-29).  
 
IQ score was compared with confidence scoring and as expected there was a strongly 
significant correlation for both the dysplasia (p<0.000) and morphology (p<0.000) 
diagnoses with a higher confidence score being associated with higher quality images 
(Table 6-30). 
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Image quality Mean Dysplasia CS Mean Morphology CS 
1 1.7 (SE 0.9) 2.2 (SE 1.3) 
2 2.0 (SE 1.0) 2.9 (SE 1.0) 
3 2.6 (SE 1.0) 3.6 (SE 0.9) 
4 2.9 (SE 1.1) 3.5 (SE 0.9) 
5 3.5 (SE 1.0) 3.7 (SE 0.9) 
p-value* 0.000 0.000 
Table 6-30 Association Between Image Quality And Confidence Score 
* chi-squared test 
 
6.3.6. Factors Associated With Dysplasia 
A further analysis was performed to see if dysplasia on H&E and OPT was 
independently associated with any of the following variables: 
 
• Morphology 
• Epithelial Displacement 
• Ulceration 
• Percentage Villousness 
• Pit Pattern Classification 
• Vasculature 
 
6.3.6.1. Dysplasia and Morphology 
The dysplasia diagnoses were strongly associated with the morphology on H&E 
(p=0.001) and OPT (p=0.003). HGD and ICA polyps on H&E were more likely to be 
associated with TVA than LGD polyps accounting for 79.9 % and 78.3% respectively. 
A different trend was seen in OPT specimens with a greater proportion (43.1%) of ICA 
polyps being classified as TA than LGD (30.5%) or HGD (25.5%) (Table 6-31 and 6-
32). 
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 TA TVA VA 
LGD 145 
(31.5%) (77.5%) 
306 
(66.4%) (65.5%) 
10 
(2.2%) (100%) 
HGD 27 
(20.2%) (14.4%) 
107 
(79.9%) (22.9%) 0 
ICA 15 
(21.7%) (8.0%) 
54 
(78.3%) (11.6%) 0 
P-value* 0.001 
Table 6-31 Association Between Dysplasia And Morphology On H&E 
Number (n), % Row, % Column; *chi-squared 
 
 TA TVA VA 
LGD 91 
(30.5%) (43.1%) 
182 
(61.1%) (47.0%) 
25 
(8.4%) (37.3%) 
HGD 55 
(25.5%) (26.1%) 
131 
(60.6%) (33.9%) 
30 
(13.9%) (44.8%) 
ICA 65 
(43.1%) (30.8%) 
74 
(49.0%) (19.1%) 
12 
(8.0%) (17.9%) 
P-value* 0.003 
Table 6-32 Association Between Dysplasia And Morphology On OPT 
Number (n), % Row, % Column; *chi-squared 
 
6.3.6.2. Dysplasia and Epithelial Displacement 
There was significant association between the dysplasia and EPD on H&E (p=0.003) 
and none of the ICA specimens were recorded as having EPD probably because it 
became an irrelevant feature of the histopathology once cancer had been diagnosed. 
However, EPD does co-exist in cancer specimens which is what makes it particularly 
challenging when histopathologically interpreting them for diagnosis (Table 6-33). 
 
No association was seen between dysplasia and EPD on OPT (p=0.172) (Table 6-34) 
which correlates with less EPD being observed on OPT specimens (Table 6-6). 
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 No Yes 
LGD 406 
(88.1%) (68.9%) 
55 
(11.9%) (72.4%) 
HGD 113 
(84.3%) (19.2%) 
21 
(15.7%) (27.6%) 
ICA 70 
(100%) (11.9%) 0 
P-value* 0.003 
Table 6-33 Dysplasia And EPD On H&E 
Number (n), % Row, % Column; *chi-squared 
 
 No Yes 
LGD 274 
(92.0%) (43.9%) 
24 
(8.1%) (58.5%) 
HGD 205 
(94.9%) (32.9%) 
11 
(5.1%) (26.8%) 
ICA 145 
(96.0%) (23.2%) 
6 
(4.0%)(14.6%) 
P-value* 0.172 
Table 6-34 Dysplasia And EPD On OPT 
Number (n), % Row, % Column; *chi-squared 
 
6.3.6.3. Dysplasia and Ulceration 
 Ulceration was significantly associated with dysplasia on OPT (p<0.000) but not on 
H&E (p=0.878). OPT diagnoses of ICA specimens were more likely to have a recorded 
diagnosis of ulceration (43.7%) in comparison to LGD (8.4%) and HGD (17.6%) 
specimens (Table 6-35 and 6-36). 
 
 No Yes 
LGD 457 
(99.1%) (69.4%) 
4 
(0.9%) (66.7%) 
HGD 113 
(99.3%) (20.2%) 
1 
(0.8%) (16.7%) 
ICA 69 
(98.6%) (10.5%) 
1 
(1.4%) (16.7%) 
P-value* 0.878 
Table 6-35 Dysplasia And Ulceration On H&E 
Number (n), % Row, % Column; *chi-squared 
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 No Yes 
LGD 273 
(91.6%) (50.9%) 
25 
(8.4%) (19.4%) 
HGD 178 
(82.4%) (33.2%) 
38 
(17.6%) (29.5%) 
ICA 85 
(56.3%) (15.9%) 
66 
(43.7%) (51.2%) 
P-value* 0.000 
Table 6-36 Dysplasia And Ulceration On OPT 
Number (n), % Row, % Column; *chi-squared 
 
6.3.6.4. Dysplasia and Percentage Villousness 
The Percentage Villousness was recorded in 10% aliquots from 0 to 100 and was a 
subjective qualitative evaluation of the surface morphology. The results showed a wide 
variation in villousness for each dysplasia diagnosis and no significant association 
(p=0.016) (Table 6.28). The ICA specimens tended to have a lower ‘Percentage 
Villousness’ recorded (Median 30) compared to those with LGD or HGD. 
 
 Number (n) Mean (SD) Range Median IQR 
LGD 298 39.9 (28.6) 0-100 40 17.5-60 
HGD 216 43.7 (29.7) 0-100 40 20-70 
ICA 151 34.7 (27.3) 0-100 30 10-50 
Total 665 39.9 (28.8) 0-100 40 10-60 
P-value* 0.016 
Table 6-37 Dysplasia And % Villousness On OPT 
 SD, Standard Deviation; IQR Interquartile Range *Chi-square for difference in medians 
 
6.3.6.5. Dysplasia and Pit Pattern Classification (PPC) 
OPT images were also grouped according to the PPC described by Kudo et al [47]. 
Each specimen was given a primary PPC, defined as the dominant pattern type observed 
in the polyp. A secondary PPC type was recorded if a further pattern type was also 
clearly observed but to a lesser extent. 
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The primary PPC was significantly associated with OPT dysplasia diagnosis (p=0.000) 
(Table 6-38). The most commonly recorded PPC types were IIIL (31.7%) and IV 
(50.8%). A primary PPC Type V was more likely to have dysplasia diagnosis of ICA 
(52.9%) rather than LGD (18.6%). The ICA OPT specimens were more frequently 
recorded as Type IIIS (33.3%) rather than Type IV (15.1%). This correlates well with 
what is known in the endoscopy literature regarding the malignant potential of polyps 
with these pit patterns [47]. 
 
The secondary PPC showed no association with OPT dysplasia diagnoses (p=0.509). 
However, type V secondary PPC was observed more frequently in ICA specimens than 
in LGD or HGD specimens. 
 
 I IIIL IIIS IV V Total 
LGD 1 
(0.3%) (100%) 
100 
(33.6%) 
(47.4%) 
21 
(7.1%) 
(46.7%) 
163 
(54.7%) 
(48.2%) 
13 
(4.4%) 
(18.6%) 
298 
HGD 
0 
63 
(29.2%) 
(29.9%) 
9 
(4.2%) 
(20.0%) 
124 
(57.4%) 
(36.7%) 
20 
(9.3%) (28.6%) 216 
ICA 
0 
48 
(31.8%) 
(22.8%) 
15 
(9.9%) 
(33.3%) 
51 
(33.8%) 
(15.1%) 
37 
(24.5%) 
(52.9%) 
151 
Total 1 211 45 338 70 665 
P-value* 0.000 
Table 6-38 Dysplasia And Primary PPC 
Number (n), % Row, % Column; *chi-squared 
 
6.3.6.6. Dysplasia and Vasculature 
There was a significant association between OPT dysplasia and the presence of a visible 
vasculature network in the polyp (p=0.028). Proportionally, the vessels were observed 
less in ICA polyps (33.1%) compared to HGD (45.8%) and LGD (45.0%) (Table 6-39). 
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 No Yes Total 
LGD 164 
(55.0%) (42.9%) 
134 
(45.0%) (47.4%) 298 
HGD 117 
(54.2%) (30.6%) 
99 
(45.8%) (35.0%) 216 
ICA 101 
(66.9%) (26.4%) 
50 
(33.1%) (17.7%) 151 
Total 382 283 665 
P-value* 0.028 
Table 6-39 Dysplasia And Vasculature On OPT 
Number (n), % Row, % Column; *chi-squared 
 
 
Figure 6-3 Polyp Vasculature On OPT In MIP View 
The Network of vessels is more visible on LGD and HGD than ICA polyps. 
 
LGD HGD 
ICA ICA 
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6.3.7. Variables Affecting Agreement In Dysplasia 
An assessment was made to see if the following variables, recorded on OPT datasets, 
affected the degree of agreement that existed in the dysplasia diagnosis between H&E 
and OPT. 
 
• Morphology 
• Percentage Villousness 
• Pit Pattern Classification 
• Presence of a Stalk. 
 
There were no associations found between epithelial displacement, ulceration or the 
observation of vessels on agreement of dysplasia diagnoses and are therefore not 
discussed any further here. 
 
6.3.8. Effect of morphology on dysplasia agreement 
Specimens classified as ICA on OPT but not on H&E were more likely to be classified 
as TA on OPT which was of borderline significance (p=0.094) (Table 6-40(i)) but when 
restricted to high quality images was non-significant (p=0.420) (Table 6-41(i)).  
 
ICA Specimens on H&E but not using OPT were less likely to have an OPT 
morphology of TA and this trend was statistically significant when considering the high 
quality images (p=0.031). However, the sample size in this group was so small (n=9) it 
is unlikely to be of any relevance (Table 6-40(ii) and 6-41(ii)) and the clinical relevance 
in the context of a cancer is likely to be nil. 
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(i) ALL SPECIMENS OPT TA OPT TVA OPT VA Total 
H&E ICA 
OPT ICA 
17 
(31.5%) (26.2%) 
32 
(59.3%) (43.2%) 
5 
(9.3%) (41.7%) 
54 
 
H&E HGD 
21 
(41.2%) (32.3%) 
25 
(49.0%) (33.8%) 
5 
(9.8%) (41.7%) 
51 
H&E LGD 
27 
(58.7%) (41.5%) 
17 
(37.0%) (23.0%) 
2 
(4.4%) (16.7%) 
46 
Total 65 74 12 151 
P-value* 0.094 
 
(ii) ALL SPECIMENS OPT TA OPT TVA OPT VA Total 
H&E ICA 
OPT ICA 17 
(31.5%) (89.5%) 
32 
(59.3%) (76.2%) 
5 
(9.3%) (55.6%) 
54 
OPT HGD 2 
(15.4%) (10.5%) 
7 
(53.9%) (16.7%) 
4 
(30.8) (44.4) 
13 
OPT LGD 0 3 
(100%) (7.1%) 
0 3 
Total 19  42  9 70 
P-value* 0.141 
Table 6-40 Association Of OPT Morphology With Dysplasia Agreement: All Specimens 
Classified as (i) ICA on OPT (ii) ICA on H&E. Number (n), % Row, % Column, *chi-squared 
 
(i) HIGH IQ ONLY OPT TA OPT TVA OPT VA Total 
H&E ICA 
OPT ICA 
14 
(29.2%) (33.3%) 
30 
(62.5%) (49.2%) 
4 
(8.3%) (44.4%) 
48 
H&E HGD 
14 
(37.8%) (33.3%) 
20 
(54.1%) (32.8%) 
3 
(8.1%) (33.3%) 
37 
H&E LGD 14 
(51.9%) (33.3%) 
11 
(40.7%) (18.0%) 
2 
(7.4%) (22.2%) 
27 
Total 42 61 9 112 
P-value* 0.420 
 
(ii) HIGH IQ ONLY OPT TA OPT TVA OPT VA Total 
H&E ICA 
OPT ICA 14 
(29.2%) (93.3%) 
30 
(62.5%) (88.2%) 
4 
(8.3%) (50.0%) 
48 
OPT HGD 1 
(12.5%) (6.7%) 
3 
(37.5%) (8.8%) 
4 
(50.0%) (50.0%) 
8 
OPT LGD 0 1 
(100%) (2.9%) 
0 1 
Total 15 34 8  57 
P-value* 0.031 
Table 6-41 Association Of OPT Morphology With Dysplasia Agreement: High Quality 
Classified as (i) ICA on OPT and (ii) ICA on H&E. Number (n), % Row, % Column, *chi-squared 
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6.3.9. Effect of percentage villousness on dysplasia agreement 
Specimens diagnosed with ICA on OPT but not on H&E tended to have a lower villous 
percentage with a median of 20% villousness for LGD H&E specimens and 30% for 
HGD H&E specimens.  This was only statistically significant when a high confidence 
score was applied (p=0.018) (Table 6-42). 
 
ALL SPECIMENS Number (n) Mean (sd) Range Median IQR 
H&E ICA 
OPT ICA 
54 38.0 (27.8) 0-90 40 10-60 
H&E HGD 51 37.8 (30.0) 0-100 30 10-60 
H&E LGD 46 27.4 (22.5) 0-90 20 10-40 
P-value* 0.146 
HIGH CS ONLY Number (n) Mean (sd) Range Median IQR 
H&E ICA 
OPT ICA 
33 33.0 (26.0) 0-90 30 10-60 
H&E HGD 13 26.9 (24.6) 0-70 30 5-50 
H&E LGD 10 20 (16.3) 0-60 20 10-22.5 
P-value* 0.018 
Table 6-42 Association Of Percentage Villousness With Dysplasia Agreement: OPT 
Classified as ICA on OPT in all specimens and in those with a high confidence score (CS) only. Number 
(n), % Row, % Column, * Chi-squared Test for difference in means. 
 
Conversely, specimens diagnosed with ICA on H&E but not on OPT showed the 
opposite with tendency towards a high villous percentage (mean villousness 75%, SD 
7.1). This, again reached statistical significance (p=0.041) however the sample size in 
this group was very small (n=2). The relevance of this is therefore unclear (Table 6-43). 
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ALL SPECIMENS Number (n) Mean (sd) Range Median IQR 
H&E ICA 
OPT ICA 54 38.0 (27.8) 0-90 40 10-60 
OPT HGD 13 63.1 (31.5) 0-100 70 40-85 
OPT LGD 3 56.7 (11.5) 50-70 50 50-70 
P-value* 0.383 
HIGH CS ONLY Number (n) Mean (sd) Range Median IQR 
H&E ICA 
OPT ICA 33 33.0 (26.0) 0-90 30 10-60 
OPT HGD 2 75.0 (7.1) 70-80 75 70-80 
OPT LGD 0 - - - - 
P-value* 0.041 
Table 6-43 Association Of Percentage Villousness With Dysplasia Agreement: ICA On H&E 
Classified as ICA on H&E in all specimens and in those with a high confidence score (CS) only. Number 
(n), % Row, % Column, * Chi-squared Test for difference in means. 
 
6.3.10. Effect of Pit Pattern Classification on dysplasia agreement 
No specimens that were diagnosed as ICA on either OPT or H&E were classed as type 
II PPC. The only association reaching statistical significance with regards to the PPC 
was when specimens had been diagnosed as ICA on H&E and HGD on OPT there 
seemed to shown a dominant Type IV PPC (p=0.048). However the sample size in this 
sub group were very small therefore are unlikely to have any significance (Table 6-44 
and 6-45). 
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ALL SPECIMENS IIIL IIIS IV V Total 
H&E ICA 
OPT ICA 
15 
(31.3%) (27.8%) 
3 
(20.0%) (5.6%) 
20 
(39.2%) (37.0%) 
16 
(43.2%) (29.6%) 
54 
H&E HGD 
18 
(37.5%) (35.3%) 
5 
(33.3%) (9.8%) 
18 
(35.3%) (35.3%) 
10 
(27.0%) (19.6%) 
51 
H&E LGD 
15 
(31.3%) (32.6%) 
7 
(46.7%) (15.2%) 
13 
(25.5%) (28.3%) 
11 
(29.7%) (23.9%) 
46  
Total 48 15 51 37 151 
P-value* 0.607 
HIGH IQ ONLY IIIL IIIS IV V  
H&E ICA 
OPT ICA 
13 
(27.1%) (36.1%) 
3 
(6.3%) (23.1%) 
18 
(37.5%) (46.2%) 
14 
(29.2%) (58.3%) 
48 
H&E HGD 
13 
(35.1%) (36.1%) 
5 
(13.5%) (38.5%) 
12 
(32.4%) (30.8%) 
7 
(18.9%) (29.2%) 
37 
H&E LGD 
10 
(37.0%) (27.8%) 
5 
(18.5%) (38.5%) 
9 
(33.3%) (23.1%) 
3 
(11.1%) (12.5%) 
27  
Total 36 13 39 24 112 
P-value* 0.416 
Table 6-44 Association Of PPC With Dysplasia Agreement: ICA On OPT 
Classified as ICA on OPT in all specimens and in those with a high IQ only. Results as number (n), % 
Row, % Column, *chi-squared 
 
ALL SPECIMENS IIIL IIIS IV V Total 
H&E ICA 
OPT ICA 
15 
(83.3%) (27.8%) 
3 
(100%) (5.6%) 
20 
(62.5%) (37.0%) 
16 
(94.1%) (29.6%) 
54 
OPT HGD 
1 
(5.6%) (7.7%) 
0 
11 
(34.4%) (84.6%) 
1 
(5.9%) (7.7%) 
13 
OPT LGD 
2 
(11.1%) (66.7%) 
0 
1 
(3.1%) (33.3%) 
0 3 
Total 18 3 32 17 70 
P-value* 0.048 
HIGH IQ ONLY IIIL IIIS IV V  
H&E ICA 
OPT ICA 
13 
(27.1%) (86.7%) 
3 
(6.3%) (100%) 
18 
(37.5%) (75.0%) 
14 
(29.2%) (93.3%) 
48 
OPT HGD 
1 
(12.5%) (6.7%) 
0 6 
(75.0%) (25.0%) 
1 
(12.5%) (6.7%) 
8 
OPT LGD 
1 
(100%) (6.7%) 
0 0 0 1 
Total 15 3 24 15 57 
P-value* 0.328 
Table 6-45 Association Of PPC With Dysplasia Agreement: ICA On H&E 
Classified as ICA on H&E in all specimens and in those with a high IQ only. Results as number (n), % 
Row, % Column, *chi-squared 
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6.3.11. Effect of the identification of stalks on dysplasia agreement 
Specimens with an OPT diagnosis of ICA and an H&E diagnosis of HGD were more 
likely not to have recognisable stalks. This trend was statistically significant when 
considering all specimens in the sub group (p=0.005) and when only high quality 
images were analysed this was also statistically significant (p=0.04) (Table 6-46). The 
presence or absence of a stalk on a specimen has so many contributing factors such as 
the location of the polyp in the colon, the experience of the endoscopist, the method of 
excision at endoscopy and the OPT processing technique that this finding cannot be 
interpreted with any importance. 
 
ALL SPECIMENS No Yes Total 
H&E ICA 
OPT ICA 
27 
(50.0%) (29.7%) 
27 
(50.0%) (45.0%) 
54 
H&E HGD 40 
(78.4%) (44.0%) 
11 
(21.6%) (18.3%) 
51 
H&E LGD 24 
(52.2%) (26.4%) 
22 
(47.8%) (36.7%) 
46 
Total 91 60  
P-value* 0.005 
HIGH IQ ONLY    
H&E ICA 
OPT ICA 
24 
(50.0%) (36.7%) 
24 
(50.0%) (52.2%) 
48 
H&E HGD 28 
(75.7%) (42.4%) 
9 
(24.3%) (19.6%) 
37 
H&E LGD 14 
(51.9%) (21.2%) 
13 
(48.2%) (28.3%) 
27  
Total 66 46  
P-value* 0.040 
Table 6-46 Association Of Stalks With Dysplasia Agreement: ICA On OPT 
 Classified as ICA on OPT in all specimens and with high IQ only. Number (n), % Row, % Column; *chi-
squared 
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6.4. PHASE TWO VALIDATION 
This statistical analysis in phase two has been based on the assumption that the H&E 
histopathology diagnosis of the colorectal polyps is the gold standard. However with an 
imaging modality such as OPT which visualises more of the polyp tissue, albeit at a 
lower resolution, there is the possibility that diagnoses made on OPT could supersede 
those made on H&E. In order to ensure the gold standard diagnosis was correct a 
selection of specimens from phase two that were ‘misdiagnosed’ were re-analysed with 
deeper H&E sections to ensure the results could be validated with confidence. Twenty 
polyps were selected to undergo this validation process. Each specimen was classified 
as ICA on OPT but had been previously diagnosed as either LGD or HGD on H&E. 
None of the polyps were re-diagnosed as ICA on routine pathology. 
 
6.5. DISCUSSION 
Phase two has been an important process in evaluating the worth of OPT as a diagnostic 
tool in the clinical market. Overall we have not demonstrated that OPT, in its current 
form and within the limitations discussed in this study, is as accurate as conventional 
histopathology techniques. 
 
A potential limitation was the use of a single pathologist as the ‘gold standard’ 
diagnostic indicator. A cohort of expert pathologists could have been used as an 
alternative to collectively diagnose polyps to improve the accuracy of results. However 
this was neither practical nor feasible to co-ordinate within the time and financial 
constraints of the study. Over 950 H&E slides of colorectal polyps were re-diagnosed in 
phase one and two and in order to select experts with more or equivocal experience to 
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our ‘gold standard’ pathologist it would have been necessary to extend the project to an 
international multi-centre study. This creates further difficulties and clinical governance 
issues when transferring large numbers of human tissue samples off site. Therefore, 
under the conditions available for this study Carey was considered the ‘gold standard’ 
pathologist.  
 
 
There was a tendency to over diagnose cancer on OPT in comparison to H&E. This may 
be a result of the poorer resolution that exists because the technology is not optimised to 
scan tissue as dense as colorectal polyps. There are many features on H&E sections that 
help the pathologist in confirming cancer and identifying anatomical features such as 
the muscularis mucosa and the invasion of cancer cells through it. On some LGD and 
HGD polyps the muscularis mucosa was identified but not consistently or reliably. The 
presence of LVI is another important feature that guides clinical management in cancer 
polyps and we were not able to differentiate the lymphatic or vascular structures in 
cancer specimens and this is, again, a result of the resolution of the images obtained. 
 
Differentiating between dysplasia subgroups was difficult but when the specimens were 
categorised into benign and malignant specimens agreement improved. Conversely 
when assessing the agreement between LGD and HGD polyps the agreement decreased. 
This suggests that the observer (me) found it easier to identify a cancer specimen than a 
HGD polyp. This is also reflected in the confidence score being low HGD diagnoses. 
 
Significantly more VA polyps were diagnosed using OPT than on H&E. This reflects 
the enhanced surface detail that OPT demonstrated in 3D on Bioptonics viewer and 
explains why the correlation of surface morphology was poorer than dysplasia. 
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However, it is important to note that the villous categories of TA, TVA and VA are 
based upon a 2D image (H&E section) and raises the question of whether it is 
appropriate to classify the OPT images in the same way. 
 
OPT under diagnosed EPD of polyps in comparison to H&E sections. This is could be 
due to the poorer resolution and the difficultly in reliably identifying the muscularis 
mucosa and lamina propria. EPD is a phenomenon associated with 2D images and in 
any given cross-section on OPT (Dataviewer) it is possible to manipulate the orientation 
of the image in the orthogonal planes to create an impression of EPD. The virtual 
sectioning ability that OPT has meant that the observer was not restricted to one view 
plane and for this reason EPD was observed less. However, the OPT surface 
morphology often showed ‘depressions’ that were likely to coincide with areas of EPD 
and may be useful in guiding the cutting of specimens in the pathology lab before they 
are sectioned. 
 
Ulceration was observed more frequently on OPT and this is not surprising given more 
surface area of the polyp was visible. However, this finding needs to be validated with 
re-sectioning of some of these specimens through the areas of ulceration to confirm this 
at a cellular level. The validation part of the study (Chapter 6 Section 6.4) re-sectioned 
some suspicious polyps to ensure the H&E diagnoses were correct but this re-sectioning 
occurred in the same orientation as previous H&E sections and not in a different plane 
through the areas of concern. We were not able to perform this analysis and were 
limited by the conditions laid out by the Tayside Tissue Bank who authorised use of the 
tissue. 
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We have shown that high quality images significantly improve diagnostic accuracy of 
dysplasia and when the observer made a diagnosis with a high confidence score it was 
usually related to high quality images. Therefore it is important to address what factors 
control the production of high quality images in an attempt to improve diagnostic 
capabilities of OPT. It is likely to be multi-factorial and related to the specimen 
selection (size, colour, tissue density etc.), the pre-scanning processing (clearing and 
agarose embedding) and the scanning technique (depth of focus, movement, exposure) 
as well as the software used to image the final dataset. As so many variables affect the 
final image acquisition it can be hard to predict what controls image quality the most 
but we have demonstrated that adequate clearing is a crucial element to OPT and the 
density of polyp tissue made optimal clearing difficult to achieve in some cases. 
 
 
The PPC, used endoscopically, correlates well with the OPT images obtained in 3D on 
Bioptonics viewer. It was clear that many specimens exhibited a dual pattern and when 
considering both the primary and secondary patterns together there was a strong 
correlation between Type V and H&E diagnosed cancer specimens. Therefore many of 
the cancer polyps that were not allocated Type V PPC as the dominant (primary) pattern 
it was often diagnosed as the secondary PPC. 
 
The vessels on OPT in MIP were observed more frequently in LGD polyps than in ICA 
polyps, which is likely to be a result of the higher tissue density of ICA polyps. The 
intricate vessel network that we have observed in some polyps has never been seen, to 
my knowledge, in this much detail before. Therefore the clinical significance of the size 
and distribution of these vessels is not known and would be an important feature to 
explore further in future work.  
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CHAPTER 7:  PIT PATTERN CLASSIFICATION 
 
7.1. BACKGROUND 
There are multiple classification techniques for colorectal polyps that relate to 
diagnostic and prognostic outcomes. Kudo’s pit pattern classification is the most widely 
used endoscopic system that evaluates the surface detail of polyps in vivo with 
diagnostic correlations [47, 126]. The original classification in 1996 was devised from 
images obtained through magnifying endoscopy and as endoscopic techniques improved 
it was further validated on chromoendoscopy using indigocarmine [127]. As research 
and endoscopy techniques have progressed modifications have been made to include 
features relating to sessile serrated adenomas (SSAs) [128] to include type II-O which 
shows open pits and the adjustment of the original type V pit pattern to include Vi and 
VN which relate to depth of submucosal invasion [48, 129]. 
 
OPT can produce detailed 3D images of colorectal polyps and the surface morphology 
is seen with far greater clarity than we have ever seen before on endoscopy with narrow 
band imaging. This therefore gives us the opportunity to see how well OPT images of 
colorectal polyps relate to the current Kudo Classification and how closely it correlates 
with the underlying histology. We may also be able to identify any further patterns that 
have not been reported on. 
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7.2. OBJECTIVE 
The primary objective was to identify if the Pit Pattern Classification is appropriate for 
OPT generated images of colorectal polyps and how well observers agree. The 
secondary aim was to assess if there is any correlation between the percentage 
villousness and pit pattern type. This Pit Pattern study was two fold and involved a 
further analysis of data collected in phase two as outlined below. 
 
7.3. PIT PATTERN ANALYSIS AND KUDO’S CLASSIFICATION 
7.3.1. Method 
3D OPT images of 59 colorectal polyps were reviewed by 10 observers (five 
pathologists and five OPT experts) blinded to the diagnostic information of each 
specimen. Observers were asked to classify each image according to the six pit pattern 
classifications described by Kudo and to record a primary and if appropriate secondary 
diagnosis. 
 
Observers were initially unfamiliar with the classification technique and judgements 
were made solely on ‘pattern recognition’. Results were analysed with the 
corresponding gold standard diagnosis made from H&E stained sections.  
 
7.3.2. Results 
590 diagnoses were collated from 59 polyps. Type I and II (Figure 7-1 and 7-2), 
seemingly benign pit patterns were allocated as a primary PPC diagnosis to 3.7% and 
2.2% of OPT images respectively (Table 7-1) [130]. 
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 Type I Type II Type IIIL Type IIIS Type IV Type V Total 
H&E LGD 
7 
(3.5%) 
(3.18%) 
3 
(1.5%) 
(23.1%) 
78 
(39.0%) 
(55.7%) 
29 
(14.5%) 
(43.3%) 
67 
(33.5%) 
(31.5%) 
16 
(8.0%) 
(11.9%) 
200 
H&E HGD 
3 
(1.6%) 
(13.6%) 
4 
(2.1%) 
(30.8%) 
34 
(17.9%) 
(24.3%) 
8 
(4.2%) 
(11.9%) 
99 
(52.1%) 
(46.5%) 
42 
(22.1%) 
(31.1%) 
190 
H&E ICA 
12 
(6.0%) 
(54.5%) 
6 
(3.0%) 
(46.2%) 
28 
(14.0%) 
(20.0%) 
30 
(15.0%) 
(44.8%) 
47 
(23.5%) 
(22.1%) 
77 
(38.5%) 
(57.0%) 
200 
Total 22 13 140 67 213 135 590 
Table 7-1 Pit Pattern Classification By 10 Observers 
Results as number (n); % Row; % Column 
 
 
 
Figure 7-1 Type I PPC 
Type I PPC seen on endoscopy (A) and the corresponding OPT image (B). 
 
 
Figure 7-2 Type II PPC 
Type II PPC seen on endoscopy (A) and the corresponding OPT image (B). 
B A LGD, TA 
B 
A 
ICA, 
TVA
HGD, 
TVA
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Type II polyps are hyperplastic polyps, as described by kudo, exhibiting asteroid shaped 
pits and these are entirely benign lesions. However, the OPT polyps in figure 7-2 clearly 
shows features very similar to this asteroid pattern but the specimen is a cancer polyp 
with TVA morphology. 
 
Type IIIS polyps (Figure 7-3) are reported to contribute to 28.3% of carcinomas in the 
literature and our study sample shows that they accounted for 15% of cancer polyps. 
However when subjectively comparing polyps that were classified as Type I and IIIS 
there were distinct similarities in the morphology. Many of the specimens showed a 
uniform pattern with solitary pits distributed throughout the surface and this may 
account for the 6% of ICA polyps that were classified as a Type I. 
 
 
Figure 7-3 Type IIIS PPC 
Type IIIS PPC seen on endoscopy (A) and the corresponding OPT image (B). 
 
LGD, 
TA
LGD, 
TVA
B 
A 
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OPT surface morphology seemed to correlate well with endoscopic images for Type 
IIIL and IV (Figure 7-4 and 7-5). These examples show the intricate network of 
elongated pits and connecting crypts with folds of mucosa well defined throughout the 
surface of the polyp. It is understandable how a cross-section through such a 
configuration would exhibit villous type features. 
 
 
Figure 7-4 Type IIIL PPC 
Type IIIl PPC seen on endoscopy (A) and the corresponding OPT image (B). 
 
A 
LGD, 
TVA
LGD, 
TA
B 
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Figure 7-5 Type IV PPC 
Type IV PPC seen on endoscopy (A) and the corresponding OPT image (B). 
 
 
Figure 7-6 Type V PPC 
Type V PPC seen on endoscopy (A) and the corresponding OPT image (B). 
A 
B 
HGD, 
TA
LGD, 
VA
A 
B 
ICA, TVA HGD, 
TVA
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There were an increasing number of cancers diagnosed from Type IIIS through to Type 
V and this was shown to be statistically significant (p<0.001 Chi-Square test for trends). 
43.0% of type V diagnoses, in this subset of 59 polyps, were not ICA and the correlates 
well with the literature which reports 37.5% of Type V pit patterns as non-malignant 
(Figure 7-6) [131]. The Type V PPC is described as amorphous with an irregular shape 
and distribution of pits. There is a wide variation in patterns that exist in the surface 
morphology of polyps and when they did not fit discretely into a single category there 
was a tendency to classify them as Type V.  This may account for the slightly higher 
number of non-malignant polyps in this category. 
 
The majority of polyps exhibited tubulovillous morphology (81.4%) and were more 
likely to be diagnosed as type IV (37.1%) or type V (26.5%). Villous Polyps were 
predominantly classified as Type IV pit pattern (80.0%, n=8) although the sample size 
is too small to interpret this with any significance (Table 7-2).  
 
 Type I Type II Type IIIL Type IIIS Type IV Type V Total 
H&E TA 
7 
(7.0%) 
(31.8%) 
2 
(2.0%) 
(15.4%) 
34 
(34.0%) 
(24.3%) 
22 
(22.0%) 
(32.8%) 
27 
(27.0%) 
(12.7%) 
8 
(8.0%) 
(5.9%) 
100 
H&E TVA 
15 
(3.1%) 
(68.2%) 
11 
(2.3%) 
(84.6%) 
104 
(21.7%) 
(74.3%) 
45 
(9.4%) 
(67.2%) 
178 
(37.1%) 
(83.6%) 
127 
(26.5%) 
(94.1%) 
480 
H&E VA 0 0 
2 
(20.0%) 
(1.4%) 
0 
8 
(80.0%) 
(3.8%) 
0 10 
Total 22 13 140 67 213 135 590 
Table 7-2 PPC Correlation With H&E Morphology Diagnoses 
Pit Pattern Classification diagnoses from all observers and their relationship to the gold standard H&E 
morphology diagnoses. Results as number (n); % Row; % Column. 
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A secondary pit pattern diagnosis was allocated to 69.3% (n=407) of polyps. This 
suggestion that a dual PPC exists has not previously been described in the literature and 
although these results focus on the primary PPC observed it may be of diagnostic value. 
 
When considering the PPC observations made by pathologists and OPT experts as two 
separate sub groups there was no significant patterns seen. OPT experts used the Type 
V classification more frequently that Pathologists (26.8% vs 19.0%) but the over all 
proportion of cancer specimens allocated a Type V PPC was very similar between both 
groups (OPT Experts 37.0% and Pathologists 40.0%) (Table 7-3). 
 
Pathologists Type I Type II Type IIIL Type IIIS Type IV Type V Total 
H&E LGD 
4 
(4.0%) 
(36.4%) 
2 
(2.0%) 
(28.6%) 
39 
(39.0%) 
(60.0%) 
9 
(9.0%) 
(40.9%) 
42 
(42.0%) 
(31.3%) 
4 
(4.0%) 
(7.1%) 
100 
H&E HGD 
2 
(2.1%) 
(18.2%) 
2 
(2.1%) 
(28.6%) 
15 
(15.8%) 
(23.1%) 
2 
(2.1%) 
(9.1%) 
59 
(62.1%) 
(44.0%) 
15 
(15.8%) 
(26.8%) 
95 
H&E ICA 
5 
(5.0%) 
(45.5%) 
3 
(3.0%) 
(42.9%) 
11 
(11.0%) 
(16.9%) 
11 
(11.0%) 
(50.0%) 
33 
(33.0%) 
(24.6%) 
37 
(37.0%) 
(66.1%) 
100 
Total 11 7 65 22 134 56 295 
 
OPT Experts Type I Type II Type IIIL Type IIIS Type IV Type V Total 
H&E LGD 
3 
(3.0%) 
(27.3%) 
 1 
(1.0%) 
(16.7%) 
39 
(39.0%) 
(52.0%) 
20 
(20.0%) 
(44.4%) 
25 
(25.9%) 
(31.6%) 
12 
(12.0%) 
(15.2%) 
100 
H&E HGD 
1 
(1.1%) 
(9.1%) 
2 
(2.1%) 
(33.3%) 
19 
(20.0%) 
(25.3%) 
6 
(6.3%) 
(13.3%) 
40 
(42.1%) 
(50.6%) 
27 
(28.4%) 
(34.2%) 
95 
H&E ICA 
7 
(7.0%) 
(63.6%) 
3 
(3.0%) 
(50.0%) 
17 
(17.0%) 
(22.7%) 
19 
(19.0%) 
(42.2%) 
14 
(14.0%) 
(17.7%) 
40 
(40.0%) 
(50.6%) 
100 
Total 11 6 75 45 79 79 295 
Table 7-3 Association Between Pit Pattern Classification And H&E Dysplasia 
Two sets of observers (Pathologists and OPT experts) were considered independently. Results as number 
(n); % Row; % Column 
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7.4. VILLOUSNESS AND PIT PATTERN ANALYSIS 
7.4.1. Method 
Results from phase two, using the 665 colorectal polyps from the archive, were re-
analysed to see if there was a correlation between the percentage villousness and the 
predominant type of pit pattern observed in the specimen.  
 
7.4.2. Results 
No polyp in this dataset was allocated a Type II PPC by the observer and therefore this 
category was excluded from the analysis. Type IV polyps showed the highest villous 
percentage (median 50%, Mean 55.8%) and accounted for 50.8% of the study sample. 
24.3% of Type V polyps were cancer polyps and this is a much smaller proportion than 
Kudo’s reported 62.5% (Table 7-4).  
 
 Number (n) 
Villous Percentage 
ICA (n) 
Kudo’s Cancer 
Polyps [131] Range Median Mean 
Type I 1 0 0 0 0 0 
Type IIIL 211 0-80 20 20.9 
18 
(8.5%) 
0 
Type IIIS 45 0-60 10 13.3 
3 
(6.7%) 
28.3% 
Type IV 338 0-100 50 55.8 
32 
(9.5%) 
37.2% 
Type V 70 0-100 20 39.4 
17 
(24.3%) 
62.5 % 
Table 7-4 Villous Percentage And Its Association With PPC 
 
One polyp in the dataset was not allocated a polyp morphology diagnosis on H&E and 
therefore excluded from this part of the analysis. Interestingly, the percentage 
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villousness of this polyp was diagnosed as 10% on OPT and was a cancer specimen. 
The pathologist was unable to classify the adenoma morphology on H&E because there 
were no identifiable surface features in the 2D glass slide due to the dominance of 
invasive cancer, which had destroyed the polyp architecture. 
 
 Number (n) 
Villous Percentage 
Range Median Mean 
H&E TA 187 0-100 10 18.6% 
H&E TVA 467 0-100 40 47.5% 
H&E VA 10 60-100 100 91.0% 
Total 664    
P-value* <0.001 
Table 7-5 Association Between Villous Percentage And Polyp Morphology 
*chi-squared for difference in means 
There was a clear trend that demonstrated the spectrum of change of villousness that we 
have seen throughout this study from tubular to villous polyps. TA polyps had the 
lowest villous percentage (18.6%) in comparison to the TVA (47.5%) and VA (91.0%) 
polyps. This finding was statistically significant and suggested that measuring the 
villous percentage of a specimen is more comparable with the current gold standard 
WHO morphology classification than Kudo’s pit pattern. 
 
7.5. DISCUSSION 
OPT of colorectal polyps has enabled us to view the surface morphology in 
considerable detail. Kudo’s classification suggests a correlation between surface 
morphology and the extent of invasion and although this may still hold true, this study 
has emulated the complexity of the surface detail of polyps. The importance of the 
serrated adenoma in the development of cancer is apparent and the type II pit pattern 
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was modified to help ease in vivo detection [128]. Further work is necessary for other 
strands of the pit pattern classification to aid diagnosis in the same way. 
 
This study is dependent upon the skill of  ‘pattern recognition’ and although this has its 
limitations as a subjective assessment, it has highlighted the inter-observer variation that 
occurs whilst making a qualitative assessment. The greatest challenge is in 
discriminating between neoplastic and non-neoplastic polyps in vivo which is done by 
experienced endoscopists, familiar with specific in vivo imaging modalities. Kwitt et al 
have explored techniques using semantic image retrieval and annotation with the aim of 
improving endoscopic detection of suspicious lesions [132]. It could have been valuable 
to have included experienced endoscopists as observers in the assessment of the 
morphology on OPT. 
 
Some colorectal polyps display features of lobulation, which do not accurately fit a 
specific pit pattern type (Figure 7-8). Understanding how a polyp grows over time to 
produce a sessile or pedunculated lesion, although multifactorial, may help us 
understand how these features developed and their diagnostic significance, if any. 
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Figure 7-7 Lobulation (L) And Villousness (V) That Do Not Fit Kudo’s PPC. 
 
We know that polyps with a high villous component have a high malignant association 
but these other features such as lobulation are not sufficiently accounted for and their 
diagnostic influence may be under-represented. Subsequently identifying these features 
using an automated or semi-automated technique, as Kwitt et al have explored, could 
minimise the inter and intra-observer variation that also exists between endoscopists 
[133]. 
 
The significance of a dual pit pattern type in each polyp is undetermined and it raises 
the possibility that information obtained through these OPT images may help further 
classify the surface morphology of polyps and improve the early detection of neoplastic 
lesions at source in vivo. 
  
 
L 
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CHAPTER 8:  INTEROBSERVER VARIATION STUDY 
 
8.1. BACKGROUND 
The inter-observer variation that exists in diagnosing colorectal polyps and specifically 
in dysplasia is well documented [87, 134-136]. Introducing a new technology with its 
limited knowledge and experience in the wider clinical market will undoubtedly create 
even further variation. The aim of this part of the study was to establish if pathologists 
can diagnose colorectal polyps using OPT after a limited training period and to 
determine how well this agrees with their H&E slide diagnosis. 
 
8.2. METHOD 
Five observers (Frank Carey, Jennifer Wilson, Shaun Walsh, David Parham and James 
Going) were selected to take part in the study from three centres in the UK (Dundee, 
glasgow and Bournemouth). All observers were pathologists with varying degrees of 
expertise in colorectal polyps, gastrointestinal pathology and OPT. 59 polyp specimens 
were selected for inclusion in the study from the phase one database. This selection was 
based upon the dysplasia and morphology diagnostic categories ensuring representation 
from each sub group where applicable. All OPT image datasets had been previously 
classified with a good image quality score (3 or more). 
 
Observers received a training session to ensure they were able to use the OPT 
technology and load datasets appropriately. An OPT Polyp Atlas was constructed and 
issued to each observed to enable them to undergo a period of training to acquaint 
themselves with the different types of images they might see in the study. The atlas was 
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available for use as a reference tool during the analysis of the 59 polyps. It comprised of 
33 polyps divided into the three main dysplasia groups: LGD (n=16), HGD (n=7) and 
ICA (n=10). 
 
Observers were asked to make diagnoses using three imaging modalities: H&E glass 
slides, H&E digital slides and OPT images. The variables recorded in all three methods 
were dysplasia (LGD, HGD and ICA), the surface morphology (TA, TVA and VA) and 
identification of EPD. Additional variables recorded using OPT alone were percentage 
villousness (0-100% in 10% aliquots) and pit pattern classification type (I, IIL, IIIS, IV 
and V). For each OPT variable, the observer was asked to record a confidence score 
ranging from 1 (low) to 5 (high). Additional variables were recorded such as the length 
of time the observer took to make a diagnosis and which viewing tool they utilised the 
most. 
 
8.3. STATISTICAL ANALYSIS 
The statistical analysis was three fold using kappa statistics to assess agreement and chi-
squared tests for association: 
 
• Agreement with the gold standard 
• Intra-observer Agreement  
• Inter-observer Agreement 
 
Firstly a comparison was made of dysplasia, morphology and EPD diagnoses using each 
of the three imaging methods from each observer with the ‘gold standard’. The second 
analysis assessed intra-observer agreement using all the three imaging methods. The 
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third analysis made a comparison between the 5 observers and the diagnoses they made 
of dysplasia, morphology, EPD, villous percentage (OPT only) and PPC (OPT only). 
 
For the purposes of analysis the H&E glass slide observations made by observer one 
were regarded as the gold standard because a reference point had to be chosen upon 
which to compare diagnoses made by subsequent observers. Observer one was an 
internationally recognised specialist gastrointestinal pathologist (Carey) with extensive 
experience in the diagnosis of colorectal polyps and a leading expert in his field. 
Therefore it was agreed that the diagnoses from observer one should be considered the 
most accurate results upon which to compare the inter-observer analysis results. 
 
8.4. RESULTS 
All of the selected specimens were from phase one and therefore the H&E slides had 
been previously seen by observer one who was involved with the whole study. For this 
reason there was a 12-month delay in starting this inter-observer analysis. Observers 
two to five had not seen any of the specimen images before. According to the ‘gold 
standard’ diagnosis, LGD polyps with TA morphology were the dominant group in the 
study (42.4%, n=25). ICA polyps accounted for 20.3% of specimens and HGD polyps 
were the minority group (13.6%) (Table 8-1). 
 
 TA TVA VA Total 
LGD 25 
(64.1%)(75.8%) 
14 
(35.9%)(53.8%) 0 39 
HGD 2 
(25.0%)(6.1%) 
6 
(75.0%)(23.1%) 0 8 
ICA 6 
(50.0%)(18.2%) 
6 
(50.0%)(23.1%) 0 12 
Total 33 26 0 59 
Table 8-1 Distribution Of IOA Specimens According To Gold Standard 
Number (n), % Row, % Column 
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All specimens were either TA or TVA polyps. The lack of VA polyps was due to the 
small numbers of villous polyps available for selection from phase one. The polyps used 
in the study had to meet the inclusion criteria of not having been seen by the observers 
before as well as being of good image quality. 40.7% (n=24) specimens were known to 
have EPD from their H&E glass slides and the majority of polyps were ‘end’ specimens 
(81.4%, n=48) instead of slices (18.6%, n=11).  
 
8.4.1. Agreement with Gold Standard: Dysplasia 
None of the pathologists showed complete agreement in all categories with the gold 
standard (GS) diagnosis when using glass slides for dysplasia. All of the pathologists 
tended to over diagnose the LGD specimens as either HGD or ICA (Figure 8-1). 
 
Figure 8-1 Dysplasia Classification Of Glass Slide 
Bar chart showing the total number of specimens classified into each dysplasia category according to the 
glass slide diagnosis by each observer. Observer one is considered the GS. 
 
Observer Five classified 13 LGD (33.3%) specimens as HGD instead of LGD and 
showed the poorest agreement with the GS. Observer Four tended to over diagnose ICA 
identifying 18 specimens in the study sample instead of 12. However, overall, the 
39 
8 
12 
34 
17 
8 
33 
14 
12 
36 
5 
18 
27 
20 
12 
LGD HGD ICA 
Obs 1 
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Obs 4  
Obs 5 
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agreement of glass slide dysplasia diagnoses was moderate to good (κ 0.556 to 0.676) 
(Table 8-2). 
 
GLASS SLIDE H&E DYSPLASIA DIAGNOSES 
OBSERVER 2 OBSERVER 3 
 LGD HGD ICA  LGD HGD ICA 
GS LGD 
32 
(82.1%) 
7 
(18.0%) 
0 GS LGD 
32 
(82.1%) 
6 
(15.4%) 
1 
(2.6%) 
GS HGD 
1 
(12.5%) 
7 
(87.5%) 
0 GS HGD 
1 
(12.5%) 
7 
(87.5%) 
0 
GS ICA 
1 
(8.3%) 
3 
(25.0%) 
8 
(66.7%) 
GS ICA 0 
1 
(8.3%) 
11 
(91.7%) 
% Agreement 79.7% % Agreement 81.6% 
Kappa (SE) 0.632 (0.089) ‘good’ Kappa (SE) 0.558 (0.121) ‘moderate’ 
Wt. Kappa  0.710 Wt. Kappa  0.571 
Sens/Spec* 66.7%/100% Sens/Spec* 91.7%/97.9% 
OBSERVER 4 OBSERVER 5 
 LGD HGD ICA  LGD HGD ICA 
GS LGD 
34 
(87.2%) 
2 
(5.1%) 
3 
(7.7%) 
GS LGD 
26 
(66.7%) 
13 
(33.3%) 
0 
GS HGD 
2 
(25.0%) 
3 
(37.5%) 
3 
(37.5%) 
GS HGD 
1 
(12.5%) 
6 
(75.0%) 
1 
(12.5%) 
GS ICA 0 0 
12 
(100%) 
GS ICA 0 
1 
(8.3%) 
11 
(91.7%) 
% Agreement 83.1% % Agreement 72.88% 
Kappa (SE) 0.676 (0.087) ‘good’ Kappa (SE) 0.556 (0.089) ‘moderate’ 
Wt. Kappa  0.740 Wt. Kappa  0.676 
Sens/Spec* 100%/87.2% Sens/Spec* 91.7%/97.9% 
Table 8-2 Agreement Of Dysplasia Between Glass Slides And The Gold Standard  
 Number (n), % Row. * Using two groups LGD/HGD and ICA. 
 
66.7% of ICA polyps received the same ICA diagnosis from all observers on glass 
slides in comparison to 58.3% on digital slides and 0% on OPT. Agreement based on 
digital slide interpretation was very similar to that of glass slides with a moderate to 
good level of agreement (κ 0.515 to 0.702) (Table 8-3). 
 
Agreement between OPT dysplasia diagnoses and the gold standard was considerably 
poorer for all observers (κ0.274 to 0.454) although it was clear that Observer Five found 
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it easier to make an accurate diagnosis than the rest of the observers with 72.8% 
agreement (Table 8-4). 
 
DIGITAL SLIDE H&E DYSPLASIA DIAGNOSES 
OBSERVER 1 OBSERVER 2 
 LGD HGD ICA  LGD HGD ICA 
GS LGD 
36 
(92.3%) 
1 
(2.6%) 
2 
(5.1%) 
GS LGD 
27 
(69.2%) 
12 
(30.8%) 
0 
GS HGD 
2 
(25.0%) 
5 
(62.5%) 
1 
(12.5%) 
GS HGD 
1 
(12.5%) 
6 
(75.0%) 
1 
(12.5%) 
GS ICA 0 
3 
(25.0%) 
9 
(75.0%) 
GS ICA 
1 
(8.3%) 
2 
(16.7%) 
9 
(75.0%) 
% Agreement 84.8% % Agreement 71.2% 
Kappa (SE) 0.702 (0.085) ‘good’ Kappa (SE) 0.515 (0.092) ‘moderate’ 
Wt. Kappa  0.760 Wt. Kappa  0.622 
Sens/Spec* 75.0%/93.6% Sens/Spec* 75%/97.8% 
OBSERVER 3 OBSERVER 4 
 LGD HGD ICA  LGD HGD ICA 
GS LGD 
33 
(84.6%) 
4 
(10.3%) 
2 
(5.1%) 
GS LGD 
35 
(89.7%) 
2 
(5.1%) 
2 
(5.1%) 
GS HGD 
2 
(25.0%) 
6 
(75.0%) 
0 GS HGD 
3 
(37.5%) 
4 
(50.0%) 
1 
(12.5%) 
GS ICA 0 
3 
(25.0%) 
9 
(75.0%) 
GS ICA 
1 
(8.3%) 
2 
(16.7%) 
9 
(75.0%) 
% Agreement 81.4% % Agreement 81.4% 
Kappa (SE) 0.655 (0.089) ‘good’ Kappa (SE) 0.630 (0.095) ‘good’ 
Wt. Kappa  0.719 Wt. Kappa  0.693 
Sens/Spec* 75.0%/95.7% Sens/Spec* 75.0%/93.6% 
OBSERVER 5  
 LGD HGD ICA     
GS LGD 
32 
(82.1%) 
7 
(18.0%) 
0     
GS HGD 
2 
(25.0%) 
6 
(75.0%) 
0     
GS ICA 0 
3 
(25.0%) 
9 
(75.0%) 
    
% Agreement 79.7%   
Kappa (SE) 0.631 (0.090) ‘good’   
Wt. Kappa  0.736   
Sens/Spec* 75.0%/100%   
Table 8-3 Agreement Of Dysplasia Between Digital Slides And The Gold Standard 
Number (n), % Row. * Using two groups LGD/HGD and ICA. 
 
 
 
 
 
185 
OPT DYSPLASIA DIAGNOSES 
OBSERVER 1 OBSERVER 2 
 LGD HGD ICA  LGD HGD ICA 
GS LGD 
35 
(89.7%) 
1 
(2.6%) 
3 
(7.7%) 
GS LGD 
26 
(66.7%) 
9 
(23.1%) 
4 
(10.3%) 
GS HGD 
7 
(87.5%) 
1 
(12.5%) 
0 GS HGD 
3 
(37.5%) 
3 
(37.5%) 
2 
(25.0%) 
GS ICA 
4 
(33.3%) 
4 
(33.3%) 
4 
(33.3%) 
GS ICA 0 
3 
(25.0%) 
9 
(75.0%) 
% Agreement 67.8% % Agreement 64.4% 
Kappa (SE) 0.279 (0.105) ‘fair’ Kappa (SE) 0.396 (0.095) ‘fair’ 
Wt. Kappa  0.355 Wt. Kappa  0.506 
Sens/Spec* 33.3%/93.6% Sens/Spec* 75.0%/87.23% 
OBSERVER 3 OBSERVER 4 
 LGD HGD ICA  LGD HGD ICA 
GS LGD 
23 
(59.0%) 
14 
(35.9%) 
2 
(5.1%) 
GS LGD 
34 
(87.2%) 
4  
(10.3%) 
1 
(2.6%) 
GS HGD 
3 
(37.5%) 
5 
(62.5%) 
0 GS HGD 
5 
(62.5%) 
2 
(25.0%) 
1 
(12.5%) 
GS ICA 
2 
(16.7%) 
5 
(41.7%) 
5 
(41.7%) 
GS ICA 
1 
(8.3%) 
7 
(58.3%) 
4 
(33.3%) 
% Agreement 55.9% % Agreement 67.8% 
Kappa (SE) 0.274 (0.094) ‘fair’ Kappa (SE) 0.358 (0.095) ‘fair’ 
Wt. Kappa  0.350 Wt. Kappa  0.496 
Sens/Spec* 41.7%/95.7% Sens/Spec* 33.3%/95.7% 
OBSERVER 5  
 LGD HGD ICA     
GS LGD 
33 
(84.6%) 
3 
(7.7%) 
3 
(7.7%) 
    
GS HGD 
5 
(62.5%) 
3 
(37.5%) 
0     
GS ICA 
2 
(16.7%) 
3 
(25.0%) 
7 
(58.3%) 
    
% Agreement 72.8%   
Kappa (SE) 0.454 (0.107) ‘moderate’   
Wt. Kappa  0.523   
Sens/Spec* 58.3%/93.6%   
Table 8-4 Agreement Of Dysplasia Between Opt And The Gold Standard 
Number (n), % Row. * Using two groups LGD/HGD and ICA. 
 
When adjusting the dysplasia categories to benign (LGD or HGD) and malignant (ICA) 
a further analysis was done to see if agreement could be improved to determine if the 
difficulty in diagnosing was in distinguishing between high and low grade dysplasia 
rather than between cancer and non-cancer on OPT (Table 8-5). This was true for all 
observers except Observer Four. Overall agreement was much better with up to 86.4% 
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observed agreements for Observer Five. The kappa statistics between the gold standard 
and OPT diagnoses was also generally better (κ 0.319 to 0.569) except for Observer 
Four, again, who had a very slightly lower kappa agreement (κ 0.357) than in the 
previous analysis using the three sub groups (LGD, HGD and ICA).  
 
 Observer 1 Observer 2 Observer 3 Observer 4 Observer 5 
% Agreement 81.4% 84.6% 84.8% 83.1% 86.4% 
Kappa (SE) 0.319 (0.115) 0.569 (0.127) 0.443 (0.152) 0.357 (0.155) 0.554 (0.139) 
Strength Fair Moderate Moderate Fair Moderate 
Table 8-5 Agreement Of Dysplasia Between Opt And The Gold Standard Categorising Dysplasia As 
Benign Or Malignant. 
 
8.4.2. Agreement With Gold Standard: Morphology 
Agreement with the gold standard diagnosis for morphology on all three imaging 
modalities was worse than for dysplasia. As there were no VA specimens included in 
the study sample, for the purposes of analysis, the TVA and VA groups were combined. 
No pathologists showed complete agreement with the gold standard for the glass slide 
H&E diagnoses although Observer Three showed the closest correlation with 74.6% 
agreement (κ 0.510) (Table 8-6). 
 
There was a marked difference in the agreement calculated from Observer One and the 
gold standard (κ 0.667) and the rest of the observers with the gold standard (κ 0.277-
0.389). This suggests that Observer One was more consistent when diagnosing glass 
slides and digital slides than the rest of the observers were and demonstrated less intra-
observer variation (Table 8-7). The TVA and VA subgroup was consistently over 
diagnosed on glass H&E slides and digital H&E slides despite the gold standard only 
classifying 44.1% of specimens as TVA or VA. This trend was evident in all observers 
(Figure 8-2). 
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Figure 8-2 Morphology Classification Of Glass Slide 
Bar chart showing the total number of specimens classified into each morphology category according to 
the glass slide diagnosis by each observer. Observer One is considered the gold standard (GS). 
 
GLASS SLIDE H&E MORPHOLOGY DIAGNOSES 
OBSERVER 2 OBSERVER 3 
 TA TVA/VA  TA TVA/VA 
GS TA 
17 
(51.5%) 
16 
(48.5%) 
GS TA 
19 
(57.6%) 
14 
(42.4%) 
GS TVA/VA 
2 
(7.7%) 
24 
(92.3%) 
GS TVA/VA 
1 
(3.8%) 
25 
(96.2%) 
% Agreement 69.5% % Agreement 74.6% 
Kappa (SE) 0.415 (0.103) ‘Moderate’ Kappa (SE) 0.510 (0.099) ‘moderate’ 
Sens/Spec 92.3%/51.5% Sens/Spec 96.2%/57.6% 
OBSERVER 4 OBSERVER 5 
 TA TVA/VA  TA TVA/VA 
GS TA 
11 
(33.3%) 
22 
(66.7%) 
GS TA 
15 
(45.5%) 
18 
(54.5%) 
GS TVA/VA 0 
26 
(100%) 
GS TVA/VA 
1 
(3.8%) 
25 
(96.2%) 
% Agreement 62.71% % Agreement 67.8% 
Kappa (SE) 0.306 (0.084) ‘fair’ Kappa (SE) 0.389 (0.097) ‘fair’ 
Sens/Spec 100%/33.3% Sens/Spec 96.2%/45.5% 
Table 8-6 Agreement Of Morphology Between Glass Slides And The Gold Standard 
Number (n); % Row 
 
Agreement between the gold standard and all observers on OPT was calculated as 
‘poor’ to ‘fair’ (κ 0.136 - κ 0.370). Observer Two showed the worst agreement with the 
33 
26 
19 
40 
20 
39 
11 
48 
16 
43 
TA TVA/VA 
Obs 1 
Obs 2 
Obs3 
Obs 4 
Obs 5 
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gold standard (κ 0.136; 52.5% agreement) and had significantly under diagnosed the TA 
group identifying only 15.2% of those classified as TA by the gold standard. Observer 
Three showed the best agreement identifying 57.6% of TA (n=19/33) and 80.8% 
(n=21/26) of the villous group (Figure 8-2 and Table 8-8).  
 
DIGITAL SLIDE H&E MORPHOLOGY DIAGNOSES 
OBSERVER 1 OBSERVER 2 
 TA TVA/VA  TA TVA/VA 
GS TA 
24 
(72.7%) 
9 
(27.3%) 
GS TA 
15 
(45.5%) 
18 
(54.5%) 
GS TVA/VA 
1 
(3.8%) 
25 
(96.2%) 
GS TVA/VA 
3 
(11.5%) 
23 
(88.5%) 
% Agreement 83.1% % Agreement 64.4% 
Kappa (SE) 0.667 (0.103) ‘good Kappa (SE) 0.320 (0.105) ‘fair’ 
Sens/Spec 96.2%/72.7% Sens/Spec 88.5%/45.5% 
OBSERVER 3 OBSERVER 4 
 TA TVA/VA  TA TVA/VA 
GS TA 
13 
(39.4%) 
20 
(60.6%) 
GS TA 
10 
(30.3%) 
23 
(69.7%) 
GS TVA/VA 0 
26 
(100%) 
GS TVA/VA 0 
26 
(100%) 
% Agreement 64.4% % Agreement 61.0% 
Kappa (SE) 0.330 (0.094) ‘fair’ Kappa (SE) 0.277 (0.081) ‘fair’ 
Sens/Spec 100%/39.4% Sens/Spec 100%/30.3% 
OBSERVER 5  
 TA TVA/VA    
GS TA 
15 
(45.5%) 
18 
(54.5%) 
   
GS TVA/VA 
1 
(3.8%) 
25 
(96.2%) 
   
% Agreement 67.8%   
Kappa (SE) 0.389 (0.097) ‘fair’   
Sens/Spec 96.2%/45.5%   
Table 8-7 Agreement Of Morphology Between Digital Slides And The Gold Standard 
Number (n); % Row 
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OPT MORPHOLOGY DIAGNOSES 
OBSERVER 1 OBSERVER 2 
 TA TVA/VA  TA TVA/VA 
GS TA 
19 
(57.6%) 
14 
(42.4%) 
GS TA 
5 
(15.2%) 
28 
(84.8%) 
GS TVA/VA 
8 
(30.8%) 
18 
(69.2%) 
GS TVA/VA 0 
26 
(100%) 
% Agreement 62.7% % Agreement 52.5% 
Kappa (SE) 0.262 (0.123) ‘fair’ Kappa (SE) 0.136 (0.060) ‘poor’ 
Sens/Spec 69.2%/57.6% Sens/Spec 100%/15.2% 
OBSERVER 3 OBSERVER 4 
 TA TVA/VA  TA TVA/VA 
GS TA 
19 
(57.6%) 
14 
(42.4%) 
GS TA 
14 
(42.4%) 
19 
(57.6%) 
GS TVA/VA 
5 
(19.2%) 
21 
(80.8%) 
GS TVA/VA 
3 
(11.5%) 
23 
(88.5%) 
% Agreement 67.8% % Agreement 62.7% 
Kappa (SE) 0.370 (0.114) ‘fair’ Kappa (SE) 0.290 (0.104) ‘fair’ 
Sens/Spec 80.8%/57.6% Sens/Spec 88.5%/42.4% 
OBSERVER 5  
 TA TVA/VA    
GS TA 
16 
(48.5%) 
17 
(51.5%) 
   
GS TVA/VA 
3 
(11.5%) 
23 
(88.5%) 
   
% Agreement 66.1%   
Kappa (SE) 0.350 (0.106) ‘fair’   
Sens/Spec 88.5%/48.5%   
Table 8-8 Agreement Of Morphology Between OPT And The Gold Standard 
Number (n); % Row 
 
 Dataviewer QuickTime Both Missing Data 
Dysplasia 176 
(59.7%) 
3 
(1.0%) 
115 
(39.0%) 
1 
(0.3%) 
Morphology 149 
(50.5%) 
6 
(2.0%) 
124 
(42.0%) 
16 
(5.4%) 
Table 8-9 Frequency Of Software Tool Used Diagnose Dysplasia And Morphology 
Number (n); % Row 
 
It was interesting to note the software tool most frequently used to make the diagnosis 
of dysplasia and morphology (Table 8-9). When diagnosing dysplasia Dataviewer was 
the only tool used for 59.7% of the diagnoses. However 40.0% of dysplasia diagnoses 
were made using both Dataviewer and QuickTime. When diagnosing morphology only 
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a slightly smaller proportion of diagnoses were made with Dataviewer alone (50.5%). 
QuickTime was not the preferred viewing tool for either dysplasia or morphology 
diagnoses.  
 
8.4.3. Intra-Observer Agreement: Dysplasia 
It was evident from the first analysis that agreement of OPT diagnoses of dysplasia with 
the gold standard was very variable. Therefore a second analysis was performed to see 
if this could be improved accounting for factors that may have contributed to 
disagreement such as an individual’s experience with OPT or H&E colorectal polyp 
diagnoses. 
 
Observer Two showed the best agreement with their own H&E diagnoses (κ 0.416) and 
when this was weighted to account for the variation of disagreement it improved further 
(κ 0.505). A weighted kappa statistic accounts for the extent of a misdiagnosis, in this 
study, so that for example in diagnosing an ICA specimen, LGD is considered worse 
than it being diagnosed as HGD. All observers showed a better agreement when 
compared to their own H&E diagnosis rather than the gold standard except for observer 
five. Observer Five showed a 72.8% (κ 0.454) agreement with the gold standard but 
62.7% (κ 0.382) agreement with their own H&E slide diagnoses (Table 8-10). 
 
The sensitivity of the results varied considerably between observers with observer two 
showing a 100% sensitivity rate of ICA specimens and Observer Four showing 27.8% 
sensitivity. Specificity of the intra-observer analysis varied from 86.3% (Observer Two) 
to 97.6% (Observer Four). 
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OBSERVER 1 
 OPT LGD OPT HGD OPT ICA 
H&E LGD 35 (89.7%) (76.1%) 1 (2.6%) (16.7%) 3 (7.7%) (42.9%) 
H&E HGD 7 (87.5%)  (15.2%) 1 (12.5%) (16.7%) 0 
H&E ICA 4 (33.3%) (8.7%) 4 (33.3%) (66.7%) 4 (33.3%) (57.1%) 
% agreement 67.8% 
Kappa (SE) 0.279 (0.105) ‘fair’; Weighted κ 0.355 
Sensitivity/Specificity 33.3%/93.6% 
OBSERVER 2 
 OPT LGD OPT HGD OPT ICA 
H&E LGD 23 (67.7%) (79.3%) 8 (23.5%) (53.3%) 3 (8.8%) (20.0%) 
H&E HGD 6 (35.3%) (20.7%) 7 (41.2%) (46.7%) 4 (23.5%) (26.7%) 
H&E ICA 0 0 8 (100%) (53.3%) 
% agreement 64.4% 
Kappa (SE) 0.416 (0.100) ‘moderate’; Weighted κ 0.505 
Sensitivity/Specificity 100%/86.3% 
OBSERVER 3 
 OPT LGD OPT HGD OPT ICA 
H&E LGD 22 (66.7%) (78.6%) 11 (33.3%) (45.8%) 0 
H&E HGD 4 (28.6%) (14.3%) 7 (50.0%) (29.2%) 3 (21.4%) (42.9%) 
H&E ICA 2 (16.7%) (7.1%) 6 (50.0%) (25.0%) 4 (33.3%) (57.1%) 
% agreement 55.9% 
Kappa (SE) 0.282 (0.096) ‘fair’; Weighted κ 0.389 
Sensitivity/Specificity 33.3%/93.6% 
OBSERVER 4 
 OPT LGD OPT HGD OPT ICA 
H&E LGD 32 (88.9%) (80.0%) 3 (8.3%) (23.1%) 1 (2.8%) (16.7%) 
H&E HGD 2 (40.0%) (5.0%) 3 (60.0%) (23.1%) 0 
H&E ICA 6 (33.3%) (15.0%) 7 (38.9%) (53.9%) 5 (27.8%) (83.3%) 
% agreement 67.8% 
Kappa (SE) 0.400 (0.091) ‘fair’; Weighted κ 0.453 
Sensitivity/Specificity 27.8%/97.6% 
OBSERVER 5 
 OPT LGD OPT HGD OPT ICA 
H&E LGD 26 (96.3%) (65.0%) 1 (3.7%) (11.1%) 0 
H&E HGD 11 (55.0%) (27.5%) 5 (25.0%) (55.6%) 4 (20.0%) (40.0%) 
H&E ICA 3 (25.0%) (7.5%) 3 (25.0%) (33.3%) 6 (50.0%) (60.0%) 
% agreement 62.7% 
Kappa (SE) 0.382 (0.089) ‘fair’; Weighted κ 0.483 
Sensitivity/Specificity 50.0%/91.5% 
Table 8-10 Comparison Of Dysplasia Between Gold Standard And OPT Within Observers 
Number(n); % Row; % Column 
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8.4.4. Intra-Observer Agreement: Morphology 
Agreement on the morphology of specimens on OPT compared to H&E glass slides 
(Gold Standard) varied from 62.7% to 79.7% within observers and this was better than 
when compared to the gold standard (Range 52.5% to 67.8%). However, similarly to the 
dysplasia intra-observer findings, observer 5 showed a slightly lower kappa statistic (κ 
0.312 versus κ 0.350) (Table 7.11).  There was a tendency to diagnose fewer TA 
specimens on OPT than on H&E glass slides. This trait was encountered for all 
observers. 
 
OBSERVER 1 OBSERVER 2 
  OPT TA OPT TVA/VA  OPT TA OPT TVA/VA 
H&E TA 
19 
(57.6%) (70.4%) 
14 
(42.2%) (43.8%) 
H&E TA 
4 
(21.1%) (80.0%) 
15 
(79.0%) (27.8%) 
H&E TVA/VA 
8 
(30.8%) (29.6%) 
18 
(69.2%) (56.3%) 
H&E TVA/VA 
1 
(2.5%) (20.0%) 
39 
(97.5%) (72.2%) 
% agreement 62.7% % agreement 72.9% 
Kappa (SE) 0.262 (0.123) ‘fair’ Kappa (SE) 0.230 (0.115) ‘fair’ 
Sensitivity/ 
specificity 
69.2%/57.6% 
Sensitivity/ 
specificity 
97.5%/21.1% 
OBSERVER 3 OBSERVER 4 
 OPT TA OPT TVA/VA  OPT TA OPT TVA/VA 
H&E TA 
14 
(70.0%) (58.3%) 
6 
(30.0%) (17.1%) 
H&E TA 
8 
(72.7%) (47.1%) 
3 
(27.3%) (7.1%) 
H&E TVA/VA 
10 
(25.6%) (41.7%) 
29 
(74.4%) (82.9%) 
H&E TVA/VA 
9 
(18.8%) (52.9%) 
39 
(81.3%) (92.9%) 
% agreement 72.9% % agreement 79.7% 
Kappa (SE) 0.423 (0.120) ‘moderate’ Kappa (SE) 0.446 (0.131) ‘moderate’ 
Sensitivity/ 
specificity 
74.4%/70.0% 
Sensitivity/ 
specificity 
81.3%/72.7% 
OBSERVER 5    
 OPT TA OPT TVA/VA    
H&E TA 
9 
(56.3%)(47.4%) 
7 
(43.8%) (17.5%) 
   
H&E TVA/VA 
10 
(23.3%) (52.6%) 
33 
(76.7%) (82.5%) 
   
% agreement 71.2%    
Kappa (SE) 0.312 (0.132) ‘fair’    
Sensitivity/ 
specificity 
76.7%/56.3%    
Table 8-11 Comparison Of Morphology Between Gold Standard And OPT Within Observers 
Number(n); % Row; % Column 
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8.4.5. Inter-Observer Agreement: Dysplasia 
Assessment of dysplasia agreement between pairs of observers was made using two 
subgroups: benign (LGD/HGD) and malignant (ICA). This analysis was carried out on 
all three imaging modalities: H&E glass slides (Table 8-12), H&E Digital slides (Table 
8-13) and OPT (Table 8-14). For each paired analysis the number of specimens with the 
same ICA diagnosis was recorded (ICA overlap). 
 
On glass slides eight specimens received a diagnosis of ICA from all observers. The 
best paired-agreement was between Observer One and Three with 96.6% agreement 
(κ0.90) and with 11 ICA specimens receiving the same diagnosis from both observers. 
The poorest agreement calculated on glass slides was between Observer Two and Four 
with 83.1% agreement (κ0.53) (Table 8-12). 
 
GLASS H&E OBS 1 OBS 2 OBS 3 OBS 4 OBS 5 
OBS 1 
100% 
(κ 1) 
93.2% 
(κ 0.76) 
ICA 8 
96.6% 
(κ 0.90) 
ICA 11 
89.8% 
(κ 0.74) 
ICA 12 
96.6% 
(κ 0.9) 
ICA 11* 
OBS 2  
100% 
(κ 1) 93.2% (κ 0.76) 
ICA 8 
83.1% 
(κ 0.53) 
ICA 8 
93.2% 
(κ 0.76) 
ICA 8 
OBS 3   
100% 
(κ 1) 89.8% (κ 0.74) 
ICA 12* 
93.2% 
(κ 0.79) 
ICA 10* 
OBS 4    
100% 
(κ 1) 89.8% (κ 0.74) 
ICA: 12* 
OBS 5     
100% 
(κ 1) 
Table 8-12 Agreement Of Dysplasia On H&E Glass Slides Between Pairs Of Observers 
% Agreement, (kappa) and ICA Overlap (ICA). *All disagreements on ICA were subsequently diagnosed 
as HGD. 	  
Seven specimens received a diagnosis of ICA from all 5 observers on digital slides and 
the best-paired agreement calculated was between Observer One and Observer Four 
with 96.6% agreement (κ0.90). However the agreement between digital images 
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appeared better than the glass slides with the worst agreement being 91.5% (κ0.71) 
between Observer Two and Three (Table 8-13). Seven of the paired analyses also 
showed that where there were disagreements in the ICA diagnoses between observers, 
all of the disagreements were classified as HGD and none as LGD.  
 
DIGITAL H&E OBS 1 OBS 2 OBS 3 OBS 4 OBS 5 
OBS 1 
100% 
(κ 1) 
93.2% 
(κ 0.78) 
ICA 9 
91.5% 
(κ 0.73) 
ICA 9* 
96.6% 
(κ 0.90) 
ICA 11 
91.5% 
(κ 0.71) 
ICA 8* 
OBS 2  
100% 
(κ 1) 
91.5% 
(κ 0.71) 
ICA 8* 
93.2% 
(κ 0.78) 
ICA 9* 
94.9% 
(κ 0.81) 
ICA 8* 
OBS 3   
100% 
(κ 1) 
94.9% 
(κ 0.84) 
ICA 10* 
93.2% 
(κ 0.76) 
ICA 8* 
OBS 4    
100% 
(κ 1) 
94.9% 
(κ 0.83) 
ICA 9 
OBS 5     
100% 
(κ 1) 
Table 8-13 Agreement Of Dysplasia On H&E Digital Slides Between Pairs Of Observers 
% Agreement, (kappa) and ICA Overlap (ICA). *All disagreements on ICA were subsequently diagnosed 
as HGD. 
 
Agreements on OPT dysplasia diagnoses were worse than with the H&E glass slides 
and digital slides. No specimens received an ICA diagnosis from all five observers. The 
best ‘paired agreement’ was between Observer One and Observer Five with 91.5% 
agreement (κ0.66) and the worst agreement was calculated between Observer One and 
Observer Three with 83.1% agreement (κ0.19) (Table 8-14). 
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OPT OBS 1 OBS 2 OBS 3 OBS 4 OBS 5 
OBS 1 
100% 
(κ 1) 
76.3% 
(κ 0.24) 
ICA 4 
83.1% 
(κ 0.19) 
ICA 2 
84.8% 
(κ 0.22) 
ICA 2 
91.5% 
(κ 0.66) 
ICA 6 
OBS 2  
100% 
(κ 1) 
79.7% 
(κ 0.35) 
ICA 5 
81.4% 
(κ 0.39) 
ICA 5 
81.4% 
(κ 0.45) 
ICA 7 
OBS 3   
100% 
(κ 1) 
91.5% 
(κ 0.57) 
ICA 4 
88.1% 
(κ 0.52) 
ICA 5 
OBS 4    
100% 
(κ 1) 
86.4% 
(κ 0.43) 
ICA 4 
OBS 5     
100% 
(κ 1) 
Table 8-14 Agreement Of Dysplasia On OPT Between Pairs Of Observers 
 % Agreement, (kappa) and ICA Overlap (ICA) 
 
8.4.6. Inter-observer agreement: Morphology 
The inter-observer analysis of the morphology diagnoses was carried out with the two 
classifications of villous (TVA and VA) and non-villous (TA). The agreement between 
each pair of observers was calculated for each imaging modality: H&E glass slides 
(Table 8-15), H&E digital slides (Table 8-16) and OPT (Table 8-17). The number of 
specimens that were given a villous diagnosis by both observers is also recorded (Vil). 
 
GLASS H&E OBS 1 OBS 2 OBS 3 OBS 4 OBS 5 
OBS 1 
100% 
(κ 1) 
69.5 
(0.41) 
Vil 24 
74.6 
(0.51) 
Vil 25 
62.7 
(0.31) 
Vil 26 
67.8 
(0.39) 
Vil 25 
OBS 2  
100% 
(κ 1) 
78.0 
(0.50) 
Vil 33 
69.5 
(0.21) 
Vil 35 
81.4 
(0.55) 
Vil 36 
OBS 3   
100% 
(κ 1) 
78.0 
(0.45) 
Vil 37 
76.3 
(0.44) 
Vil 34 
OBS 4    
100% 
(κ 1) 
84.8 
(0.52) 
Vil 41 
OBS 5     
100% 
(κ 1) 
Table 8-15 Agreement Of Morphology On H&E Glass Slides Between Pairs Of Observers 
% Agreement, (kappa) and TVA/VA Overlap (Vil).  
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Agreement between observers of morphology on H&E glass slides was lower than that 
with dysplasia. 37.3% of specimens were classified as either TVA or VA by all five 
observers. Observer Four and Five showed the best agreement (84.8%, κ0.52) and the 
worst agreement was between Observer One and Four (62.7%, κ0.31) (Table 8-15). 
 
On digital slides, the agreement overall appeared a little better than with glass slides 
(74.6% to 84.8%, κ0.36 to 0.67). 52.5% specimens were diagnosed as TVA or VA by 
all observers. Observer One and Observer Four still showed the poorest agreement as 
they had done with glass slides (Table 8-16). 
 
DIGITAL H&E OBS 1 OBS 2 OBS 3 OBS 4 OBS 5 
OBS 1 
100% 
(κ 1) 
81.4% 
(κ 0.60) 
Vil 32 
76.3% 
(κ 0.48) 
Vil 33 
74.6% 
(κ 0.43) 
Vil 34 
84.8% 
(κ 0.67) 
Vil 34 
OBS 2  
100% 
(κ 1) 
78.0% 
(κ 0.44) 
Vil 37 
76.3% 
(κ 0.36) 
Vil 38 
83.1% 
(κ 0.59) 
Vil 37 
OBS 3   
100% 
(κ 1) 
81.4% 
(κ 0.41) 
Vil 42 
84.8% 
(κ 0.59) 
Vil 40 
OBS 4    
100% 
(κ 1) 
83.1% 
(κ 0.51) 
Vil 41 
OBS 5     
100% 
(κ 1) 
Table 8-16 Agreement Of Morphology On H&E Digital Slides Between Pairs Of Observers 
% Agreement, (kappa) and TVA/VA Overlap (Vil).  
 
The agreement of OPT morphology varied from 57.6% to 76.3% (κ-0.003 to κ0.48) 
(Table 8-17). The negative kappa statistic that was calculated between Observer Two 
and Three suggests that there was no agreement at all between observers and even less 
than would be expected by chance. It is clear that observers found making a 
morphology diagnosis on OPT more difficult than on H&E slides. 
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OPT OBS 1 OBS 2 OBS 3 OBS 4 OBS 5 
OBS 1 
100% 
(κ 1) 
59.3% 
(κ 0.12) 
Vil 31 
74.6% 
(κ 0.48) 
Vil 26 
59.3% 
(κ 0.16) 
Vil 25 
62.7% 
(κ 0.23) 
Vil 25 
OBS 2  
100% 
(κ 1) 
57.6% 
(κ -0.003) 
Vil 32 
76.3% 
(κ 0.27) 
Vil 41 
69.5% 
(κ 0.13) 
Vil 38 
OBS 3   
100% 
(κ 1) 
71.2% 
(κ 0.37) 
Vil 30 
67. 8% 
(κ 0.31) 
Vil 28 
OBS 4    
100% 
(κ 1) 
72.9% 
(κ 0.36) 
Vil 33 
OBS 5     
100% 
(κ 1) 
Table 8-17 Agreement Of Morphology OPT Between Pairs Of Observers 
% Agreement, (kappa) and TVA/VA Overlap (Vil).  
 
8.4.7. Epithelial Displacement 
According to the gold standard, EPD was identifiable in 39.0% of specimens. Only four 
of these specimens received a concurrent diagnosis of EPD by all observers on both 
glass and digital slides. Agreement between paired observers was marginally better on 
glass slides (64.4% to 84.8%, κ0.18 to 0.68) than digital slides (54.2% to 84.8%, κ0.05 
to 0.68) (Table 8-18 and 8-19). Observer Four had the poorest paired agreements on 
glass slide (Observer One κ0.18; Observer Two κ0.28; Observer Three κ0.33 and 
Observer Five κ0.41). These were the four lowest agreements calculated (Table 8-18).   
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GLASS H&E OBS 1 OBS 2 OBS 3 OBS 4 OBS 5 
OBS 1 
100% 
(κ 1) 
84.8% 
(κ 0.68) 
EPD 19 
74.6% 
(κ 0.43) 
EPD 11 
64.4% 
(κ 0.18) 
EPD 6 
81.4% 
(κ 0.61) 
EPD 17 
OBS 2  
100% 
(κ 1) 
76.3% 
(κ 0.46) 
EPD 11 
69.5% 
(κ 0.28) 
EPD 7 
83.1% 
(κ 0.64) 
EPD 17 
OBS 3   
100% 
(κ 1 
79.7% 
(κ 0.33) 
EPD 5 
79.7% 
(κ 0.52) 
EPD 11 
OBS 4    
100% 
(κ 1) 
76.3% 
(κ 0.41) 
EPD 8 
OBS 5     
100% 
(κ 1) 
Table 8-18 Agreement Of EPD On H&E Glass Slides Between Pairs Of Observers 
% Agreement, (kappa) and EPD Overlap (EPD).  
 
DIGITAL H&E OBS 1 OBS 2 OBS 3 OBS 4 OBS 5 
OBS 1 
100% 
(κ 1) 
81.4% 
(κ 0.62) 
EPD 21 
72.9% 
(κ 0.42) 
EPD 13 
62.7% 
(κ 0.16) 
EPD 5 
84.8% 
(κ 0.68) 
EPD 19 
OBS 2  
100% 
(κ 1) 
67.8% 
(κ 0.34) 
EPD 13 
54.2% 
(κ 0.05) 
EPD 4 
76.3% 
(κ 0.52) 
EPD 18 
OBS 3   
100% 
(κ 1) 
76.3% 
(κ 0.30) 
EPD 5 
78.0% 
(κ 0.51) 
EPD 13 
OBS 4    
100% 
(κ 1) 
67.8% 
(κ 0.20) 
EPD 5 
OBS 5     
100% 
(κ 1) 
Table 8-19 Agreement Of EPD On H&E Digital Slides Between Pairs Of Observers 
% Agreement, (kappa) and EPD Overlap (EPD).  
 
The recognition of EPD on OPT showed no agreement in seven of the ten paired 
analyses (Table 8-19). Therefore it is likely that any agreement that did occur in the 
remaining three pairs occurred by chance. The sample size was very small and the 
observers obviously found identifying EPD on OPT difficult.  
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OPT OBS 1 OBS 2 OBS 3 OBS 4 OBS 5 
OBS 1 
100% 
(κ 1) 
54.2% 
(κ -0.02) 
EPD 5 
83.1% 
(κ 0.32) 
EPD 3 
78.0% 
(κ 0) 
EPD 0 
69.5% 
(κ 0.11) 
EPD 4 
OBS 2  
100% 
(κ 1) 
57.6% 
(κ -0.02) 
EPD 1 
59.3% 
(κ 0) 
EPD 0 
67.8% 
(κ 0.28) 
EPD 9 
OBS 3   
100% 
(κ 1) 
94.9% 
(κ 0) 
EPD 0 
72.9% 
(κ -0.09) 
EPD 0 
OBS 4    
100% 
(κ 1) 
78.0% 
(κ 0) 
EPD 0 
OBS 5     
100% 
(κ 1) 
Table 8-20 Agreement Of EPD On OPT Between Pairs Of Observers 
% Agreement, (kappa) and EPD Overlap (EPD).  
 
8.4.8. Villousness on OPT 
Observers were asked to analyse the surface morphology of each specimen by OPT and 
estimate what proportion of it had villous features. This was a subjective assessment 
and estimated to the nearest 10% (Table 8-21). Observer Two’s diagnoses had a higher 
villous percentage (Median 50%) than the rest of the observers. 
 
 Range Median IQR 
Observer 1 0-80 20 0-40 
Observer 2 10-90 50 50-70 
Observer 3 10-90 30 10-50 
Observer 4 0-100 20 0-50 
Observer 5 0-80 30 10-40 
Table 8-21 Percentage Villousness Diagnosed By Each Observer (%) 
 
There were no meaningful correlations found between pairs of observers when 
interpreting Pearson’s correlation coefficient (Range 0.024 to 0.327). It is evident from 
the scatter plots that the observers did not consistently agree on the percentage 
villousness (Table 8-22). 
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Table 8-22 Scatter Plots Of Percentage Villousness Between Pairs Of Observers 
Pearson’s Correlation Coefficient (R2) 
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8.4.9. Pit Pattern Classification 
The Pit Pattern Classification most commonly diagnosed was Type IV accounting for 
up to 64.4% of specimens in one series by Observer One. Type I (0% to 11.9%) and II 
(0% to 5.1%) were infrequently used as the dominant pit pattern type for the OPT 
polyps (Table 8-23).  
 
Despite observers having limited experience with the Pit Pattern Classification 
technique described by Kudo et al [47], the median confidence score for diagnosing the 
PPC was four for most observers. Observer Two was the most confident using the PPC 
with a median confidence of five (Mean confidence score 4.5). 
 
 I II IIIL IIIS IV V MISSING 
Observer 1 0 1 
(1.7%) 
10 
(16.9%) 
1 
(1.7%) 
38 
(64.4%) 
8 
(13.6%) 
1 
(1.7%) 
Observer 2 0 2 
(3.4%) 
20 
(33.9%) 
3 
(5.1%) 
20 
(33.9%) 
14 
(23.7%) 0 
Observer 3 7 
(11.9%) 
3 
(5.1%) 
6 
(10.2%) 
2 
(3.4%) 
31 
(52.5%) 
10 
(16.9%) 0 
Observer 4 1 
(1.7%) 
1 
(1.7%) 
7 
(11.9%) 
8 
(13.6%) 
26 
(44.1%) 
16 
(27.1%) 0 
Observer 5 3 
(5.1%) 0 
21 
(35.6%) 
8 
(13.6%) 
17 
(28.8%) 
8 
(13.6%) 
2 
(3.4%) 
Table 8-23 PPC Diagnosed On OPT By Each Observer 
Number (n); % Row. 
 
8.5. DISCUSSION 
The agreement on the dysplasia and morphology of colorectal polyps is an important 
part of the WHO classification of adenomatous polyps and can significantly impact on a 
patient’s clinical management. However, more importantly, the completeness of 
excision of cancer polyps and extension of invasive cancer beyond the muscularis 
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mucosa is highly significant when considering an individuals risk for recurrent disease 
and further intervention. 
 
The current literature quotes the inter-observer agreement in glass slide diagnosis of 
malignant polyps as κ 0.725 between experienced pathologists and κ 0.516 between 
more junior pathologists in a series of 88 polyps [87]. Costantini et al looked more 
specifically at the dysplasia and morphology agreement between four pathologists in a 
series of 100 polyps. They found the agreement to be moderate for dysplasia (κ0.54, 
95% CI 0.48-0.61) and moderate for morphology (κ0.34; 95% CI 0.28-0.41)[134]. Our 
series of 59 polyps shows a similar level of agreement on H&E glass slides with a 
weighted kappa statistic for dysplasia from κ 0.571 to κ 0.740 thus confirming what is 
already in the literature. However, the morphology agreement in our study sample on 
H&E glass slides was slightly better than in Constantini’s study (mean study κ0.405 
versus Constantini’s κ0.34). 
 
A much earlier study in 1985 by Brown et al showed that agreement ranged from 
κ0.230 to κ0.369 when considering the degree of dysplasia although at this time 
dysplasia was categorised as mild, moderate or severe instead of the two classifications 
we now know as LGD and HGD [137]. Our study findings have shown agreements on 
glass slide dysplasia diagnoses that are slightly better than those published in the 
literature and this may be a factor of the experience of the observers carefully selected 
to take part in this part of the study. In addition, since some of these earlier papers were 
published, the WHO has introduced guidelines and recommendations, which have 
influenced the way in which specimens are analysed. Their diagnosis has been 
standardised in present day pathology leading to better training and less inter-observer 
variation. 
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The introduction of virtual microscopy or digital H&E slides had added another 
paradigm to the diagnosis. Our study of digital slides (mean κ 0.627) has shown an 
agreement that is equivocal or slightly better than the agreement on glass slides (mean κ 
0.622) for dysplasia. However, the morphology diagnosis was marginally worse on 
digital slides (mean κ0.405 vs κ0.397). Interestingly, a series of 457 polyps by Risio et 
al in 2010 compared virtual microscopy with traditional optical microscopy and showed 
that, although in many parameters virtual microscopy adds nothing, when assessing 
morphology the inter-observer agreement was better (κ0.66 vs κ0.52) [138]. 
 
OPT inter-observer agreement in diagnosis was poorer than the glass or digital H&E 
slides had shown and this might be expected, introducing a new technique which has 
not previously been marketed or widely used for pathological analysis of human 
specimens. However, taking this into consideration the agreement for dysplasia was fair 
to moderate between the observers and gold standard diagnosis (Mean κ0.366; mean 
weighted κ 0.446). An improvement in the weighted kappa statistic implies that when 
misdiagnoses were made, they were often marginal errors and were not a result of 
diagnosing a LGD specimen as ICA or vice versa. This is also reflected in the 
improvement in the kappa statistics when analysing the benign (LGD and HGD) and 
malignant (ICA) sub groups (mean κ0.448). Therefore a proportion of the disagreement 
that occurred was between the LGD and HGD groups, reflecting what we already know 
from the literature. 
 
Dataviewer, gives the closest correlation of OPT images to the H&E histopathology cut 
slides of the specimens. Therefore, it is not surprising that three of the observers, as 
pathologists, tended towards using this tool for analysing dysplasia almost exclusively 
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(98.3%-100%). Two observers reported using both Dataviewer and the 3D 
reconstructed QuickTime movies to make their analysis. Observer Four used 
QuickTime movies alone to make a dysplasia diagnosis on three occasions and as each 
specimen has a cut surface they may have felt that this gave them enough information to 
make an assessment without scrolling through the cross-sections independently. 
 
Analysing which tools the observers used gives us some insight into how they reached 
their diagnoses of the specimens, what criteria they used in order to reach it and how 
receptive they were to a learn and interpret a new technology. Observer One and Three 
were experienced gastrointestinal histopathologists and they almost exclusively used the 
cross-sectional images in dataviewer to make their diagnoses of dysplasia, morphology 
and villous percentage. Observer Five had previous research experience with OPT and 
this was evident by their versatility in using all viewing tools available. The majority 
(96.6%) of dysplasia and morphology diagnoses from Observer Five were made using 
both QuickTime and Dataviewer. 
 
The QuickTime tool was predominantly used to identify the PPC, as visualising the 3D 
surface morphology of polyps is the only way this can be assessed. However, two 
observers recorded using both tools on several occasions and this suggests that they may 
have identified an additional pattern on cross-sectional images that helped confirm their 
diagnoses. 
 
Observers were asked to group the specimens according to the WHO morphology 
subgroups of tubular, tubulovillous or villous and by definition this is based upon 
appearances from cross-sections of specimens. Therefore, this descriptive limitation will 
have influenced how the diagnoses in this study were made. For this reason other 
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classification groups such as the percentage villousness and pit pattern classification 
were explored to see if OPT could be of additional diagnostic benefit.  
 
There was a tendency for all observers to diagnose fewer TA specimens on glass slides 
than the gold standard observer. This initial finding raises the possibility that the gold 
standard (Observer One) may have over diagnosed TA specimens and could have 
biased the subsequent results of agreement in morphology. This accounts for the high 
sensitivity (92.3% to 100%) for villous morphology but low specificity (33.3% to 
57.6%) that occurred on glass slide diagnoses. This same trait is also seen in the digital 
slide analysis. 
 
When comparing OPT morphology for each observer with the gold standard diagnoses, 
agreement was worse (mean κ 0.282 vs κ 0.405). Therefore, the intra-observer analysis 
was performed to identify if the potential bias of the gold standard diagnosis had any 
influence. The mean kappa statistic was marginally better (κ 0.335) but it is unlikely 
this finding is significant when taking the sensitivity (69.2% to 97.5%) and specificity 
(21.1% to 72.7%) into account. 
 
Observer One and Five had the most experience with viewing OPT images prior to 
starting this study and this is reflected in the higher agreement of dysplasia diagnoses on 
OPT that was recorded (91.5% agreement; κ 0.66). However this was not true for the 
morphology analysis and suggests that Observer One found it difficult to make the 
morphology diagnoses on OPT, demonstrated by the lower agreement seen when 
compared to the gold standard (62.7%; κ 0.262).  
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The inter-observer variation analysis of dysplasia was moderate to very good on glass 
slides and good to very good on digital slides. This replicates what is already in the 
literature regarding inter-observer variation. However, when comparing OPT diagnoses 
between observers it was clear there was a greater degree of variability between pairs 
and agreement overall was much poorer. Our study has shown that agreement in 
morphology was worse than dysplasia in all imaging modalities and although this 
replicates most studies, Jensen et al looked at a series of 187 polyps and found 
agreement between observers was better for morphology than dysplasia. However, this 
Danish study from 1995 also uses the old classification technique of mild, moderate and 
severe dysplasia before it was standardised to LGD and HGD. This may have some 
bearing on the different results [139]. 
 
An endoscopy inter-observer variation study of 80 colorectal polyps was carried out 
comparing different endoscopic imaging techniques such as white light, auto 
fluorescence and narrow band imaging. They demonstrated that expert observers 
showed a substantial agreement (κ 0.63) when predicting polyp histology where as non-
experts showed only a fair agreement (κ 0.30) and this finding was significant 
(p<0.001) [140]. Despite using a different imaging modality in our study it raises the 
concern that the training and experience of the observers are likely to have had a 
significant impact on the outcomes. 
 
The pit pattern classification has been shown to relate to polyp histology. Sakamoto et 
al showed a good agreement between observers making the PPC analysis (κ0.63) [141]. 
This study does not reflect such a reliable and consistent pattern of PPC results between 
the five observers and this is likely to be a result of the observers being pathologists and 
not endoscopists who are more familiar with the PPC. Including observers with 
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different experience in techniques such as radiologist and endoscopists may have an 
affect on the agreement observed here. 
 
It cannot be refuted that OPT shows more surface detail than H&E slides. This will 
have had a significant effect on the subsequent morphology diagnoses of the specimens 
with much greater variability and therefore can account for the poorer agreements that 
were observed. Although, whether this is a reflection of the diagnostic ability of the 
observer or as a result of the additional information seen on OPT it is unclear. A further 
factor, which affects the results, is the specimen type. ‘End’ specimens show a larger 
surface area from which a morphology diagnosis can be made than ‘slices’. Therefore 
when an observer lacks experience in a classification technique such as the pit pattern 
they may not be able to extrapolate the limited information on a slice specimen reliably 
enough to make an accurate assessment.  
 
8.6. CONCLUSION 
There are many external factors that have not been recorded in this study that could 
have an influence on dysplasia and morphology of colorectal polyps. As previously 
discussed, the location of a polyp in the colon, the size of the specimen, the method of 
excision, the type of specimen (end versus slice) and the quality of the OPT processing 
are just a few that would impact the analysis. In addition the experience of the observers 
selected for the study will undoubtedly affect the results. Despite trying to standardise 
as many of these factors as possible, selection bias and reporting bias is inevitable. 
However, it is important to recognise that the emphasis of the inter-observer variation 
study was on reaching a diagnosis rather than reflecting on the clinical implications of 
it. 
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We have shown through this inter and intra-observer analysis that agreement amongst 
observers is better for dysplasia than morphology on OPT and that agreement on these 
diagnoses between glass and digital H&E slides supersedes that of OPT with this study 
size and these particular observers. Identifying morphology and dysplasia types in 
colorectal polyps is based primarily on a qualitative assessment pertaining to pattern 
recognition. Given the varying skillset required to interpret digital 2D and 3D 
monochrome images as well as H&E slides it could have been valuable to include 
endoscopists or radiologists in the observer group. 
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CHAPTER 9: MULTISPECTRAL ANALYSIS  
 
 
One of the biggest advantages of OPT is in the adaptability of its technology. Previous 
studies have demonstrated the benefits drawn from performing a multispectral analysis 
on human tissue, such as liver biopsies, using OPT [108] and we saw from phase one 
results that combining information from different filter channels gave more detailed 
images of polyps (Chapter 5, Fig 5-10). 
 
A multispectral analysis involves scanning a specimen at different wavelengths by 
changing the light filter in the OPT scanner. The commercially manufactured OPT 
Scanner 3001 by the Belgium owned company SkyScanner was produced with three 
standard filters: GFP+ (Green Fluorescent Protein +, excitation wavelength 460-
500nm), GFP1 (Green Fluorescent Protein 1, excitation wavelength 395-455nm) and 
Cy3 (Cyan 3, excitation wavelength 530-600nm). As discussed in Chapter 4 the GFP+ 
and Cy3 channels were selected for the main study.  
 
Through a collaboration with the inventor of OPT, James Sharpe, at The Centre for 
Genomic Regulation (CRG), Barcelona we were able to perform a multispectral 
analysis using two additional filter channels: TXR (Texas Red, excitation wavelength 
540-580nm) and CFP (Cyan Fluorescent Protein, excitation wavelength 426-466nm). 
Eight polyp specimens from phase one were sent to the CRG in Barcelona to be scanned 
with a CFP filter. These specimens were selected to represent each of the dysplasia sub 
groups: LGD (n=2), HGD (n=4) and ICA (n=2). 
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9.1. LOW GRADE DYSPLASIA 
Two LGD polyps from phase one, each classified by the gold standard with 
tubulovillous morphology were scanned with the CFP filter in combination with the 
GFP+ and Cy3 filters (Figure 9-1 and 9-2). When scrutinising the image datasets on a 
high resolution viewing screen and comparing the level of detail in each specimen from 
a qualitative point of view, there didn’t seem to be a significant difference between the 
standard filters and the CFP filter set. The images in Figure 9.1 suggest that the GFP1 
filter set showed more surface detail, demonstrated by the rim of fluorescent blue at the 
edge of the specimen. 
 
 
Figure 9-1 LGD TVA Polyp I 
Scanned with (A) standard set of filters and (B) using CFP filter instead of GFP1. 
CFP/GFP+/Cy3 
GFP1/GFP+/Cy3 
A 
B 
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Likewise, the second example (Figure 9-2) also demonstrates a slightly enhanced image 
on the GFP1 filter set but this may be a result of the brightness of the image created, 
partly by the false colouring of channels rather than a due to a true difference. 
 
 
Figure 9-2 LGD TVA Polyp II 
Scanned with (A) the standard set of filters and (B) using the CFP filter instead of GFP1. 
GFP1/GFP+/Cy3 
CFP/GFP+/Cy3 
A 
B 
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9.2. HIGH GRADE DYSPLASIA 
Four HGD polyps were scanned in the same way, with a tubulovillous (n=3) or tubular 
(n=1) morphology. The same filter sets were used as before (Figure 9-3 and 9-4). 
 
 
Figure 9-3 HGD TVA Polyp 
Scanned with (A) the standard set of filters and (B) using the CFP filter instead of GFP1. An area of EPD 
is demarcated in A. 
GFP1/GFP+/Cy3 
CFP/GFP+/Cy3 
A 
B 
 
EPD 
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Figure 9-4 HGD TA Polyp 
Scanned with (A) the standard set of filters and (B) using the CFP filter instead of GFP1. 
 
The standard filter set showed slightly better images for the HGD specimens than the 
CFP filter set, as they had done with LGD specimens. The polyp in Figure 9-3 also 
shows EPD and this was confirmed on the H&E stained section. 
GFP1/GFP+/Cy3 
CFP/GFP+/Cy3 
A 
B 
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Features of dysplasia on OPT, as previously identified in phase one, can be seen with 
better clarity on multispectral imaging. The HGD polyp shows a denser architecture 
throughout the core of the polyp and when sections of the specimen are isolated this 
becomes more apparent (Figure 9-5). 
 
 
Figure 9-5 LGD And HGD Observed On Multispectral OPT Images 
Sections of a LGD and HGD polyp scanned on GFP1, GFP+ and Cy3 filters to demonstrate the 
differences seen on OPT. 
 
9.3. INVASIVE CANCER 
Two ICA specimens were scanned using the CFP filter set and both were classified as 
tubulovillous polyps (Figure 9-6 and 9-7). The GFP1 filter set, again, showed a better 
quality image that was sharper and hence appeared to show more detail but it was a 
‘brighter’ specimen, which may have bias the outcome.  However it is worth noting that 
although the different filter channels are falsely coloured, the brightness of the specimen 
is not altered between reconstructions of the raw data sets. Therefore the brightness is a 
direct result of the information picked up on each channel before it is superimposed to 
 
LGD HGD 
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produce the multispectral image and is therefore a product of the multispectral scanning 
in itself.  
 
 
Figure 9-6 ICA TVA Polyp I 
Scanned with (A) the standard set of filters and (B) using the CFP filter instead of GFP1. 
 
The second ICA example (Figure 9-7) shows the core of the polyp with its vasculature 
and evidence of invasion through the muscularis mucosa (arrows) and this ‘blurring of 
the boundaries’ is characteristic of invasive cancer in polyp specimens as seen on OPT.  
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Figure 9-7 ICA TVA Polyp II 
Scanned with (A) the standard set of filters and (B) using the CFP filter instead of GFP1. Direction of 
invasion of cancer indicated with arrows. 
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This is accentuated when compared on a bigger scale to the LGD polyp, which does not 
exhibit this feature and the boundaries of the stalk beyond the muscularis mucosa are 
much clearer (Figure 9-8).   
 
 
Figure 9-8 Muscularis Mucosa On LGD And ICA Polyp 
A LGD and ICA polyp showing the muscularis mucosa (dotted line) and subsequent invasion of cancer 
into the stalk that can be seen. 
 
9.4. HIGHER RESOLUTION SCANNING 
One of the limitations of OPT, that we have found, is that the highest resolution of the 
standard scanner does not give as much cellular detail as a H&E slide. It may be that 
resolution down to a cellular level is not required in order to make an accurate diagnosis 
however, Sharpe has advanced the technology during the course of this study beyond 
what has been used in phase one and two. 
 
An ‘optical bench’ was constructed that uses the same techniques as OPT but in an open 
environment in a climate controlled dark room (Figure 9-9 and 9-10). The components 
and methodology behind image acquisition are the same as the table-top scanner used in 
this study but on a much larger scale and is able to produce images at a significantly 
higher resolution. 
 
 
LGD ICA 
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Figure 9-9 Optical Bench For High Resolution OPT, CRG Barcelona 
 
 
Figure 9-10 Cuvette Containing BABB Where Specimen Is Located For Image Acquisition 
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B 
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We used this advanced OPT technology to scan a colorectal polyp specimen from phase 
one (Figure 9-11). Our initial intentions were to scan a polyp from each dysplasia 
subtype on the optical bench, however limitations encountered during the scanning 
process prevented this from occurring. 
 
One of the major limitations was the length of time taken to scan a specimen. Complete 
inertia was essential for good image capture and therefore the specimen was not 
suspended on a rotating mount but instead held in a micro-gripper. However the size 
and weight of the polyp specimen created technical difficulties using this method and 
very small movements presented problems. Rather than scan the whole specimen as one 
entity, the optical bench scanned it in sections and the resulting images were to be 
reconstructed and tiled together. 
 
Each scan of a section or ‘slab’ of tissue could take up to 14 hours and this length of 
time in the scanner created inevitable photobleaching and with small movements meant 
that accurate tiling was difficult to achieve. The back projection algorithm used to 
create and reconstruct the images was modified to account for the photobleaching 
however as the integrity of the specimen was paramount in this study in order to retain 
it diagnostic detail and return it to the NHS Tayside Tissue Bank archive unchanged, we 
were not able to complete scanning of the whole specimen. 
 
The optical bench has a diffraction-limited resolution of approximately 3 microns. As 
discussed, OPT has most commonly been used to visualise embryonic specimens which 
clear very well in BABB. Larger and denser human tissue specimens, such as colorectal 
polyps, do not clear as well. For this reason it was estimated that the resolution obtained 
on the optical bench for colorectal polyps was approximately 10 microns. 
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Figure 9-11 Polyp Scanned On Optical Bench 
Example of Polyp specimen scanned on the optical bench. Images show the original raw image followed 
by reconstructed cross sections in orthogonal planes (X,Y and Z). Sections represent the polyp stalk. 
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The depth of focus at this high resolution, and therefore higher magnification, also 
presented problems within the limits of the size of the optical lens used. The surface 
detail of the polyp was significantly improved but at the expense of detail further into 
the centre of the specimen and this was largely due to photon scattering that occurred as 
the light penetrated deeper into the tissue. At this high resolution, back ground 
interference can be seen in the reconstructed sections X, Y and Z (arrow). This was 
picked up from signals in the agarose medium surrounding the polyp and this reduces 
the sharpness of the image. In addition the reconstructed section Z shows the ring 
artefact that manifests as a result. 
 
9.5. CONCLUSION 
The higher resolution scanning technique of the optical bench and the multispectral 
potential of OPT takes the technology beyond what the main part of this study has 
utilised. It is clear that there are several limitations to the technique at this early stage, 
which need to be addressed, but we have shown that it is possible to improve the quality 
and detail of images of colorectal polyps in this way. 
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CHAPTER 10:  PHASE 3 - CLINICAL IMPLEMENTATION 
 
10.1. BACKGROUND SUMMARY 
The aim of phase three was to explore the potential use of OPT in the clinical diagnostic 
pipeline in NHS Tayside. Early in phase one we established that scanning whole post 
mortem specimens that had not been embedded in paraffin wax blocks had the potential 
to produce good quality images with good diagnostic detail (Figure 10-1). We have also 
seen the limitations presented by OPT in the length of time taken to process specimens 
prior to scanning but in order to assess the diagnostic utility of OPT in a clinical setting 
phase three was established. Scanning of whole polyps also has the advantage of 
avoiding artefacts caused by cutting the specimen and processing it 
 
 
Figure 10-1 Uncut Post-Portem Polyps 
 Uncut post mortem polyp specimens demonstrating the detail attainable on OPT on cross section (A) and 
in MIP view (B). 
A B 
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10.2. METHOD 
Colorectal polyps were identified from source in the Endoscopy Unit at Ninewells 
Hospital in NHS Tayside and were processed, intact, for OPT scanning on site in the 
Pathology Department. Patients who underwent colonoscopy for the colorectal 
screening programme were invited to participate. An information leaflet regarding the 
use of their tissue for research, published by Tissue Bank, was given to each patient 
whilst they were awaiting their colonoscopy.  They also had the opportunity to ask me 
questions prior to signing an NHS Tayside Tissue Bank consent form (Appendix IV). 
 
Following colonoscopy, pathology specimens were examined for their suitability for 
inclusion into the study and then entered into the OPT pre-scanning process as before. 
Polyps were assessed for inclusion with regards to their size (<15mm) and examined to 
ensure they had not previously been tattooed. All specimens had to undergo a 24-hour 
period of fixation in formaldehyde prior to being processed and embedded in agarose as 
per SOP LAB 370 (Appendix VII). 
 
Each specimen spent a minimum period of 48 hours being optically cleared in BABB 
before being scanned on OPT at a high resolution with GFP+ and Cy3 filters. The raw 
images captured were then checked for movement artefact prior to being reconstructed 
with NRecon software as before. The specimen was then de-embedded from its agarose 
plug and rehydrated to PBS. It was then returned to its formaldehyde solution in order 
to undergo routine processing in the histopathology lab. 
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10.3. RESULTS 
19 patients consented to take part in the study. Eight specimens were collected from 
seven patients over a 3 month time period. All specimens were subsequently diagnosed 
as LGD polyps and with either tubulovillous (n=7) or tubular morphology (n=1). None 
of the specimens scanned contained invasive cancer or high grade dysplasia. All 
specimens were fixed for a 24 hour period and optically cleared in BABB for a mean 
time of 70.1 hours (IQR 68-71 hours). The images obtained showed the polyp surface 
morphology with very good clarity but subjectively poorer quality views of the cross-
sectional detail (Figure 10-2 and 10-3). 
 
 
Figure 10-2 3D OPT Polyps 
Two polyps showing the 3D surface morphology rendered using Bioptonics Viewer. 
 
There was a considerable degree of ring artefact in some of the specimens due to 
microscopic fragments of tissue or dust in the agarose (Figure 10-3). This reduced the 
quality of the image somewhat and affected subsequent diagnostic accuracy on OPT. 
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Figure 10-3 Cross-sectional views of a Polyp on Dataviewer 
The ring artefact that reduces the quality of the image can be seen 
 
Post OPT scanning the specimens were returned for routine histopathological 
assessment in a mean time of 165.25 hours (6.89 days) with a minimum of 129 hours 
(5.38 days) and maximum of 194 hours (8.08 days) from the time of excision. The 
specimens were scanned once with the exception of one specimen that was scanned 
twice due to movement artefact. 
 
10.4. DISCUSSION 
 The UK NHS bowel cancer screening programme (BCSP) committee have made 
recommendations that 90% of the histopathology specimens should be reported on 
within 7 days [85]. From the knowledge gained from phase one and two we knew that 
this was not likely to be achievable, with OPT, given the time taken for fixing, 
embedding, optical clearing, scanning and post OPT de-embedding. Therefore this 
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anticipated delay was mentioned to all the patients during the consent procedure. 
Although a delay of a few days would be considered acceptable, several weeks would 
not and therefore there was short window in which the specimens could be processed. 
 
The sample size in phase three was small and this was due to the rate at which 
specimens were collected. We know from the pilot study in the UK BCSP that 
approximately 300 colonoscopies were anticipated each year in each regional screening 
centre covering an eligible screening population of approximately 50,000 people (aged 
60-69). The polyp detection rate was found to be 35-45% and therefore for every 3 
patients who consented to the study only one was likely to have a polyp detected [142]. 
However, once the polyp had been removed, it was further assessed for inclusion to 
ensure it would be suitable for OPT scanning. This process was therefore time 
consuming and yielded a small sample size. 
 
There was a poor range of different dysplasia sub groups in the sample size and this was 
inevitable due to the study design and length. In order to identify a cancer polyp using 
this methodology of polyp selection, with a reported detection rate of 2% in endoscopy 
specimens from the BCSP, it could take 1-2 years unless the manpower on the project 
was increased and the sample selection extended outwith the screening population [29]. 
However, the purpose of phase three was to identify if OPT could be integrated into the 
clinical diagnostic pipeline and not primarily to assess the diagnostic ability of the 
specimens. However, ultimately this would need to be addressed. In order to assess this 
within the context of a ‘clinical study’, the project would need to be extended over a 
significantly longer timeframe and require a full lab of technicians trained in OPT to 
process the samples efficiently in order to meet the reporting recommendation time of 7 
days. 
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All the polyps showed ring artefact in the OPT images to some degree. This is usually 
due to impurities within the agarose plug around the specimen. This may have been 
caused by a processing error whilst the polyps were being embedded whereby dust or 
microscopic particles had contaminated the agarose solution. However, since it occurred 
in all eight specimens despite being embedded at different points in time, this is less 
likely. The specimens were removed directly from the patient and placed in a fixative 
before they were washed and embedded in agarose. They would have unavoidably 
carried faecal and cellular residue with them into the fixative solution. The washes 
involved agitation within PBS but not mechanical scrubbing of the specimen itself, 
therefore preserving the mucosal epithelium as much as possible. However, if residue 
remained on the polyp despite these ‘washes’ and it was then transferred into the 
agarose solution it could account for the ring artefact. 
 
Furthermore, it is worth highlighting the subtle differences in the polyp processing pre-
OPT to understand why this was not encountered during phase one and two as 
frequently. The archived specimens would have been washed and processed through an 
automated tissue processor in the pathology lab prior to being embedded in wax for 
H&E slides to be cut. Most of the impurities in the fixative and washing solutions 
would have been eliminated by the tissue processor and indeed any that were later 
discovered in the paraffin wax would have been further removed when they were de-
embedded from wax and re hydrated through the tissue processor at MRCT for use in 
this study. In order to address this issue, a more vigorous washing process could be 
employed or the specimen could have been scanned without being suspended in an 
agarose medium. If ring artefact were to have occurred in phase one or two the 
specimens were often re-processed and re-embedded in an attempt to clear the agarose 
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solution. However, with the time constraints placed on phase three of the study this was 
not possible and the first images obtained had to be accepted. 
 
The 3D surface rendering to show the villous morphology was of good quality despite 
the issues encountered with ring artefact and this is partly due to the software 
Bioptonics. It has the ability to alter the opacity of the specimen to cancel out and hence 
remove the artefact. In doing this, the detail of the centre of specimen is compromised 
but not at the expense of the surface detail. Therefore developing the software itself and 
improving its functions could enhance images further. This is an additional benefit of 
OPT technology but without further collaborations with software companies was not 
explored within the scope of the study. 
 
10.5. CONCLUSION 
OPT, with its current limitations, does not allow for the specimens to be processed in 
the clinical diagnostic pipeline without causing significant delay to the reporting 
timeline. Therefore, several modifications such as enhanced clearing techniques and 
software optimisation would need to be explored further to overcome the limitations we 
have encountered. Therefore OPT currently shows significant promise in its potential as 
a research tool but not currently as an independent diagnostic tool for colorectal polyps. 
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CHAPTER 11: DISCUSSION 
 
In 1876, a German scientist, Wissowzky first described the use of Haematoxylin and 
Eosin dyes as a dual staining agent for histopathology. His work followed on from the 
earlier independent discoveries of Haematoxylin by Böhmer (1865) and Eosin by 
Fischer (1875), also German scientists [143]. Over the last 140 years time appears to 
have stood still and this well-known and trusted methodology, although modernised to 
some extent, is still regarded as the gold standard diagnostic stain in clinical pathology 
today. 
 
The introduction of a new technology, such as OPT, into clinical medicine brings with it 
many challenges. It can be difficult to change or supersede a well-established technique 
that we know works well, is reproducible and accurate. This research has highlighted 
some of the diagnostic difficulties that conventional histopathology techniques present 
for diagnosing colorectal polyps. The serial sectioning of specimens is a destructive 
method and visualises only a very small proportion of the excised tissue in two 
dimensions. Furthermore, phenomenon such as epithelial displacement can be 
misinterpreted on a two dimensional slide and the subjective and qualitative nature of 
histopathology inevitably causes inter and intra-observer variation for features such as 
dysplasia. The clinical management of patients post polypectomy in the Bowel Cancer 
Screening Programme is reliant upon features identified using histology and therefore 
diagnostic accuracy is crucial.  
 
Optical Projection Tomography, as a three dimensional non-destructive digital imaging 
technology has several potential advantages over conventional histology techniques. It 
therefore has the potential to supersede these methods when analysing small biological 
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specimens such as colorectal polyps or lymph nodes. However despite this theoretical 
advantage OPT may have, this study has demonstrated that is has a long way to go 
before it can be accepted into the commercial clinical market as a reliable and accurate 
diagnostic tool. 
 
Some of the limitations of OPT that have been outlined by this study occurred as a 
result of the study design (i.e. using archived specimens). Specimens were selected in 
chronological order from a database of archived colorectal polyps in a single centre, 
from where the National UK Bowel Cancer Screening Programme (BCSP) had 
originated. From early pilot studies of the BCSP we know that within the first year of 
screening the overall colonoscopy activity had increased by 31% in Scotland and 21% 
in England having a significant impact on waiting times for symptomatic colonoscopy. 
In addition, the throughput in the pathology department for biopsy and polypectomy 
specimens also increased by up to 30% in some of the busiest centres [31]. Therefore 
polyps obtained from the screening period were estimated to be the largest single source 
of tissue from the shortest time period. This was an important factor to consider, as 
substantial changes in the prevalence of colorectal cancer, which may have occurred if 
the selection period was very long, would affect the calculation of kappa statistics. 
 
Using specimens from the Tissue Bank archive enabled rapid access to a large volume 
of specimens within a short time period. Despite this, sequential sampling from the 
archive would not have selected enough cancer polyps by chance to meet the pre-study 
power calculation. Therefore additional cancer polyps were ‘cherry picked’ and also 
sourced through another database held by the Colorectal Multidisciplinary Team 
(MDT). 
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Sample size calculations were performed and are based on the power to detect whether 
a given observed kappa statistic exceeds a lower limit (0.6) in a test with 5% statistical 
significance. As noted earlier the kappa statistic is a measure of agreement between 
OPT and H&E (i.e. between two observers) in recording polyp cancers. We usually 
focus on obtaining a sample size to give an 80% power. The required sample size also 
depends on the proportions of samples classified as cancer polyps. In the initial 
planning of the study various scenarios were considered and details are given in 
Appendix II. It was found that for an observed kappa statistic of 0.85 and with 2% of 
samples being cancer polyps, the sample size needed to meet the above requirements 
was 662. For 15% of samples being cancer polyps the required sample size was 100. 
Our sample size for phase two was 665 and included 10.5% (n=70) cancer polyps and 
therefore the study was powered to more than 80% under the conditions noted above. 
Without the cherry picking of cancer polyps this is unlikely to have been achieved 
within the limitations of the length and size of the study. However, if the observed 
kappa statistic is lower than 0.85 then the sample size investigations show that larger 
samples are required in order to detect whether it exceeds 0.6. 
 
Using archived specimens from paraffin wax blocks presented limitations to the study. 
Once the polyps had been removed from their wax they were very brittle and therefore 
liable to fragment. This was unavoidable and the inclusion criteria for the study had to 
be modified to ensure the samples selected were robust enough and suitable for OPT. In 
particular, it became apparent during phase one that villous specimens were at a higher 
risk of splitting and therefore only represented a small proportion of the study sample 
(1.5%; n=10). We know from the literature that villous adenomas comprise 
approximately 7% of polyps removed and are associated with a higher risk of 
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malignancy than tubular or tubulovillous polyps [39] therefore in reducing this sub-
group of specimens we were skewing the study sample.  
 
The optical clearing process using BABB was the rate-limiting step to the study. 
Experiments were carried out to see if altering the composition of BABB, heating the 
specimens gently in a water bath or agitating the sample could speed up the process. 
However for various reasons, as discussed in Chapter 4, there was no benefit found. 
Human tissue is denser than the embryonic specimens which were first used when OPT 
was invented. In phase one we showed that post-mortem whole polyps produced very 
clear images albeit with a very protracted optical clearing period (up to 37 days) and 
therefore we know that OPT has the potential but not that we could demonstrate on a 
larger scale within the time limits of this study and using archived specimens.  
 
Dysplasia has been a controversial area in histopathology for many years and OPT has 
only accentuated what we already know in that distinguishing between high and low 
grade dysplasia is difficult. The graded change of cellular dysplasia cannot easily be 
placed into discrete groups without disagreement of the qualitative analysis and we have 
demonstrated this on glass slides, digital images and using OPT. OPT was not able to 
distinguish easily between LGD and HGD but it showed a reasonable specificity 
(83.7%) and sensitivity (77.1%) for cancer polyps and this is evident from the 
agreement improving from κ 0.27 to κ 0.40 when considering benign and malignant 
polyps alone. However, OPT tended to over diagnose ICA in specimens and potentially, 
if this was the only diagnostic tool, could lead to subsequent unnecessary investigations 
and surgery with the associated morbidity and mortality risks that come with it.  
Therefore several aspects of OPT were explored to see if any part of the process could 
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be optimized to address the under-diagnosed ICA polyps or to further improve the 
clarity of images. 
 
Under the conditions agreed with Tissue Bank, it was necessary to return all tissue 
specimens in a good condition so as to preserve their diagnostic properties for future 
use. Therefore we were limited with regards to how much the polyps could be altered 
and chemically processed. We showed through the validation study of phase one that 
specimens that had undergone standard OPT processing retained their diagnostic 
information when re-analysed post-OPT. However, OPT has the advantage of being 
able to apply immunochemical stains to identify specific features and it would have 
been advantageous to have been able to do this to fully explore its potential but we were 
only able to use unstained specimens in this study. In addition, we know from other 
studies using OPT that it can assess the cellular response to some drugs and to identify 
the intricate 3D cellular or genetic interactions that may exist in tissues giving us a 
better understanding as to why and how neoplastic tissues grow [109, 110, 113, 114]. 
 
Tumour growth in colorectal cancer is linked to angiogenesis as the vasculature 
provides the nutrients and oxygenation that promote cell proliferation. Takebayashi et al 
showed that the microvessel count is significantly related to relapses of disease in 
primary colorectal carcinomas specimens [144]. We have demonstrated in this study 
that the vascular network within colorectal polyps is detectable on OPT in the MIP 
View. CD31 (PECAM-1) is an immunoglobulin present on surface cell receptors 
strongly expressed by endothelial cells. It has been proven to identify angiogenesis in 
colorectal cancer and therefore would have been a useful marker in order to validate our 
observations. 
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Using this knowledge we could have studied the vasculature pattern, with clinical 
correlation, in more depth with the aim of identifying prognostic indicators. In addition, 
the vasculature pattern may give an indication as to why some polyps bleed and some 
do not leading to the detection of the so-called ‘interval cancers’ picked up between 
negative bowel cancer screening tests [145]. However, immunochemical staining of 
large blocks of polyp tissue would have irreversibly altered to tissue specimen and 
therefore could not be done within the limitations of this study. Furthermore, other 
studies have shown that immunochemical staining of myofibroblasts and smooth 
muscle cells in normal colonic tissue and colorectal polyps may help identify the 
muscularis mucosa and subsequently distinguish between invasive cancer and epithelial 
displacement [146].  
 
Through the collaboration with CRG, Barcelona we explored how improvements in the 
hardware could enhance imaging of colorectal polyps by increasing image resolution. 
However, this was at the expense of photobleaching and movement artefact during the 
protracted time taken to capture the images. Altering the technology of OPT itself was 
not within the remit of this study but having the opportunity to explore its potential in 
the imaging market was valuable. 
 
Conventional fluorescence imaging has a limited set of light filters with which to 
visualise specimens and therefore information detected within a specimen is limited to 
the wavelength upon which it is scanned. Fluorescent molecules emit light (photons) on 
a whole spectrum of wavelengths and by imaging them in a multispectral way these 
individual signals can be identified and calculated to produce an image. By performing 
such an analysis it may be possible to identify specific features of the tissue with more 
clarity than with a standard filter. The green filters (GFP1 and GFP+) showed more 
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surface detail of the specimen where as the red filters penetrated deeper and showed 
better clarity of the centre of the polyp. In smaller polyps the green filters seemed to be 
adequate but in the larger polyps the red filter was required to show the internal features 
in more detail.  
 
Assessment of the villous morphology of colorectal polyps is an interesting feature of 
OPT. The surface morphology is shown with good clarity and we know from the 
literature that a larger size and higher villousness of a polyp is related to severe 
dysplasia and an increased risk of cancer [137]. In this study we have correlated the 
surface morphology with current known classification techniques used in 
histopathology such as the WHO classification of TA, TVA and VA and in endoscopy 
such as Kudo’s Pit Pattern Classification (PPC). However, it is not surprising that 
relating this 3D morphology (PPC) to 2D H&E classification showed no significant 
association. 
 
Utilising archived specimens that had already been cut and had some tissue removed for 
H&E sectioning created a limitation in the morphology diagnosis especially when 
examining ‘slice’ specimens where very little surface was visible. The surface detail 
was, as expected, more informative on ‘end’ specimens and this is reflected in the 
results with a better sensitivity for dysplasia (78.7% vs 73.9%) and with no significant 
difference in specificity (83.5% vs 84.4%). The overall agreement was largely 
unchanged (κ 0.27 end vs κ 0.26 slice). The surface morphology diagnoses showed no 
significant difference between ‘end’ and ‘slice’ specimens and this may reflect the 
complexity of the surface morphology as well as the appropriateness of correlating a 2D 
diagnosis with 3D images. 
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The percentage villousness was classified into 10% aliquots to assess the relationship 
with polyp dysplasia diagnoses but no significant association was found. This is likely 
to be due to the amorphous structure of malignant polyps with ulceration and distorted 
surface features leading to a observed lower villous morphology. However a significant 
association was found between the percentage villous component and its H&E 
morphology diagnoses. The identification of a dual pit pattern type in 69.3% of the 
specimens and other features such as ‘lobulation’ raises the question as to whether 
Kudo’s PPC can be re-defined further to aid the early detection of suspicious lesions. 
 
Fundamentally diagnosing polyp morphology is a ‘pattern recognition’ technique and 
the subjective nature of this methodology makes it somewhat obsolete. From this study 
we have a large database of digitally generated images of colorectal polyps and this 
should be exploited further. Re-defining a well-validated classification technique such 
as Kudo’s without attempting to automate the analysis would be premature. During the 
final stages of this study we collaborated with Professor Stephen McKenna and Dr 
Jianguo Zhang in the Department of Computer Sciences at the University of Dundee 
and explored the potential for carrying out an automated analysis of the images. 
Through funding obtained from the Dundee Cancer Centre a pilot study of 90 polyps 
was set up to investigate this. There were several aspects of polyp diagnoses that could 
be explored with an automated analysis and the study focused on distinguishing 
between different types of dysplasia using 3D texture analysis. This work is still in its 
very early stages requiring software development as well as interpretation and 
validation. However it has showed that automated pattern recognition of polyp 
dysplasia was possible [147]. 
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The inter-observer variation study demonstrated that OPT showed poorer agreement 
between dysplasia diagnoses and surface morphology than on H&E sections. The 
agreement in OPT dysplasia diagnoses was calculated as fair to moderate amongst the 
observers with a mean sensitivity of 48.3% (range 33.3% to 75.0%). When comparing 
this with the results of the main study, the sensitivity was significantly higher at 77.1%. 
This suggests that experience in viewing OPT images played an important factor in 
making an accurate diagnosis of dysplasia and therefore with better training in viewing 
OPT images would be essential. 
  
OPT does not display cellular level detail on unstained tissue in the same way that H&E 
stained slides do and this seems to be the biggest disadvantage when comparing the 
technology to conventional histology. However, with the obvious issues that exist with 
inter-observer variation there still remains a need to develop the analysis of polyp tissue 
further in order to address this. In order to integrate a technology such as OPT into the 
clinical pipeline it has to adhere to a multitude of factors and it must be fit for purpose. 
The diagnoses made must be as accurate if not supersede current accepted 
methodologies. It should be relatively easy to use without the need for several months 
or years of training for the work force. In terms of pathological diagnoses the speed at 
which the results can be obtained is always an important factor to consider and it must 
be cost effective if an institution such as the National Health Service is going to take it 
on. 
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CHAPTER 12:  CONCLUSION 
 
The future of OPT as a diagnostic tool is limited by its resolution and also to a certain 
extent by the techniques available firstly to adequately clear the biological specimen, 
secondly in the hardware used to capture the images and thirdly in the software 
available to view and analyse them. Each of these areas were addressed throughout the 
course of the study in order to explore OPT’s potential and with improvements in 
multispectral imaging and introducing an automated analysis it could still have 
diagnostic uses although we have not been able to demonstrate this in its entirety within 
the limitations of this study. 
 
One of the most interesting features that have emerged from this research relates to the 
PPC. Although it is a well-known endoscopic classification, our experience in the UK is 
that it does not significantly influence clinical decision making by the endoscopist. The 
identification of a particular PPC may raise suspicion regarding the underlying 
histology but there are no defined guidelines that indicate how specimens should be 
excised or followed up based on this. 
 
The high definition images, obtained on OPT, that demonstrate the intricate surface 
morphology of colorectal polyps and the advantage of whole specimen visualisation 
may be beneficial in pathology. For example in refining the villousness and combining 
what we have observed in the PPC with conventional histology, OPT might be useful in 
guiding the histological plane of sectioning through polyps. By doing this OPT can 
potentially visualise areas, not macroscopically detectable, of early cancer and 
distinguish them from EPD. 
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The value of digital pathology has grown exponentially in the last two decades and has 
presented pathologists with the opportunity for automated or semi-automated analysis 
methods. Once calibrated and validated, this could potentially enable diagnoses to 
become more objective and reproducible than the current techniques. 
 
Future work in OPT should focus on improving the optical clearing process of polyps 
and developing the hardware to enhance the resolution of images. We have started to 
explore, through a collaboration with McKenna and Zhang, the growing potential in the 
automated analysis of OPT generated images and investigating new or alternative 
software may help re-define the surface morphology and reduce inter-observer 
variation. Finally further analysis of the villousness of colorectal polyps may help in 
vivo diagnosis of colorectal polyps at endoscopy and guide pathology sectioning.  
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Personal details
 
 
 
Project Title
Optical Projection Tomography in Colorectal Polyps
 
Precis of Project
Optical projection tomography (OPT) is a newly developed technology (MRC Technology) which
produces 3D images and virtual sections in three orthogonal planes of small biological tissues (1-
15 mm diameter) (ref). OPT has been widely used in developmental biology Up to 20% of screen-
detected cancers are polyp cancers (invasive malignancy confined to the stalk of an adenoma).
Pathological diagnosis of these tumours by 2D conventional histology is difficult and distinction of
cancer from traumatic epithelial misplacement is a major quality issue in screening (ref). About
10% of FOB positive individuals have a malignant tumour and the introduction of the screening
programme, in addition to increasing the numbers of colorectal polyps Optical projection
tomography (OPT) is a newly developed technology (MRC Technology)which produces 3D
images and virtual sections in three orthogonal planes of small biological tissues (up to about 20
mm diameter). OPT has been widely used in developmental biology but we now wish to assess its
utility in diagnosis.
Up to 20% of screen-detected colorectal cancers are polyp cancers (invasive malignancy confined
to the stalk of an adenoma). Pathological diagnosis of these tumours by 2D conventional histology
is difficult and distinction of cancer from traumatic epithelial misplacement is a major quality issue
in screening. About 10% of FOB positive individuals have a malignant tumour and the introduction
of the screening programme, in addition to increasing the numbers of colorectal polyps requiring
pathological assessment, has led to a major shift in the stage at which malignant tumours present.
 
 
The experience of the Scottish Pilot of FOB testing for colorectal cancer was that almost 20% of
tumours presented as polyp cancers (invasive malignancy confined to the stalk of a resected
Tayside Tissue Bank - Request for Tissue Specimens
Request No: TR000168
Request Date: 08/09/2009
Researcher Institution Department
Frank Carey University of Dundee Pathology
Co-workers
Co-researcher: Dr Sarah Wedden
Clinican: Prof RJC Steele
Pathologist: Prof Frank Carey
 
 
 
 
 
 
 
polyp). This is a rare event in non-screened populations. Diagnosis of such a cancer can mean
that cure is achieved without recourse to formal surgical excision. There is, however, a recognised
risk of over-diagnosis in this context. The major adverse effect is incorrectly labelling a patient with
malignant disease. The reason for the difficulty is that polyps are often traumatised within the
colon leading to misplacement of non-malignant mucosa into the stalk.
In 2D histology (the current gold standard) this can easily resemble carcinoma.
 
About 30% of FOB positive individuals identified in the screening programme have potentially
premalignant adenomas. Many of these individuals are referred for further colonoscopy. The
presence of a villous surface architecture and/or microscopic high grade dysplasia is useful in
identifying at risk individuals but this has again proven to be prone to interobserver variation in
diagnosis using conventional histology and has not been included in follow-up guidelines( ref.
Atkin WS, Morson BC, Cuzick J. Long term risk of colorectal cancer after excision of rectosigmoid
adenomas. NEJM 1992;236:658-62).
 
Both scenarios exemplify the limitations of 2D histology in assessing complicated 3D processes.
There is a compelling need to develop new approaches for more robust diagnosis. OPT imaging,
with its unique combination of 3D images and 2D virtual sections through the whole specimen, has
the potential to transform such difficult diagnoses.
 
We propose to use OPT on fixed paraffin-embedded samples of colorectal polyps covering a
range of pathologies (the samples are dewaxed, scanned and then re-embedded). The images will
be blindly assessed by a pathologist and compared to conventional 2D images. The experience
will then be used to assess a series of fixed whole polyps prior to embedding in an atempt to guide
block taking and making a more reproducible assessment of polyp architecture.requiring
pathological assessment, has led to a major shift in the stage at which malignant tumours present.
 
 
The experience of the Scottish Pilot of FOB testing for colorectal cancer was that almost 20% of
tumours presented as polyp cancers (invasive malignancy confined to the stalk of a resected
polyp). This is a rare event in non-screened populations. Diagnosis of such a cancer can mean
that cure is achieved without recourse to formal surgical excision. There is, however, a recognised
risk of over-diagnosis in this context. The major adverse effect is incorrectly labelling a patient with
malignant disease. The reason for the difficulty is that polyps are often traumatised within the
colon leading to misplacement of non-malignant mucosa into the stalk.
In 2D histology (the current gold standard) this can easily resemble carcinoma.
 
About 30% of FOB positive individuals identified in the screening programme have potentially
premalignant adenomas. Many of these individuals are referred for further colonoscopy. The
presence of a villous surface architecture and/or microscopic high grade dysplasia is useful in
identifying at risk individuals but this has again proven to be prone to interobserver variation in
diagnosis using conventional histology and has not been included in follow-up guidelines( ref.
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There is a compelling need to develop new approaches for more robust diagnosis. OPT imaging,
with its unique combination of 3D images and 2D virtual sections through the whole specimen, has
the potential to transform such difficult diagnosesOptical projection tomography (OPT) is a newly
developed technology (MRC Technology)which produces 3D images and virtual sections in three
orthogonal planes of small biological tissues (up to about 20 mm diameter). OPT has been widely
used in developmental biology but we now wish to assess its utility in diagnosis.
Up to 20% of screen-detected colorectal cancers are polyp cancers (invasive malignancy confined
to the stalk of an adenoma). Pathological diagnosis of these tumours by 2D conventional histology
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in screening. About 10% of FOB positive individuals have a malignant tumour and the introduction
of the screening programme, in addition to increasing the numbers of colorectal polyps requiring
pathological assessment, has led to a major shift in the stage at which malignant tumours present.
 
 
The experience of the Scottish Pilot of FOB testing for colorectal cancer was that almost 20% of
tumours presented as polyp cancers (invasive malignancy confined to the stalk of a resected
polyp). This is a rare event in non-screened populations. Diagnosis of such a cancer can mean
that cure is achieved without recourse to formal surgical excision. There is, however, a recognised
risk of over-diagnosis in this context. The major adverse effect is incorrectly labelling a patient with
malignant disease. The reason for the difficulty is that polyps are often traumatised within the
colon leading to misplacement of non-malignant mucosa into the stalk.
In 2D histology (the current gold standard) this can easily resemble carcinoma.
 
About 30% of FOB positive individuals identified in the screening programme have potentially
premalignant adenomas. Many of these individuals are referred for further colonoscopy. The
presence of a villous surface architecture and/or microscopic high grade dysplasia is useful in
identifying at risk individuals but this has again proven to be prone to interobserver variation in
diagnosis using conventional histology and has not been included in follow-up guidelines( ref.
Atkin WS, Morson BC, Cuzick J. Long term risk of colorectal cancer after excision of rectosigmoid
adenomas. NEJM 1992;236:658-62).
 
Both scenarios exemplify the limitations of 2D histology in assessing complicated 3D processes.
There is a compelling need to develop new approaches for more robust diagnosis. OPT imaging,
with its unique combination of 3D images and 2D virtual sections through the whole specimen, has
the potential to transform such difficult diagnoses.
 
We propose to use OPT on fixed paraffin-embedded samples of colorectal polyps covering a
range of pathologies (the samples are dewaxed, scanned and then re-embedded). The images will
 
 
 
  
be blindly assessed by a pathologist and compared to conventional 2D images. The experience
will then be used to assess a series of fixed whole polyps prior to embedding in an atempt to guide
block taking and making a more reproducible assessment of polyp architecture.
 
This work has not been approved by the ethics committee
 
Specimens requested
 
 
Services requested
Dewaxing and clearing of specimens. Re-embedding in paraffin
 
Funding
 
 
Additional comments
Quantity Tumour Site In Form
200 Colon Paraffin Block: Tumour
Name of funder Grant number
MRC Not given
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will then be used to assess a series of fixed whole polyps prior to embedding in an atempt to guide
block taking and making a more reproducible assessment of polyp architecture.
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Request No: TR000348
Request Date: 15/07/2013
Additional request for TR0168
Lead Researcher
Frank Carey (University of Dundee)
Coworkers
Prof Frank Carey (Pathologist)
Prof Bob Steele (Clinician)
Precis of Project
As part of the investigation of the utility of optical projection tomography (OPT) in diagnosing
morphological abnormalities in colorectal polyps (approved as TR168) we have identified a number of
cases in which we feel that  there is a need to cut further sections for conventional histology. We
have been advised that this requires  the Access Committee   s approval and we are now seeking this.
The circumstances are as follows: 
 
OPT was evaluated in a number of ways; we used a "teaching set" of good examples of various
abnormalities in polyps to define OPT criteria for polyp architecture, dysplasia, epithelial
misplacement and invasive cancer. These criteria were than used to "diagnose" a further series and
compared to the conventional pathological diagnosis. The result, in brief, showed that OPT does not
appear to have any value in this regard. Some straightforward cancers were labelled as benign and
OPT was not shown to have any value in discriminating degrees of dysplasia. 
 
In 29 cases diagnosed as benign on conventional histology OPT reported features consistent with
malignancy. We could take the view that our original diagnosis was made in the recommended standard
way and leave it at that. We do feel, however, that we should examine some deeper sections from the
existing blocks to rule out any undetected pathology. The patient were all bowel screening subjects
under the care of Prof. Steele, and none have any clinical evidnence 10 years later of progressive
malignant disease. In the very unlikely event that significant (i.e. malignant) abnormality is found
in any individual the case would be reviewed in consultation with the patient   s GP and the
clinical relevance or otherwise of the observations determined with them. Any further action would
be at their discretion.  
 
We would ask for 3 deeper levels on each block, ensuring that some tissue is left in the sample for
any future clinical purpose. 
 
This work has not been approved by the ethics committee
Quantity Tumour Site In Form
Name of funder Grant number
MRC Technology N/A
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OPT DGF Application 12 February 2009:
Sample size calculations
Ruth Keogh
February 9, 2009
1 Stage 2: Sample size calculations based onKappa statis-
tics for agreement between OPT and H&E and for in-
terobserver agreement
The estimate of the agreement between polyp classifications using OPT and H&E,
or between classifications from two individuals, is
ˆ =
PG
i=1 pii  
PG
i=1 pi·p·i
1 PGi=1 pi·p·i (1)
=
p0   pe
1  pe (2)
where G is the number of classification categories, pij is the proportion of polyps
classified in category i by H&E and in category j by OPT, pi· =
PG
j=1 pij and
p·i =
PG
j=1 pji. The statistic ˆ takes values in the range from -1 to 1, with  = 1
indicating complete agreement between OPT and H&E/2 observers and  = 0
indicating no agreement between OPT and H&E/2 observers beyond that which is
expected by chance. The variance of ˆ is (Fleiss et al 1969)
vˆar(ˆ) =
1
n (1  pe)2
8<:
GX
i=1
pii (1  (pi· + p·i)(1  ˆ))2 + (1  ˆ)2
GX
i 6=j
pij(pi· + p·j)2   (ˆ  pe(1  ˆ))2
9=; .
(3)
We can write the variance of ˆ as (Flack et al 1988)
vˆar(ˆ) =
⌧2 (ˆ)
n
, (4)
1
 
 
 
 
 
where
⌧ (ˆ) = (1 p0)2
GX GX
i6=j
pij(pi·+p·j)2 (1 p0)
GX
i=1
pii(pi·+p·i){2(1 pe) (1 p0)(pi·+p·i)}
(5)
The aim is to determine the sample size required so that an ↵-level test of H0 :
  0 against the alternativeHa :  > 0 will have power of at least 1    when
 = 1. Flack et al (1988) give the result
n  
⇢
z1 ↵max {⌧ (ˆ| = 0)}+ z1  max {⌧ (ˆ| = 1)}
0   1
 2
(6)
where max {⌧ (ˆ|)} is the maximum value which ⌧ (ˆ) can take given the marginal
probabilities pi· and p·i.
Flack et al (1988) note that⌧ (ˆ) is maximised by maximising the double summa-
tion in (5). The double summation is maximised by placing all of the off diagonal
probability (1   p0) on the pij corresponding to the largest marginals pi· and p·i.
The remaining off-diagonal cells are set to 0. This assumes that the two sets of
marginal probabilities are the same (or close).
2 Sample size calculations
For an observed Kappa statistic 1 we calculate the sample size required so that
we have the ability to “accept” a hypothesis that the true  exceeds a lower limit
0 with 5% statistical significance (Type I error) and 80% power. We consider
possible values for 1 of 0.95, 0.9, 0.85, 0.8, 0.7, 0.6, and values for 0 of 0.5, 0.6,
0.7, 0.8, 0.9.
2.1 Villous morphology
The following sample size calculations are based on 60% of polyps being villous
and 40% not being villous.
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0
0.5 0.6 0.7 0.8 0.9
1
0.95 15 22 35 73 401
0.9 21 33 62 192 -
0.85 30 52 122 855 -
0.8 43 87 295 - -
0.7 107 384 - - -
0.6 459 - - - -
Table 1: Sample size required so that the 5%-level test of H0 :   0 versus
Ha :  > 0 has at least 80% power when  = 1: Assuming a two-way classifi-
cation of polyps as villous/not villous, where 60%/40% are assumed to be classified
as villous/not villous on both classification instruments (2 observers or OPT and
H&E).
2.2 High and low grade dysplasia
The following sample size calculations are based on 15% of polyps having high
grade dysplasia and 85% having low grade dysplasia.
0
0.5 0.6 0.7 0.8 0.9
1
0.95 28 41 67 140 767
0.9 40 63 120 370 -
0.85 56 100 236 1655 -
0.8 82 167 572 - -
0.7 203 740 - - -
0.6 870 - - - -
Table 2: Sample size required so that the 5%-level test ofH0 :   0 versusHa :
 > 0 has at least 80% power when  = 1: Assuming a two-way classification
of polyps as high grade/low grade dysplasia, where 15%/85% are assumed to be
classified as high grade/low grade dysplasia on both classification instruments (2
observers or OPT and H&E).
2.3 Epithelial displacement
The following sample size calculations are based on 30% of polyps having epithe-
lial displacement and 70% not having epithelial displacement.
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0
0.5 0.6 0.7 0.8 0.9
1
0.95 17 25 40 84 460
0.9 24 38 72 221 -
0.85 34 60 141 985 -
0.8 50 100 340 - -
0.7 123 442 - - -
0.6 526 - - - -
Table 3: Sample size required so that the 5%-level test of H0 :   0 versus
Ha :  > 0 has at least 80% power when  = 1: Assuming a two-way clas-
sification of polyps as having epithelial displacement/no epithelial displacement,
where 30%/70% are assumed to be classified as yes/no on both classification in-
struments (2 observers or OPT and H&E).
2.4 Polypoid cancer
The following sample size calculations are based on 2% of polyps being polypoid
cancer and 98% not being polypoid cancer.
0
0.5 0.6 0.7 0.8 0.9
1
0.95 180 271 446 933 5065
0.9 258 420 802 2467 -
0.85 368 662 1576 11049 -
0.8 537 1111 3829 - -
0.7 1334 4931 - - -
0.6 5696 - - - -
Table 4: Sample size required so that the 5%-level test of H0 :   0 versus
Ha :  > 0 has at least 80% power when  = 1: Assuming a two-way classifi-
cation of polyps as being polypoid cancer yes/no, where 2%/98% are assumed to
be classified as being polypoid cancer yes/no on both classification instruments (2
observers or OPT and H&E).
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APPENDIX IV 
MRC TECHNOLOGY: STANDARD OPERATING PROCEDURE LAB423 
OPT PROCEDURE FOR DGF POLYPS 
ISSUE NO. 1.8 
 
ORIGINATOR: GWEN CRANSTON 
UPDATES: MARIA COATS 
 
1. Purpose 
Procedure for the receipt, storage and labelling of wax embedded samples from NHS Tayside 
archives 
 
2. References 
None 
 
3. Equipment and Materials 
3.1. Equipment 
Biopsy Bags 
Cassettes 
Shallow metal embedding moulds 
HB Pencil; Label Sheets, L4731REV 
Lab Book 
Hard Drive 
3001 OPT Scanner 
Tissue Processor 
Embedding Station 
Cold Plate 
 
3.2. Materials 
Wax blocks containing polyp samples 
 
4. Safety Precautions and Waste Disposal 
See specific SOPs for laboratory procedures. 
 
Prior to release of blocks to MRCT the batch will be photographed by the digital imager in Ninewells 
Pathology Lab. Images will be saved by Maria Coats. Transfer images to ES3. 
 
Two lab books will be used to record all experimental procedures: 
 
I DGF Sample Processing - for Receipt of Samples, Wax De-embedding, Agarose Embedding, Agarose 
De-Embedding, Wax Embedding  
 
II DGF Data Processing – for Scanning and Reconstruction 
 
 
5. Procedure 
 
5.1. Transport of samples 
Wax blocks will be removed from NHS Tayside archives by a qualified person. The wax 
blocks will be transported between Edinburgh and Dundee by registered mail or in a vehicle 
with business insurance cover.  
The wax blocks will be securely sealed in an appropriate box and  
‘Pathological Specimen’ tape will be attached to the box along with the following information, 
on headed paper,  
Details of the contents e.g. 10x wax embedded human polyp samples. Non-hazardous. In 
addition the following contact details will be placed on the box. 
 
Dr Sarah Wedden  
MRC Technology, Crewe Road South, Edinburgh EH4 2SP, Tel: 0131 311 7010 
OR 
Miss Maria Coats 
 
 
 
Department of Surgery & Molecular Oncology, Level 6, Ninewells Hospital & Medical 
School, Dundee DD1 9SY, Tel: 01382 740101 
 
5.2. Receipt of Samples 
On arrival at MRCT the Pathology ID & Block ID will be entered into Excel spreadsheet: 
ES3\BIOPTONICS\DGF Polyp Project Spreadsheets 
 
The pathology ID is NS followed by the 2 small digits at the end of the block (year of sample) 
followed by the larger 6 digit number. Each sample also has a specimen number (eg: 1,2,3) +/- 
Block ID (eg: A,B,C etc) beneath the NS number. 
 
NS007911oo = NS00007911 
Specimen : 1 
Block : A 
 
An MRCT ID will be used that will remain with each specimen throughout its time at MRCT. 
This is comprised of the five digit number (bold), specimen number and Block ID if applicable 
(i.e.: 079111A) If there is no block ID for a particular specimen then this will be omitted. 
 
Each time the spreadsheet has a new batch of specimens added it will be saved with new date. 
The old version will then be moved into the ‘old spreadsheets’ folder. A copy of the first five 
columns (Pathology ID, Block ID, Arrival Date, MRCT ID and Batch Number) will be printed 
out and attached in the project lab book. The MRCT ID code will be used for all subsequent 
OPT procedures. 
 
Blocks will be stored in labelled boxes, at room temperature in LG17.  
 
All experimental information will be entered into dedicated lab book, which will be signed off 
and countersigned. 
 
5.3. Labels 
Labels will be printed on L4731REV, which are stored in the stationery cupboard. 
Template \\Es3\bioptonics\DGF Polyp project\Labels.doc 
 
7 labels are required for each sample:  
Label 1 – tube containing sample post wax de-embed 
Label 2-  tube containing fragments not to be OPT scanned 
Label 3 – embedding petri dish 
Label 4 – 60ml bottle containing embedded sample 
Label 5 – de-embed tube 
Labels 6 & 7 - spares 
 
Labels will be sealed with Scotch ‘Magic’ tape when attached to bottles/tubes to protect the ink 
from solvents. 
 
5.4. Wax Section Pre-OPT 
In the first instance, quality control will be assured by comparing digital images taken when 
the specimens leave and arrive back at Dundee. Any concerns and a wax section will be cut 
and H&E stained in Dundee. 
 
5.5. De-Waxing 
See SOP LAB422 (Section 6, Automated Procedure).  
A maximum of 10 samples will be de-waxed at any one time.  
 
Samples will be transferred into a labelled tube, bijous or universal depending on sample size. 
Some blocks will contain more than one piece of tissue. 
 
If samples are to be agarose embedded within 72 hours store in cold room in PBS. 
If samples are to be stored beyond 72 hours they will be stored in Neutral Buffered Formalin.  
 
 
 
 
In some cases not all of the fragments will be selected for OPT, in these cases a second tube 
will have to be labelled.  
Tube 1 for OPT in PBS 
Tube 2 for storage in NBF – marked with a cross on the lid and returned to the cold room for 
storage. 
 
If 2 bits of tissue from the same block are to be OPT scanned, the MRCT ID will be amended 
manually on the labels. An underscore followed by the number _1 or _2 will be added to the 
end of the 7 digit number e.g. 079111A_1. 
 
5.6. Agarose Embedding 
Samples stored in Neutral Buffered Formalin will be washed 2 x 30 minutes in PBS. 
 
See SOP LAB 370v1.4 for procedure. 
A maximum of 8 samples will be embedded at any one time.  
Attach ID labels to the petri dishes and 60ml bottles. 
If a block contains more than 1 specimen that may require scanning they will be identified as 
XXXXXXX_1 and XXXXXXX_2 etc. The MRCT ID will be amended manually and re-taped.  
Arrange in rows front to back: Tube containing sample, petri dish, mount, and 60ml bottle.  
 
 
 
 
 
Before proceeding with the embedding, all the tubes, bottles and labels should be checked and 
signed off by second person. The agarose used for embedding will be standard (1%) and for 
large samples this should be increased to (1.3%). 
 
During the agarose trimming procedure, the tube and petri dish should remain in the row until 
the mounted sample has been sealed in the bottle. 
 
The storage tube will be kept and used for storage of the sample following agarose de-
embedding (5.12 – see below). 
 
 
 
 
5.7. OPT Scanning 
Samples will be scanned using the 3001 OPT Scanner with appropriate filter(s). See chapter 6 
in 3001 OPT Scanner Manual for procedure. 
 
Scans will be carried out at High Resolution, with a rotation step of 0.45 degrees. The largest 
possible zoom will be selected so that the whole sample is in the field of view. 
 
The scan files will be saved on Edmrct02\C\DGF Polyps\MRCT ID 
The MRCT ID will be entered as the filename prefix with an underscore at the end.  
 
The file path does not need an underscore. If for any reason a scan is to be done at standard 
resolution then for identification purposes it will have an additional ‘S’ at the end of the MRCT 
ID when it is saved only. 
 
Before proceeding with the scan, the file path and filename prefix should be checked and 
signed off by second person. 
 
For any subsequent scans of the same sample the letter _B, _C, _D etc will be added to the end 
of the MRCT ID. 
 
Scan data will be checked for vertical and lateral movement using Dataviewer before removal 
of sample from the scanner. See chapter 9 in the OPT Scanner Manual for procedure. 
 
If a sample has been difficult to align, check one channel in NRecon to find out the post 
alignment value. Re-scan if this could be improved.  
 
If the scan has to be repeated the first scan data should not be kept, the folders will be 
overwritten if the folder name is not altered.   
 
Only one mount/sample will be removed from a bottle at any one time. Samples will be 
returned to their bottle immediately on removal from the scanner and before the next sample is 
prepared for scanning. 
 
If a block(s) need to be re-glued, only one should be removed from the bottle at a time. 
 
On completion of the scan the data will be copied from Edmrct02 to Edmrct00335. The current 
spreadsheet in: 
\\Es3\bioptonics\DGF Polyp project\Spreadsheets will be updated with the scan date, transfer 
date. 
 
5.8. Reconstruction 
Reconstructions will be carried out on Edmrct0035,  
 
See chapter 8 in 3001 OPT Scanner Manual for procedure. 
Record post-alignment value in lab book 
Reconstruction files will be saved into the parent scan folder and will be named recon_gfp1, 
recon_gfp+ etc. If more than one reconstruction is performed it will be saved as recon_gfp1, 
recon2_gfp1, recon3_gfp1 etc. 
 
The reconstruction set up date will be entered into the spreadsheet. 
When completed enter Y into Recon complete column. 
When reconstruction has been reviewed enter date into spreadsheet. 
 
5.9. Dataviewer 
Reconstructed data will be checked for quality by MRCT staff using Dataviewer. A decision 
will be made as to whether the sample requires re-scanning or the reconstruction needs to be 
repeated.  See chapter 9 in the OPT Scanner Manual for Dataviewer procedure. 
 
5.10. Data Transfer and Back Up 
As soon as possible after the review has been approved, transfer specimen folder containing the 
scan & recon folders to a Hard Drive & Ednas3\biodata\DGFPolyp project\Scans and Recons.  
 
 
 
Update the spreadsheet. 
 
Delete scan folder from Edmrct0002 and update the spreadsheet. When Ednas3 has been 
backed up, delete Folders from Edmrct00335 Update the spreadsheet.  
 
5.11. Sample storage 
Following scanning, samples will be stored in BABB at room temperature until a decision has 
been made as to whether they will have to be re-scanned or de-embedded. This will be 
following review of reconstructed data. This time will be kept to absolute minimum,, (in our 
experience long term storage in BABB has no detrimental effect on the tissue). 
  
5.12. Agarose De- Embedding of Samples 
See SOP LAB 413 for procedure. 
 
A maximum of 16 samples will be processed at any one time.  
Tubes will be labelled and placed in rack, and the 60ml bottles containing the agarose plugs 
will be lined up in front of the appropriate tube.  
 
 
 
The agarose plug will be removed from the mount and placed into labelled tube containing 
100% methanol. The tube lid should be replaced before the next sample bottle is opened. This 
process will be checked and signed off by second person. 
 
When pouring off solutions, the tube should be immediately re-filled and lid replaced before 
the next tube is opened. 
 
5.13. Post OPT Storage 
Samples will be transferred into original storage tubes from 5.5  containing: 
PBS, if wax embedding is to proceed within 72 hours or Neutral Buffered Formalin if wax 
embedding is to proceed >72 hours. 
Tubes will be stored in the cold room until they are wax embedded. 
 
5.14. Wax Embedding 
See SOP310 v1.3 for details. The program to be used is POLYP.  
Delay the start in PBS.  
 
Solution Time hours P/V Temp °C 
PBS 0.5   
20% Alcohol 0.5   
50% Alcohol 0.5   
70% Alcohol 1.0   
100% Alcohol 0.5   
100% Alcohol 0.5   
100% Alcohol 1.5   
Xylene 0.5   
Xylene 0.5   
 
 
 
Xylene 1.5   
Wax 0.5 Yes 62 
Wax 0.5 Yes 62 
Wax 1.5 Yes 62 
 
Enter finish time as appropriate for the next day. 
 
Remember to switch on the embedding station as required. 
 
When the program is finished, remove wire basket into a plastic tray. Transfer cassettes into 
heated compartment of the embedding station 
Open up photographs, if available, on the LG17 PC. Using the photos as a reference, embed 
the tissue into a pre-filled shallow wax mould in the same orientation as in the photo. Place the 
mould on the small clod plate and press the tissue to the base so that the flat cut surface of the 
tissue is flat against the bottom of the mould. 
 
Remember to re-embed any part of the polyp which has been stored  and not processed for 
scanning 
 
Place the original, labelled, cassette into the wax and then place the original label into the wax. 
Top up with wax if necessary. 
Transfer to the cold plate to set. 
When set, score around the edge of the cassette and remove the block or bang firmly on the 
bench face down to release. 
Store block in original box, as detailed on the spreadsheet.  
Return metal moulds to the embedding station for  cleaning.  
 
5.15. Wax Section Post OPT 
Some of the initial samples processed will be returned to Dundee to be sectioned and H&E 
stained. These slides will be compared to the original H&E’s to ensure the tissue is undamaged 
by the OPT procedure. 
 
  
APPENDIX V 
MRC TECHNOLOGY: STANDARD OPERATING PROCEDURE LAB422 
DE-EMBEDDING WAX BLOCKS: MANUAL & AUTOMATED PROCEDURE 
ISSUE NO. 1.3 
 
ORIGINATOR: JOANNE FARRELL 
UPDATES: GWEN CRANSTON 
 
1. Purpose 
The de-embedding of paraffin wax embedded tissue blocks 
 
2. References 
None 
 
3. Equipment and Materials 
 
3.1. Equipment 
Leica wax embedding station 
Leica ASP 300S Tissue Processor 
Tissue Tek cassettes 
Wire baskets and hooks 
Metal embedding moulds 
Glass troughs with lids 
Labels 
50ml tubes 
Single-edged blades 
HB pencil 
Biopsy Bags 
 
3.2. Materials 
Xylene 
Ethanol 
PBS 
10% NBF (if long-term storage required after de-embedding) 
 
4. Safety Precautions and Waste Disposal 
Purple nitrile gloves, lab coat and safety glasses should be worn at all times. 
 
Xylene is toxic and flammable and should be used in fume hood only. In the case of a spillage the 
area should be well ventilated. If spillage is of a large volume open windows and evacuate area. 
Close lab doors and allow to evaporate, or absorb with chemical binder, seal in orange bag and 
arrange disposal with William Tracey (see SOP LAB101). Small amounts can be absorbed with 
tissues & left in fume hood to evaporate. 
 
Waste xylene should be disposed of into the metal drum in flammable cupboard in LG17. 
Ethanol is disposed of down fume hood sink with running water. Ethanol and xylene are flammable; 
use of naked flames is prohibited in LG17.  
 
Take care when handling tissue cassettes in and out of the embedding station as it is hot & may 
cause burns. Care should be taken when using single-edged blades. 
 
5. Manual Procedure 
 
5.1. Removing Excess Wax 
Using a single-edged blade, remove as much wax from the block as possible, taking care not to 
damage the tissue. The remainder should not be cut away from the plastic cassette so as to preserve 
the identity number. 
 
Place the remainder of the wax block and the plastic cassette into a metal embedding mould and 
place in the embedding station to melt the remainder of the wax. Each mould should be pre-labelled 
(label + HB pencil) with the same code as the plastic cassette, so as to prevent any mix-ups should 
 
 
 
the plastic cassettes get disturbed. The amount of time needed to melt the excess wax will depend on 
the amount remaining and the size of the block, and should be monitored, but allow up to 30 
minutes. 
 
5.2. Xylene 
Once the excess wax has melted, the tissue should be carefully returned to its original cassette (thus 
retaining the code) using forceps, and secured with a new lid. Pass cassettes through a series of three 
Xylene washes, 40 minutes in each, in glass troughs in the fume hood, shaking gently on rocker. 
 
5.3. Ethanol 
Transfer cassettes to a glass trough containing 100% ethanol and wash for 30 minutes, shaking 
gently on rocker. Wash a further twice in 100% ethanol, for 60 minutes at a time, again on rocker.  
 
5.4. Rehydrate 
Continue rehydrating through a series of ethanols, 90, 70, 50, 30 and 10%, 60 minutes in each, 
shaking gently on rocker. Specimens can then be transferred to pre-labelled tubes and washed in 
sterile PBS, 2 x 30 minutes, on roller. 
 
5.5. Post-rehydration 
Specimens can be stored for up to 72 hours at 4°C in sterile PBS. Alternatively, store specimens in 
10% NBF at 4°C if not being further processed within 72 hours. 
Original cassette can be kept for re-embedding at a later stage if required. 
 
 
6. Automated Procedure 
 
6.1. Specimen Transfer 
 
Using a single-edged blade, remove as much wax from the block as possible, taking care not to 
damage the tissue. The remainder should not be cut away from the plastic cassette so as to preserve 
the identity number. 
 
Place the remainder of the wax block and the plastic cassette into a metal embedding mould and 
place in the left hand, dry compartment of the embedding station to melt the remainder of the wax. 
 
The amount of time needed to melt the excess wax will depend on the amount remaining and the 
size of the block, it should be monitored, but allow up to 30 minutes. 
 
If required remove the printed label with a blunt instrument from the top of the cassette. 
 
Carefully transfer the sample(s) back into the original cassette and seal with a new lid. 
If there are very small pieces of sample it may be necessary to put them in a biopsy bag before 
placing in the cassette.  
 
Place the cassette into the tissue processor basket.  
 
Store the paper label in a mega cassette. The mega cassette will also be use to store the sample 
cassette after processing through the tissue processor.  
 
6.2. Tissue Processor De-Waxing 
 
Programme Name: De-Wax 3 
 
Container Fluid Time minutes 
1 Xylene 60’ 
2 Xylene 60’ 
3 Xylene 60’ 
4 100% Alcohol 30’ 
5 100% Alcohol 30’ 
6 100% Alcohol 30’ 
7 70% Alcohol 30’ 
 
 
 
8 50% Alcohol 30’ 
9 20% Alcohol 30’ 
10 PBS 30’ 
 
Delay the finish in PBS 
 
If the last programme to be run through the processor ended in  water, programme then an ethanol 
wash cycle must be run prior to the De-wax 3.  
 
To do this, remove the washing ethanol container and place it in position 4 (100% ethanol).  Leave 
the 100% ethanol in front of the processor.  
Run the ethanol wash programme.  
When completed return ethanol bottles to the correct position. 
 
6.3. PBS Washes and Post De-Waxing 
Transfer cassettes into a tray/box of PBS to prevent drying out of the sample. Remove specimen 
from cassette, and transfer to pre-labelled tubes containing PBS. 
Tube and cassette numbers will be signed and countersigned in the lab book. 
 
Place on roller for 30 minutes. 
Change PBS, incubate for a further 30 minutes. 
 
Specimens can be stored for up to 72 hours at 4°C in PBS.  
 
Alternatively, store specimens in 10% NBF at 4°C if not being further processed within 72 hours. 
 
Store the original cassette in mega cassette with the corresponding label. 
 
  
APPENDIX VI 
MRC TECHNOLOGY: STANDARD OPERATING PROCEDURE LAB370 
EMBEDDING OF SAMPLES FOR OPT 
ISSUE NO. 1.4 
 
ORIGINATOR: LISA DUFFY 
UPDATES: GWEN CRANSTON 
 
1. Purpose 
Embedding samples in agarose, for OPT Scanning. 
 
2. References 
James Sharpe’s method at HGU. 
 
3. Equipment and Materials 
 
3.1. Equipment 
Pastettes 
Curved forceps 
Metal spatula 
Metal mounts 
Large petri dishes 
Small, deep petri dishes 
Glass petri dishes 
60ml screw-top glass bottles 
Single-edged blade 
Microtome blade 
MicrowaveHot;Hand 
Whatman 113V wet-strengthened filter paper (Cat. No. 1213-185) 
Filter funnel 
Glass tools 
Cold plate 
Line Template 
Waterbath 
 
3.2. Materials 
Tissue Sample 
1% Low Melting Point Agarose in H2O (Invitrogen 155170-019) 
Methanol 
PBS 
Superglue 
BABB. (Benzyl Benzoate: Benzyl Alcohol 2:1) 
Ethanols: 30-70% (if required for storage). 
 
 
 
4. Safety Precautions and Waste Disposal 
Safety glasses must be worn at all times when ‘wet work’ is being carried out. 
Take care when handling hot agarose as can cause scalds/burns. Use Hot Hand. 
Loosen lid on Duran bottle when microwaving agarose. 
Nitrile gloves should be worn when working with BABB and methanol. 
Methanol is highly flammable and toxic. Keep away from naked flames. Dispose of down sink with 
plenty of water.  
Waste BABB should be stored in designated Winchester, for commercial disposal by William 
Tracey (see SOP EQP 101).  
Spillage should be wiped up immediately with paper towels, BABB contaminated items should be 
left to evaporate off in fumehood before disposing in orange bags Residues can be cleaned using 
Decon or ethanol. Caution should be taken when using BABB, as it can melt some plastics, e.g. 
pipettes. 
Take care when handling blades. Dispose of in Sharpsafe. 
 
 
 
 
5. Procedure 
 
5.1. Specimen Preparation 
Specimens are usually stored in 4% PFA or Formalin. This must be removed before embedding: 
wash sample in PBS, 3 x 5 minutes, on roller. 
Specimen stored in methanol/ethanol should be rehydrated to PBS prior to embedding.  
 
5.2. Embedding 
Make up LMP agarose in water, 1% is standard. Agarose concentration can be increased for large 
specimens. 
 
Melt the agarose in the microwave (power 3 for 3-4 min, depending on volume) swirling gently to 
ensure it has completely dissolved. Allow to cool until hand-hot and filter through Whatman filter 
paper into a new bottle.  
 
Place in 33oC water bath. When at temperature, fill a small, deep Petri dish with the agarose, 
(~40mls) and place on the cold plate.  
 
Small specimens e.g. E10 mouse embryos, can be embedded side by side. Larger specimens should 
be embedded one per dish.  
 
Transfer the specimen to the agarose with as little excess PBS as possible.  
Larger specimens can be washed in molten agarose prior to placing in the embedding dish; this will 
reduce the transfer of excess PBS.  
 
Orientate the specimen as required, using the glass tools /forceps. When the agarose is just above 
setting point (roughly 28oC) move the specimen so that it is suspended in the middle of the agarose, 
parallel to the base.  
 
Use the line around the middle of petri dish as a guide to the mid point. 
 
 
Allow the agarose to set on the cold plate 10-15 min. transfer to the cold room for 15 min + to 
ensure agarose is cold and will not stick to the base of the petri dish. 
 
5.3. Trimming & Mounting Agarose Plugs 
Use a single-edged blade to trim plug. Insert blade, do not remove blade, and then remove agarose 
between blade & edge of petri dish. Continue until specimen is embedded in a rectangular block of 
agarose (as large as possible).  
 
Turn plate over and tap or prise block out of petri dish into palm of hand. Place block on large petri 
dish lid and place lid on top of line template, alternatively plastic guillotine can be used.  
 
Using a microtome blade with one end taped roughly trim block ideally keeping as much agarose 
around specimen as possible; when attached to mount there should be excess agarose hanging over 
edge. 
 
     
      CUT 
 
 
 
 
 
 
 
Orientate the specimen so that long axis, e.g. head to tail, is directly above vertical line. Check this 
on more than one face of block. 
When cutting the face that will be attached to the mount, ensure that there is at least 5mm between 
specimen and end of block. 
Place one end of the specimen on or below red line.  
 
Trim top edge of block along a horizontal black line: it is important that this cut is completely 
straight as this is the edge which will be glued to the mount.  
The distance between a red & black line is 5mm. 
Trim off excess agarose from opposite edge to face being glued, leaving a small amount of agarose 
~3mm. If cut too close to specimen the edge may be seen in scan. 
Dry the face to be glued briefly on a non-embossed tissue. Do not allow any other face to touch 
tissue as debris will affect OPT image. 
Wipe mount with methanol to remove any grease and apply superglue onto the ridged surface of the 
mount. Caution: Excess glue will run down side of mount, apply appropriate amount. 
 
Place agarose plug onto mount with specimen as central as possible. Press gently for 15 seconds. 
Leave at least 10-15 minutes to set. 
Use a microtome blade to trim agarose from four straight faces of block. Start cut close to top of 
sample and angle cut so that it is in line with edge of mount. 
Then cut off the four corners at an angle as before. You should now have eight angled sides, 
forming an octagon shape at the top of the plug.  
If any of the faces meet in a right angle trim the right angle away.  
During trimming process, regularly check blade for glue. Always trim using a clean, glue-free blade. 
 
              
      Specimen on mount          View from above 
 
5.4. Dehydration of Agarose Plugs 
Using forceps, place mount into a labelled 60ml screw top glass bottle and fill with methanol. 
The aspirator pump with Pasteur pipette attached can be used to remove methanol.  
Change methanol at least three times with an overnight incubation at room temperature.  
The day before scanning is planned, replace the methanol with BABB.  
Incubate in light tight box, if fluorescently labelled or stained.  
The bottles should be placed in the fume hood at room temperature with the lids off, to allow the 
methanol to evaporate off. 
The length of time in BABB is dependant on the size of the agarose plug. Large samples will require 
at least 16 hours and results may well improve after 24hours + in BABB.  
Sample and agarose should be completely transparent before OPT scanning. 
  
APPENDIX VII 
MRC TECHNOLOGY: STANDARD OPERATING PROCEDURE LAB413 
DE-EMBEDDING OF BIOLOGICAL SPECIMENS POST OPT 
ISSUE NO. 1.0 
 
ORIGINATOR: JOANNE FARRELL 
 
1. Purpose 
De-embedding of biological specimens from agarose, after OPT scanning. 
  
2. References 
None 
    
3. Equipment and Materials 
 
3.1. Equipment 
Shaking incubator 
Vibromax 
Glass petri dishes 
50ml Falcon tubes 
20ml screw-top glass bottles 
Fine forceps or needle 
Hot Hand 
Kimberly Clark “Safeskin” nitrile gloves 
Safety glasses 
Printed labels 
Scotch ‘Magic’tape. 
  
3.2. Materials 
Agarose plugs 
Methanol 
0.29M sucrose (autoclaved or made fresh for immediate use) 
4% PFA (if required for storage) 
Ethanols: 10-70% 
PBS 
  
4. Safety Precautions and Waste Disposal 
Safety glasses and nitrile gloves should be worn. 
Take care when handling hot sucrose as can cause scalds/burns. Use Hot Hand.  
 
Methanol is highly flammable and toxic. Keep away from naked flames. Dispose of down sink with 
plenty of water. Ethanol is highly flammable. Keep away from naked flames. Dispose of down sink 
with plenty of water. 
 
4% PFA is harmful. Wear nitrile gloves and dispense in fume hood. Dispose of in designated 
Winchester. 
Waste BABB should be stored in designated Winchester, until commercial disposal by Lanstar (see 
SOP EQP 101). Spillage should be wiped up immediately with paper towels, and BABB allowed to 
evaporate off in fumehood before being placed in orange bags for disposal. Residues can be cleaned 
using Decon. Caution should be taken when using BABB, as it can melt some plastics, e.g. pipettes, 
universal tubes. 
 
Take care when handling needles as they are very sharp. Dispose of in Sharpsafe. 
 
5. Procedure 
 
5.1. Removing BABB 
Cut agarose plug from metal mount if not already detached, and transfer to a 50ml Falcon tube with 
a printed label attached. 
Cover label with Scotch ‘Magic’ Tape to ensure code is not washed off. 
Completely remove BABB by washing in 100% methanol, shaking gently at room temperature.  
 
 
 
Many changes of methanol will be required; continue washes until  pour-off is clear in 
water, followed by a final methanol wash. 
 
5.2. Rehydrate Agarose 
Transfer agarose plug to: 
 
→ 70% ethanol, 60’ shaking gently at RT. 
→ 50% ethanol  ↓ 
→ 30% ethanol  ↓ 
→ 10% ethanol  ↓ 
 
If specimen is floating after 60 minutes, replace ethanol and wait until   it sinks. 
The time required for this will be dependant on size of agarose plug. 
 
5.3. 0.29M Sucrose 
Replace 10% ethanol with 0.29M sucrose in H2O, and transfer to 20ml screw-top glass bottles. 
Incubate for 60 minutes at RT, shaking gently on vibromax. 
 
Replace RT 0.29M sucrose with that heated to 57°C and incubate for 30-60 minutes at 57°C in 
shaking incubator. 
 
Gently shake to see if agarose has melted/fallen away from specimen. You may have to incubate for 
longer (time is dependant on plug size), or increase temperature to 60°C for a brief period. 
If the agarose has not yet melted/fallen away, pour sucrose and agarose plug into a petri dish. Use 
fine forceps or a needle to carefully pull away agarose from specimen. Check under microscope if 
necessary. 
 
When agarose has been removed from specimen, wash a further twice in fresh 57°C 0.29M sucrose. 
Transfer to PBS to wash off sucrose. 
 
5.4. Long-term Storage 
If long-term storage is required, place in 4% PFA and store at 4°C.  PBS is not suitable for 
long-term storage. Alternatively, dehydrate and store in 100% ethanol at -20°C. 
  
APPENDIX VIII 
MRC TECHNOLOGY: STANDARD OPERATING PROCEDURE LAB310 
PROCESSING OF SAMPLES IN TP1050 TISSUE PROCESSOR 
ISSUE NO. 1.4 
 
ORIGINATOR: GWEN CRANSTON 
UPDATES: JOANNE FARRELL 
 
1. Purpose  
Processing samples using the ASP300S Tissue Processor. 
  
2. References 
Leica ASP300S Tissue Processor Operating Manual. 
 
3. Equipment and Materials 
 
3.1. Equipment 
ASP 300S Tissue Processor 
Tissue embedding station 
Tissue Tek cassettes 
Wire basket 
Wire hook 
White tray 
 
4. Safety Precautions and Waste Disposal 
Purple nitrile gloves, lab coat and safety glasses should be worn at all times. 
 
Tissue Processor contains Xylene which is toxic and flammable. There should be no contact with 
Xylene during processing but in case of spillages area should be well ventilated. If spillage is of a 
large volume open windows and evacuate area. Close lab doors and allow to evaporate, or absorb 
with chemical binder, seal in orange bag and arrange disposal with William Tracey (see SOP 
LAB101). Small amounts can be absorbed with tissues & left in fume hood to evaporate. 
 
Waste Xylene should be disposed of into metal drum in flammable cupboard in LG17. Take care 
when removing basket from molten wax, it is hot and may cause burns. Ethanol is disposed of down 
fume hood sink with running water. Ethanol and Xylene are flammable; use of naked flames is 
prohibited in LG17.  
 
5. Procedure 
 
5.1. Machine Set Up 
Check that bottles containing solvents are the correct ones (methanol is occasionally used in 
processor in position 1 and 10). Also check volumes in bottles are between the maximum and 
minimum levels indicated. 
  
Place specimen into a Tissue Tek cassette and close the lid. Very small specimens (e.g. 9.5 day 
embryos) should first be placed between two pieces of foam and wrapped in biopsy paper, or placed 
in a Leica biopsy cage. For reference, up to three 12.5 day embryos can be processed in one cassette. 
  
Place up to 10 cassettes into metal basket; if more than 10 are being processed use dividers (see 
manual for detailed instructions). Place lid onto basket. 
Ensure grey/dull stripe on the end of the metal basket is wax free. 
Close lid and lock, you will hear it click. 
  
5.2. Running a Program 
Refer to APS300S Operating manual for full instructions. 
 
Press screen to activate. 
  
Select required program from Favourites menu displayed on the first screen, the program will 
immediately start.  
 
 
Enter the number of blocks. Select the solution to be delayed, if required 
  
After the program has been started the finish time and other parameters can be altered if required.   
  
 or  
  
Select All Programs and then press the symbol corresponding to the program you require. 
  
Press Edit if any changes are required. 
Press Finish Time, select the day you want to finish and enter the time (24 hour clock).  
  
Select Run Options and enable/disable as required.  
  
5.3. Removing Samples from Machine 
When program is finished remove the basket containing cassettes using wire hook and place in 
white tray (to catch molten wax). Transfer cassettes into the left hand tray in tissue embedding 
station. 
  
5.4. Machine Clean Up 
Return wire basket to retort. Solidified wax can be removed by putting it through a cleaning cycle: 
  
Run a clean program. 
  
When program is finished, unlock retort and wipe up any remaining liquid, ensuring there is no wax 
remaining on lid or around seal. 
  
5.5. Solution Management 
PBS, 20% Ethanol and cleaning water have a 28 day alarm set in the reagent management system. 
Change and uptdate the system when prompted.  
 
DO NOT SWITCH OFF POWER TO TISSUE PROCESSOR. 
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OPTColorectalPolypsDiagnosisSheet
HistopathologyDiagnosis:
Tickonlyone
LowGrade F
HighGrade F
Carcinoma F
ClearMargins:
 
YesF NoF CS:.....
istopathology iagnosis:
Tickonlyone
Lo  rade
igh rade
Carcino a
Clear argins: Yes o CS:.....
MorphologyDiagnosis:
AccordingtotheWHOClassificationofTumours:
TubularAdenoma F
TubulovillousAdenoma F CS:....... ToolUsed:........
VillousAdenoma F
%Villousness:..............(nearest10%)
 
Toolused:.......
AccordingtothePitPatternClassification:
F TypeI:Roundpit
F TypeII:StellarorAsteroidpit
F TypeIIIS:Smallroundortubularpit(smallerthanI)
F TypeIIIL:Largeroundortubularpit(largerthanI)
F TypeIV:Dendritic orgyrusͲlikepit
F TypeV:AmorphousornonͲstructuredpit
orphology iagnosis:
Accordingtothe ClassificationofTu ours:
Tubular deno a
Tubulovillous deno a CS:....... Tool sed:........
illous deno a
 illousness:..............(nearest10 )
 
Toolused:.......
AccordingtothePitPatternClassification:
TypeI: oundpit
TypeII:Stellaror steroidpit
TypeIIIS:S allroundortubularpit(s allerthanI)
TypeIIIL:Largeroundortubularpit(largerthanI)
TypeI : endritic orgyrusͲlikepit
Type : orphousornonͲstructuredpit
Polypoid
 
Cancer:
DepthofInvasion:
X:.......
Y:.......
Z:.......
LVI:
 
YesF NoF CS:........
Polypoid
 
Cancer:
epthofInvasion:
X:.......
Y:.......
Z:.......
L I: Yes o CS:........
ConfidenceScore(CS)ofdecision:
1– VeryUncertain
2– Somedoubt
3– Equivocal
4–
 
Reasonablysure
5– Verycertain
Toolusedtomakediagnosis:
DV–
 
DataViewer
 
(2D)
QT–
 
Quicktime
 
movies(3D)
B– Bothusedequally
I II IIIS
IIIL IV V
OPTSpecimenNumber:.......................
REFERENCETOOLS:
AnatomicalFeatures:
Tickallthatyoucansee
MuscularisMucosae F CS:...... ToolUsed:......
Stalk F CS:...... ToolUsed:......
Vessels F CS:...... ToolUsed:......
EPD F CS:...... ToolUsed:......
Ulceration F CS:...... ToolUsed:......
Serrated F CS:...... ToolUsed:......
nato icalFeatures:
Tickallthatyoucansee
uscularis ucosae CS:...... Tool sed:......
Stalk CS:...... Tool sed:......
essels CS:...... Tool sed:......
EP  CS:...... Tool sed:......
lceration CS:...... Tool sed:......
Serrated CS:...... Tool sed:......
TimeSpent:
Tickthemostapplicable
0Ͳ
 
10minsF 10Ͳ20minsF 20Ͳ30minsF 30Ͳ40minsF 40Ͳ50minsF 50Ͳ60minsF >60minsF
Ti eSpent:
Tickthe ostapplicable
0Ͳ 10 ins 10Ͳ20 ins 20Ͳ30 ins 30Ͳ40 ins 40Ͳ50 ins 50Ͳ60 ins >60 ins
ToolUsed:......
CS:.....
ToolUsed:......
CS:.....
Master Copy
DateDiagnosisMade:
..........................
Onlycompleteifapplicable
Haveyoucomebacktochange
 
yourdiagnosis?
 
DateDiagnosisChanged
..........................
ate iagnosis ade:
..........................
nlyco pleteifapplicable
aveyouco ebacktochange
 
yourdiagnosis?
ate iagnosisChanged
..........................
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AUTOMATIC ANALYSIS OF DYSPLASIA IN OPTICAL PROJECTION 
TOMOGRAPHY OF COLORECTAL POLYPS 
 
BACKGROUND  
Colorectal Cancer (CRC) is the second most commonly diagnosed cancer in the UK. 
Screening has reduced mortality by up to 21% and detected large numbers of 
adenomas and polypoid cancers. Diagnosis of these lesions shows marked 
interobserver variation using conventional 2D histopathology. High-grade dysplasia 
and villous architecture are histological features of potential clinical utility in pre-
malignant colorectal polyps. Quantifying these features may provide a more robust 
diagnosis of the complicated 3D tissue architecture. 
 
Optical Projection Tomography (OPT) is a novel whole mount in vitro imaging 
technology that produces 3D images of small biological specimens. Subtle changes 
have been noted when unstained human tissue has been scanned possibly reflecting 
the different cellular composition of tissues. OPT images can be viewed using 
volume or surface rendering software or as 2D virtual sections. OPT has the potential 
to transform the difficult diagnosis of a polypoid cancer and allow an automated 
analysis of features such as dysplasia. 
 
PRELIMINARY WORK 
A preliminary study is currently in progress evaluating the use of OPT as a diagnostic 
tool for early CRC and is being carried out by the University of Dundee in association 
with  Medical Research Council Technology (MRCT). A direct comparison of OPT 
images with the corresponding Haematoxylin & Eosin (H&E) stained sections has 
enabled us to learn to recognise and interpret key polyp features (e.g. dysplasia, 
villousness, vasculature, EPD and ulceration). 
 
We have demonstrated, using OPT, that describing polyp morphology discretely as 
tubular, tubulovillous or villous may grossly under-represent the true evaluation of 
villousness. Similarly, dysplasia exists as a continuum from low-grade dysplasia 
(LGD) through high-grade dysplasia (HGD) to established invasive carcinoma (ICA) 
and this spectrum of change is emphasised using OPT. Conventional histopathology 
relies on the qualitative assessment of images by experienced individuals. OPT 
provides complex, intricate digital images and extrapolation of quantitative data 
obtained from the whole specimen may distinguish features such as dysplasia with 
more certainty. 
 
STUDY OBJECTIVE  
To develop new computer algorithms to automatically quantify the histopathological 
diagnosis of dysplasia within colorectal polyps using images obtained through OPT. 
 
PLAN OF WORK  
Our objective will be addressed by a three-phase study over a 9-month period. 
Preliminary work has generated a large source of OPT digital images of colorectal 
polyps. There are more than 1000 polyp datasets (600 LGD, 250 HGD and 150 ICA) 
that will be used to carry out the quantitative analysis in this study. 
 
Phase I – 2D virtual sections of OPT imaged polyps will be annotated in direct 
correspondence with H&E stained sections in order to delineate areas of dysplasia 
and carcinoma (Figure 1). This will be carried out by an individual experienced in 
OPT images and with a good understanding of colorectal polyp histopathology. 
 
 
 
Phase II – Annotated digital 
images will be analysed using 
pattern recognition software, 
developed for this purpose, to 
identify quantifiable features 
that can distinguish the three 
categories of dysplastic change 
(LGD; HGD and ICA). 
 
Phase III – Information gained 
from Phase II will be collated, 
extrapolated and applied to 
serial sections of the same 
polyp generating a 3D analysis.  
 
FUTURE WORK  
This pilot study will produce a validated and automated analysis technique for 
dysplasia in colorectal polyps and enable us to further evaluate the complex growth 
of these malignant pre-cursors. OPT is ideally placed to take advantage of the 
continuing advances in digital pathology and links well to ongoing basic science 
research on the development of CRC in animal models. Future work would initially 
focus on other clinically significant features such as villous morphology and 
vasculature patterns. Quantifying these features will reduce inter-observer variation 
in diagnoses and identify risk factors, which could indicate earlier surveillance is 
necessary. In addition, techniques developed in this study may also be applicable to 
other cancer types. Following this pilot study we plan an application for a full-scale 
inter-disciplinary UKRC grant. 
 
RESEARCH POTENTIAL 
This collaborative study between the School of Computing's Computer Vision & 
Image Processing group (Dr Jianguo Zhang, Prof. Stephen McKenna), the School of 
Medicine, Dentistry and Nursing (Miss Maria Coats) and the Department of 
Pathology, NHS Tayside (Prof. Frank Carey) is focused upon improving the accuracy 
and reliability of diagnosing early CRC. The long-term implications of the results to 
the wider population will be promulgated through changes in the screening 
programme. As a young clinical investigator, Coats (PI) has already attracted 
research funding through the Melville Trust Fellowship Award to advance other fields 
of interest that have emerged relating to pit pattern classification. In addition, both 
national and international collaborations have been set up to develop hardware, 
validate our results and create the crucial link in translational research from bench to 
bedside. 
 
REQUESTED FUNDS 
We request the salary for a full-time post-doctoral researcher for 9 months (£27,730 
at grade 7) with the experience needed to develop and evaluate pattern recognition 
software based on state-of-the-art feature extraction and machine learning 
algorithms. In addition we request £1200 for consumables (a PC, a pen-based tablet 
for image annotation, and a contribution towards group software licenses), and 
£1000 towards the cost of dissemination. The total funds requested are £29,930. 
 
LGD 
HGD 
Figure 1. Example annotation of a Colorectal Adenoma 
